Sentence,class,file
"2005;44(12):1559-63, http://dx.doi.org/10.1093/rheumatology/kei092.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2008;27(11):1403-10, http://dx.doi.org/10.1007/s10067-008- 0934-9.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2009;51(3):371-6, http://dx.doi.org/10.1111/j.1442- 200X.2008.02740.x.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2011;97(8):886-9, http://dx.doi.org/10.1016/j.otsr.2011.05.016.CLINICS 2015;70(1):30-33 Differences between MRSA and MSSA in septic arthritis Helito CP et al.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"Except for eth- Table 1 |Toxicological thresholds selected for calculating the margin of exposure Agent RouteLD50 [mg/kg bw]aAverage animal BMDL10b[mg/kg bw]Human thresholds for sensitivity analysis Heroin Intravenous 21.8 (mouse) 2 - (RN: 561-27-3) 22.5 (rat)Cocaine (RN: 50-36-2) Intravenous 13 (dog) 2 - 16 (mouse)17 (rabbit)20 (rabbit) 17.5 (rat) Tetrahydrocannabinol (THC) (RN: 1972-08-3) Oral 482 (rat) 56 LOEL 50.04 mg/kg bw (psychotropic effects) 55666 (rat) Nicotine (RN: 54-11-5) Oral 17.8 (bird) 3 LOAEL 50.008 mg/kg bw/day (heart rateacceleration) 56,579.2 (dog) 3.34 (mouse) 50 (rat) Alcohol (ethanol) (RN: 64-17-5) Oral 5560 (guinea pig) 531 BMDL1.5 50.4 g/kg bw (liver cirrhosis mortality)213450 (mouse)6300 (rabbit)7060 (rat) Methadone (RN: 76-99-3) Oral 70 (mouse) 8 - 86 (rat) Amphetamine (RN: 300-62-9) Oral 135 (unspecified) 7 - 21 (mouse)30 (rat) Methamphetamine (RN: 537-46-2) Unreported 82 (mouse) 8 -3,4-Methylenedioxymethamphetamine (MDMA) (RN: 42542-10-9)Oral 325 (rat) 32 - Diazepam (RN: 439-14-5) Oral 500 (mammal) 27 - 48 (mouse) 328 (rabbit)249 (rat) aLD50 values were obtained from tabulations in ChemIDplus Advanced (United States National Library of Medicine; http://chem.sis.nlm.nih.gov/che midplus) except for MDMA, for which the value was taken from Shulgin24.",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"Notes on heroin dosage and tolerance (http://www.erowid.org/chemicals/ heroin/heroin_dose1.shtml, (2001), Date of access: 2014/04/13).",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"http://stats.oecd.org/index.aspx?queryid 530127, (2014), Date of access: 2014/04/13.",OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"http://apps.who.int/gho/data/node.main.1250?lang 5en, (2014), Date of access: 2014-04-24).",OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"Methamphetamine dosage (http://www.erowid.org/chemicals/meth/ meth_dose.shtml, (2003), Date of access: 2014/04/23).",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"Methylenedioxymethamphetamine (MDMA, Ecstasy) (http://www.nhtsa.gov/ people/injury/research/job185drugs/methylenedioxymethamphetamine.htm, (2014), Date of access: 2014/04/23).",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
Diazepam (http://www.nhtsa.,Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"European Monitoring Centre for Drugs and Drug Addiction (http://www.emcdda.europa.eu/publications/drug-profiles/ benzodiazepine, (2013), Date of access: 2014/04/24).",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
"European Monitoring Centre for Drugs and Drug Addiction (http://www.emcdda.europa.eu/publications/drug-profiles/cocaine, (2013), Date of access: 2014/06/12).",Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
Participant organisations in ALICE RAP can be seen at http://www.alicerap.eu/about-alice-rap/partner-institutions.html.,Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/19/srep08126.PMC4311234.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/30/srep08152.PMC4311235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8152 | DOI: 10.1038/srep08152 4",Non-OADS,/arxiv_data1/oa_pdf/81/30/srep08152.PMC4311235.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/34/srep08012.PMC4311244.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8012 | DOI: 10.1038/srep08012 8",Non-OADS,/arxiv_data1/oa_pdf/00/34/srep08012.PMC4311244.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/d8/srep08129.PMC4311246.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: All co-authors are present or former Cellectis employees.,Non-OADS,/arxiv_data1/oa_pdf/0a/b6/srep08150.PMC4311247.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8150 | DOI: 10.1038/srep08150 7",Non-OADS,/arxiv_data1/oa_pdf/0a/b6/srep08150.PMC4311247.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/7f/srep08151.PMC4311251.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8151 | DOI: 10.1038/srep08151 8",Non-OADS,/arxiv_data1/oa_pdf/0c/7f/srep08151.PMC4311251.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/91/srep08149.PMC4311253.pdf
Statistical analysis .All of the statistical analyses were conducted using R 3.0.1 (available from URL: http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/24/f2/srep08136.PMC4311255.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/f2/srep08136.PMC4311255.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8136 | DOI: 10.1038/srep08136 9",Non-OADS,/arxiv_data1/oa_pdf/24/f2/srep08136.PMC4311255.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/7f/srep08146.PMC4311257.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8146 | DOI: 10.1038/srep08146 6",Non-OADS,/arxiv_data1/oa_pdf/3f/7f/srep08146.PMC4311257.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/6a/main.PMC4311262.pdf
Direct link to deposited data DNA methylation array: http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE44661 Gene expression array: http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE44660 SNP array: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE44019 .,OADS,/arxiv_data1/oa_pdf/b5/6a/main.PMC4311262.pdf
http://dx.doi.org/10.1016/j.gdata.2014.06.007 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/6a/main.PMC4311262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/6a/main.PMC4311262.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/b5/6a/main.PMC4311262.pdf
"Pathophysiology ofcoronary artery disease leading toacute coronary syndromes John AAmbrose* andManmeet Singh Address: Department ofMedicine, Division ofCardiology, UCSF Fresno Medical Education Program, Fresno, CA,USA *Corresponding author: John AAmbrose (jamambrose@yahoo.com) F1000Prime Reports 2015, 7:08(doi:10.12703/P7-08) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/7/8 Abstract Acute myocardial infarction (AMI) andsudden cardiac death (SCD) areamong themost serious and catastrophic ofacute cardiac disorders, accounting forhundreds ofthousands ofdeaths each year worldwide.",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"Pathophysiological progression of atherosclerosis Diagram showing risk factors and progression of atherosclerosis Page 2 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:08 http://f1000.com/prime/reports/m/7/8",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"Thin-capped fibroatheroma Smooth muscle  migrationMacrophage LDL accumulationmonocyte LDL SMC migrationnecrotic coreLUMEN Zoom Out View Thin Fibrous Cap Inflammatory Cells Asymptomatic Atherosclerotic Plaquefibrous cap ENDOTHELIUM Diagram shows an artery and the formation of an asymptomatic atherosclerotic plaque Page 3 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:08 http://f1000.com/prime/reports/m/7/8",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"Page 4 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:08 http://f1000.com/prime/reports/m/7/8",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"Page 5 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:08 http://f1000.com/prime/reports/m/7/8",Non-OADS,/arxiv_data1/oa_pdf/47/3a/medrep-07-08.PMC4311268.pdf
"Recent advances in the management of resistant hypertension Athanasios J. Manolis1*, Manolis S. Kallistratos1, Michalis Doumas2, Stamatina Pagoni3and Leonidas Poulimenos1 Addresses:1Asklepeion General Hospital, Cardiology department, 1 Vassileos Pavlou Ave Voula, Athens, 16673, Greece;2Hippokration Hospital, Aristotle University, Thessaloniki, Greece;3General Hospital “G Gennimatas ”, Athens, Greece * Corresponding author: Athanasios J. Manolis (ajmanol@otenet.gr) F1000Prime Reports 2015, 7:03 (doi:10.12703/P7-03) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/7/3 Abstract And suddenly, following the preliminary results of renal denervation and carotid baroreceptor stimulation, a big interest in resistant hypertension rose, and all interventionists, many of them with no previous experience with hypertension, fell in love with hyper tension and especially resistant hypertension.",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"Carotid baroreceptor stimulation Carotid baroreceptors play akeyrole inblood pressure regulation and impairment intheir function hasbeen associated with development and maintenance of Page 2of6 (page number notforcitation purposes)F1000Prime Reports 2015, 7:03 http://f1000.com/prime/reports/b/7/3",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"This trial was carried out, even the non-procedural part of Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:03 http://f1000.com/prime/reports/b/7/3",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"Diaz KM, Booth JN, Calhoun DA, Irvin MR, Howard G, Safford MM, Muntner P, Shimbo D: Healthy lifestyle factors and risk of Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:03 http://f1000.com/prime/reports/b/7/3",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"Boden WE, O ’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB John, Weintraub WS: Optimal medical therapy Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:03 http://f1000.com/prime/reports/b/7/3",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:03 http://f1000.com/prime/reports/b/7/3",Non-OADS,/arxiv_data1/oa_pdf/01/c3/medrep-07-03.PMC4311269.pdf
"Neural crest migration: trailblazing ahead Paul M.Kulesa1,2*andRebecca McLennan1 Addresses:1Stowers Institute forMedical Research, 1000 E.50thSt,Kansas City, MO 64110, USA;2Department ofAnatomy andCell Biology, University ofKansas School ofMedicine, Kansas City, KS,66160, USA *Corresponding author: Paul M.Kulesa (pmk@stowers.org) F1000Prime Reports 2015, 7:02(doi:10.12703/P7-02) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/7/2 Abstract Embryonic cellmigration patterns areamazingly complex inthetiming andspatial distribution ofcells throughout thevertebrate landscape.,OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Page 2of7 (page number notforcitation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"These data support the concept that neural crest Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:02 http://f1000.com/prime/reports/b/7/2",Non-OADS,/arxiv_data1/oa_pdf/b5/56/biolrep-07-02.PMC4311270.pdf
"Controversies in pulmonary hypertension due to left heart disease Martino Cheli1and Jean Luc Vachiery2* Addresses:1Department of Internal Medicine, University of Genoa, Via Balbi, 5, 16126 Genova, Italy;2Department of Cardiology, Hôpital Erasme, Université Libre de Bruxelles, Franklin Rooseveltlaan 50, 1050 Brussel, Belgium * Corresponding author: Jean Luc Vachiery (jeanluc.vachiery@erasme.ulb.ac.be) F1000Prime Reports 2015, 7:07 (doi:10.12703/P7-07) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/7 Abstract Left heart failure is currently the most prevalent cause of pulmonary hypertension (PH) worldwide and this is due mainly to the increased left ventricular and pulmonary venous pressures seen in thiscondition.,Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
"Page 2 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:07 http://f1000.com/prime/reports/m/7/7",Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
"Page 3 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:07 http://f1000.com/prime/reports/m/7/7",Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
"Page 4 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:07 http://f1000.com/prime/reports/m/7/7",Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
"Page 5 of 5 (page number not for citation purposes)F1000Prime Reports 2015, 7:07 http://f1000.com/prime/reports/m/7/7",Non-OADS,/arxiv_data1/oa_pdf/00/ac/medrep-07-07.PMC4311271.pdf
"Programming implantable cardioverter/defibrillators and outcomes Fritz W. Horlbeck* and Joerg O. Schwab Address: Department of Medicine - Cardiology, University of Bonn, 53105 Bonn, Germany * Corresponding author: Fritz W. Horlbeck (fritz.horlbeck@ukb.uni-bonn.de) F1000Prime Reports 2015, 7:10 (doi:10.12703/P7-10) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/10 Abstract Implantable cardioverter-defibrillators are complex technical devices with a multitude of programming options for the physician.,Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"(Adapted according to Schwab JO [38]) Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"[4]) Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C: Programming implantable cardioverter-defibrillators in patients with primary Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"Leenhardt A, Defaye P, Mouton E, Delay M, Delarche N, Dupuis J, Bizeau O, Mabo P, Cheggour S, Babuty D: First inappropriate implantable cardioverter defibrillator therapy is often due to Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2015, 7:10 http://f1000.com/prime/reports/m/7/10",Non-OADS,/arxiv_data1/oa_pdf/64/db/biolrep-07-10.PMC4311272.pdf
"Box 5371, Seattle, WA 98105, USA * Corresponding author: Michael W. Schwartz (mschwart@uw.edu) F1000Prime Reports 2015, 7:12 (doi:10.12703/P7-12) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/7/12 Abstract Our current understanding of glucose homeostasis is centered on glucose-induced secretion of insulin from pancreatic islets and insulin action on glucose metabolism in peripheral tissues.,Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Extra-hypothalamic sites such as the dorsal vagal complex of the hindbrain are also implicated in the indirect control Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"In 1952,Henrikson performed the first surgical intervention forthe treatment of obesity, and with subsequent refine-ment bariatric surgery has emerged as a relatively safe and effective therapeutic option for some obese patients Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:12 http://f1000.com/prime/reports/b/7/12",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/biolrep-07-12.PMC4311273.pdf
"Managing anxiety associated with neurodegenerative disorders Brian P. Gomoll* and Anand Kumar Address: Department of Psychiatry, University of Illinois at Chicago, 912 South Wood Street, Chicago, IL, 60612, USA * Corresponding author: Brian P. Gomoll (bpgomoll@gmail.com) F1000Prime Reports 2015, 7:05 (doi:10.12703/P7-05) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/5 Abstract Anxiety is a common symptom among patients with cognitive impairment.,Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:05 http://f1000.com/prime/reports/m/7/5",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Non-pharmacologic approaches Non-pharmacologic approaches to anxiety in the setting of cognitive impairment include cognitive therapies, beha- vioral therapies, cognitive-behavioral therapies, environ-mental approaches, and diet and exercise approaches.Strong studies of these approaches for comorbid anxietyand dementia are lacking; however, cognitive-behavioralapproaches to anxiety in general have a strong evidencebase and therefore seem promising for cognitivelyimpaired patients if their level of functioning is such Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:05 http://f1000.com/prime/reports/m/7/5",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:05 http://f1000.com/prime/reports/m/7/5",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Trinh NH, Hoblyn J, Mohanty S, Yaffe K: Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:05 http://f1000.com/prime/reports/m/7/5",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:05 http://f1000.com/prime/reports/m/7/5",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/medrep-07-05.PMC4311274.pdf
"Eugene D. Shapiro Address: Departments of Pediatrics, Epidemiology of Microbial Diseases and Investigative Medicine, Yale University Schools of Medicine and of Public Health and Graduate School of Arts and Sciences, New Haven, CT, USA Email: Eugene.Shapiro@Yale.edu F1000Prime Reports 2015, 7:11 (doi:10.12703/P7-11) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/bf/medrep-07-11.PMC4311275.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/11 Abstract Whether or not Borrelia burgdorferi can persist after conventional treatment with antimicrobials has been a very controversial issue.,Non-OADS,/arxiv_data1/oa_pdf/3d/bf/medrep-07-11.PMC4311275.pdf
"A positive result of a Page 2 of 3 (page number not for citation purposes)F1000Prime Reports 2015, 7:11 http://f1000.com/prime/reports/m/7/11",Non-OADS,/arxiv_data1/oa_pdf/3d/bf/medrep-07-11.PMC4311275.pdf
"Page 3 of 3 (page number not for citation purposes)F1000Prime Reports 2015, 7:11 http://f1000.com/prime/reports/m/7/11",Non-OADS,/arxiv_data1/oa_pdf/3d/bf/medrep-07-11.PMC4311275.pdf
"Connective tissue disease-associated pulmonary arterial hypertension Robin Condliffe* and Luke S. Howard Addresses: Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield; National Pulmonary Hypertension Service, Hammersmith Hospital, London, United Kingdom * Corresponding author: Robin Condliffe (robin.condliffe@sth.nhs.uk) F1000Prime Reports 2015, 7:06 (doi:10.12703/P7-06) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/6 Abstract Although rare in its idiopathic form, pulmonary arterial hypertension (PAH) is not uncommon in association with various associated medical conditions, most notably connective tissue disease (CTD).",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Reproduced with permission [77] Page 2 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Abbreviaitons: mPAP, mean pulmonary arterial pressure; PAH, pulmonary arterial hypertension; PVR, pulmonary vascular resistance; SSc, systemic sclerosis; WHO FC, World Health Organisation Functional Class Page 3 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Unlike in the original study, the between Page 4 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Abbreviations: IPAH, idiopathic pulmonary arterial hypertension; PAH, pulmonary arterial hypertension; SSc, systemic sclerosis Page 5 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Abbreviations: IPAH, idiopathic pulmonary arterial hypertension; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; NT-proBNP , N-terminal pro-brain natriuretic peptide; SSc, systemic sclerosis Page 6 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Antiphospholipid syndrome is a risk factor Page 7 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Wipff J, Kahan A, Hachulla E, Sibilia J, Cabane J, Meyer O, Mouthon L, Guillevin L, Junien C, Boileau C, Allanore Y: Association between Page 8 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, Muller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR, DETECT study group: Evidence-based detection of Page 9 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, Eisenberg MJ, Joyal D, Hudson M, Boutet K, Serban A, Masetto A, Baron M: High prevalence of occult left heart disease in Page 10 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"Page 11 of 11 (page number not for citation purposes)F1000Prime Reports 2015, 7:06 http://f1000.com/prime/reports/m/7/6",Non-OADS,/arxiv_data1/oa_pdf/fb/58/medrep-07-06.PMC4311276.pdf
"The role of mast cells in cancers Thiago T. Maciel1-5, Ivan C. Moura1-5and Olivier Hermine1-6* Addresses:1INSERM UMR 1163, Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, 24 Boulevard du Montparnasse, 75015, Paris, France;2Paris Descartes –Sorbonne Paris Cité University, Imagine Institute, 24 Boulevard du Montparnasse, 75015, Paris, France;3CNRS ERL 8254, 24 Boulevard du Montparnasse, 75015, Paris, France;4Laboratory of Excellence GR-Ex, 24 Boulevard du Montparnasse, 75015, Paris, France;5Centre de Référence National des Mastocytoses (CEREMAST), 149 rue de Sèvres, 75015, Paris, France;6Service d ’Hématologie clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 149 rue de Sèvres, 75015, Paris, France * Corresponding author: Olivier Hermine (ohermine@gmail.com) F1000Prime Reports 2015, 7:09 (doi:10.12703/P7-09) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/7/9 Abstract Mast cells are immune cells that accumulate in the tumors and their microenvironment during disease progression.,Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:09 http://f1000.com/prime/reports/m/7/9",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"This may open new avenues in expanding the arsenal of Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:09 http://f1000.com/prime/reports/m/7/9",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, Dangi-Garimella S, Wang E, Munshi HG, Khazaie K,Bentrem DJ: Crosstalk between mast cells and pancreatic Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:09 http://f1000.com/prime/reports/m/7/9",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:09 http://f1000.com/prime/reports/m/7/9",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2015, 7:09 http://f1000.com/prime/reports/m/7/9",Non-OADS,/arxiv_data1/oa_pdf/b7/fe/medrep-07-09.PMC4311277.pdf
"* Corresponding author: Laurie A. Boyer (lboyer@mit.edu) F1000Prime Reports 2015, 7:01 (doi:10.12703/P7-01) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/7/1 Abstract The replacement of nucleosomal H2A with the histone variant H2A.Z is critical for regulating DNA- mediated processes across eukaryotes and for early development of multicellular organisms.,Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"In mouse trophoblast cells, H2A.Z appears to be redistributed to Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Overall levels of H2A.Z are lower at enhancers compared with promoters, whereas H3.3 Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Valdés-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ, Stirzaker C, Clark SJ: Acetyla- tion of H2A.Z is a key epigenetic modification associated with Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Mao Z, Pan L, Wang W, Sun J, Shan S, Dong Q, Liang X, Dai L, Ding X, Chen S, Zhang Z, Zhu B, Zhou Z: Anp32e, a higher eukaryotic Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2015, 7:01 http://f1000.com/prime/reports/b/7/1",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/biolrep-07-01.PMC4311278.pdf
"Spinal muscular atrophy: from tissue specificity to therapeutic strategies Daniel M. Iascone1-4, Christopher E. Henderson*1-4and Justin C. Lee1-4 Addresses:1Department of Rehabilitation and Regenerative Medicine;2Pathology and Cell Biology;3Neurology; and4Neuroscience; Center for Motor Neuron Biology and Disease; Columbia Stem Cell Initiative; Columbia Translational Neuroscience Initiative, Columbia UniversityMedical Center, 630 West 168 thStreet, New York, NY 10032, USA * Corresponding author: Christopher E. Henderson (chris.henderson@biogenidec.com) F1000Prime Reports 2015, 7:04 (doi:10.12703/P7-09) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/7/4 Abstract Spinal muscular atrophy (SMA) is the most frequent genetic cause of death in infants and toddlers.,Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"For Page 2 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 3 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 4of14 (page number notforcitation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 5of14 (page number notforcitation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Moreover, the finding that increasing SMN in the Page 6 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 7 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"CMAP and MUNE have been examined inSMA patients, and areknown tocorrelate with age, SMN2 copy number, and motor function [136,137] .Similar tohuman patients, CMAP andMUNE measurements ofthesciatic nerve inSMND7mice exhibit preserved neuromuscular function intheearly postnatal in  Page 8of14 (page number notforcitation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 9 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 10 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 11 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S, Wilton SD, Burghes, Arthur HM: Improved antisense oligonu- cleotide design to suppress aberrant SMN2 gene transcript Page 12 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Zhang Z, Pinto AM, Wan L, Wang W, Berg MG, Oliva I, Singh LN, Dengler C, Wei Z, Dreyfuss G: Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular Page 13 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
"Page 14 of 14 (page number not for citation purposes)F1000Prime Reports 2015, 7:04 http://f1000.com/prime/reports/b/7/4",Non-OADS,/arxiv_data1/oa_pdf/2a/98/biolrep-07-04.PMC4311279.pdf
http://www.anbg.gov.au/cgi-bin/apni?taxon_id=36201.,OADS,/arxiv_data1/oa_pdf/1f/38/RPS-9-193.PMC4311284.pdf
/ RPS 2014; 9(2): 115-122    122 (http://www.btny.purdue.edu/weedscience/2004/arti cles/gianthogweed04.pdf)   9.,Non-OADS,/arxiv_data1/oa_pdf/90/e4/RPS-9-115.PMC4311289.pdf
"10. http://www.mdidea.com, Research Update Dodder  Seed, 2003.",Non-OADS,/arxiv_data1/oa_pdf/90/e4/RPS-9-115.PMC4311289.pdf
"Vidal JP, Kirk-Othmer Encyclopedia of Chemical Technology, Wiley Online Library, 2006, http://dx.doi.org/10.1002/0471238961.22011409051 91615.a01.pub2  12.",Non-OADS,/arxiv_data1/oa_pdf/0e/85/RPS-9-83.PMC4311294.pdf
"But only for a small  number of genes meta-analyses have been carried  out and a list of latest positive results is available at  http://obesitygene.pbrc.edu/  which showed positive  associations of obesity phenotypes with a total of  113 candidate genes, of which only for 18 genes a  minimum of five positive studies had been reported  as often the study groups were small74.",Non-OADS,/arxiv_data1/oa_pdf/3b/e2/IJMR-140-589.PMC4311311.pdf
"Available from:  http://www.censusindia.ne t, accessed  on June 16, 2012.",OADS,/arxiv_data1/oa_pdf/b8/10/IJMR-140-637.PMC4311317.pdf
Available from: http://www.ccdisabilities.nic.in/page.,Non-OADS,/arxiv_data1/oa_pdf/b8/10/IJMR-140-637.PMC4311317.pdf
"Available from: http://www.sristek.com/products_ mindomatics.as p, accessed  on June 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/20/02/IJMR-140-644.PMC4311318.pdf
"Statistical analysis : Sensitivity, specificity, positive  predictive (PPv) and negative predictive values (NPv)  of tests were calculated using online available tool  [http://faculty.vassar.edu/lowry/VassarStats.htm l].",OADS,/arxiv_data1/oa_pdf/1a/a0/IJMR-140-649.PMC4311319.pdf
"Available from: http://www.hpa- standardmethods.org.uk/pdf_sops.as p, accessed on January  1, 2013. verma R, Sood S, Bala M, Mahajan N, Kapil A, Sharma vK, 9. et  al.",OADS,/arxiv_data1/oa_pdf/1a/a0/IJMR-140-649.PMC4311319.pdf
"Available from: http://www.nvbdcp.gov.in/den- cd.htm l, accessed on December 5, 2012.",OADS,/arxiv_data1/oa_pdf/67/44/IJMR-140-660.PMC4311321.pdf
"Available from: http://www.who.int/csr/ resources/publications/dengue/Denguepublication/en /, accessed  on December 2, 2012.",Non-OADS,/arxiv_data1/oa_pdf/67/44/IJMR-140-660.PMC4311321.pdf
Previously published sequences of NDM-1  isolates retrieved from the National Center for  Biotechnology ( http://www.ncbi.nlm.nih.gov ) were used  as the reference sequence.,OADS,/arxiv_data1/oa_pdf/e6/4f/IJMR-140-672.PMC4311323.pdf
"Available from: http://www.cdc.gov/nhsn/ PDFs/pscManual/9pscSSIcurrent.pdf , accessed on November  3, 2014.",OADS,/arxiv_data1/oa_pdf/29/77/IJMR-140-691.PMC4311327.pdf
Available from: http://www.who.int/surgery/publications/ BestPracticeProtocolsCPSafety07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/49/JFMPC-3-295.PMC4311330.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/49/JFMPC-3-295.PMC4311330.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/b7/49/JFMPC-3-295.PMC4311330.pdf
Available from:  http://www.mciindia.org/RulesandRegulations/ GraduateMedicalEducationRegulations1997.aspx [Last cited in 2014 Jun 14].,Non-OADS,/arxiv_data1/oa_pdf/a5/c9/JFMPC-3-300.PMC4311331.pdf
Available  from: http://mospi.nic.in/mospi_new/upload/SAARC_ Development_Goals_%20India_Country_Report_29aug13.,Non-OADS,/arxiv_data1/oa_pdf/a5/c9/JFMPC-3-300.PMC4311331.pdf
Available from: http://www.wpba4gps.co.uk/ fileadmin/user_upload/secure/mindmaps/PDF_files_for_ Competency/Community_Orientation.pdf  [Last cited in  2014 Jul 02].,OADS,/arxiv_data1/oa_pdf/a5/c9/JFMPC-3-300.PMC4311331.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a5/c9/JFMPC-3-300.PMC4311331.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/c9/09/JFMPC-3-305.PMC4311332.pdf
Available from: http://wwwphprimer.afmc.ca/Part  1-TheoryThinkingAboutHealth/Chapter 4BasicConceptsIn  PreventionSurveillanceAndHealthPromotion/ Thestagesofprevention.,Non-OADS,/arxiv_data1/oa_pdf/0c/04/JFMPC-3-309.PMC4311333.pdf
An Pediatr  (Barc)  2014;pii: S1695-403300283-5.Access this article online Quick Response Code: Website:    www.jfmpc.com Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/0c/04/JFMPC-3-309.PMC4311333.pdf
Available  from: http://www.who.int/cardiovascular_diseases/en/ cvd_atlas_14_deathHD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.pib.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.planningcommission.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.currentscience.ac.in/ Volumes/102/04/0557.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.hrln.org/hrln/images/ stories/pdf/HRLN-Using-The-Law-For-Public-Health-Y.%20 Madhavi%20 -%20N.%20Raghuram.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.articles.economictimes.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.indianexpress.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.articles.economictimes.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available  from: http://www.articles.timesofindia.indiatimes.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
"Pharma  Biz, June 29, 2013 Available from: http://www.pharmabiz.",Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.pib.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.rti.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.prsindia.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from:  http://health.india.com/news/whats-needed- is- political-will-dr-devi-shetty/.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from: http://www.apps.who.int/gb/ebwha/pdf_ files/WHA64/A64_R9-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/JFMPC-3-313.PMC4311335.pdf
Available from:  https://catalogue.ic.nhs.uk/publications/primary -care/ general -practice/gp-work-serv/gp-work-serv -rep.pdf [Last  accessed on 14 Feb 2014].,Non-OADS,/arxiv_data1/oa_pdf/4e/e5/JFMPC-3-333.PMC4311338.pdf
Available from: http://www.independent.co.uk/ news/obituaries/vprofessor-joseph-murray-surgeon-who - performed-the-first-successful-kidney-transplant-8360442.,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from:  http://www.srtr.org/annual_reports/archives/2007/2007_ Annual_Report/default.htm.,OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.patient.co.uk/doctor/ quality -and-outcomes- framework-qof-2013 -2014  [Last  accessed on 2013 Oct 01].,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.eguidelines.,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.nhs.uk/Livewell/Screening/ Pages/Checks30to64.aspx [Last accessed on 2013 Oct 01].,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
com Available from: http://www.gponline.com/ Clinical/article/976430/the -basics -smoking -cessation/ [Last accessed on 2013 Oct 01].,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.gpnotebook.co.uk/simplepage.,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.gpnotebook.co.uk/simplepage.,Non-OADS,/arxiv_data1/oa_pdf/72/80/JFMPC-3-345.PMC4311340.pdf
Available from: http://www.who.int/whr/2001/en/whr01_ en.pdf [Last cited on 2012 Nov 21].,OADS,/arxiv_data1/oa_pdf/b9/4b/JFMPC-3-359.PMC4311342.pdf
Available  from: http://www.planningcommission.nic.in/reports/ genrep/rep_uhc0812.pdf pg 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/39/JFMPC-3-362.PMC4311343.pdf
Available from: http://www.who.int/ macrohealth/action/Report%20of%20the%20National%20 Commission.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/39/JFMPC-3-362.PMC4311343.pdf
Available from: http://www.who.int/countryfocus/ cooperation_strategy/ccsbrief_ind_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/39/JFMPC-3-362.PMC4311343.pdf
Available from: http://www.mciindia.org/tools/ announcement/MCI_booklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/39/JFMPC-3-362.PMC4311343.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs253/ en.,Non-OADS,/arxiv_data1/oa_pdf/99/53/JFMPC-3-393.PMC4311349.pdf
Available from:http://www.Path.org/files/TS_  ach _ eff_swm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/53/JFMPC-3-393.PMC4311349.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs311/en/ [Last accessed on 2014 Oct 6].,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/JFMPC-3-400.PMC4311351.pdf
Available at http://www.thehindu.com/todays-paper/ tp-national/tp-andhrapradesh/article1928668.ece [Last  accessed on 2014 Nov 26].,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/JFMPC-3-400.PMC4311351.pdf
Available from: http://www.searo.who.,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/JFMPC-3-400.PMC4311351.pdf
Available from:  http://www.ahrq.gov/professionals/clinicians-providers/ guidelines-recommendations/guide/ [Last accessed on  2014 Oct 7].,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/JFMPC-3-400.PMC4311351.pdf
"World Health Organization Controlling the global obesity  pandemic  (document on the internet) Available from:  http://www.who.int/nutrition/topics/obesity/en/[Last  accessed on 2014, Jul 17].",Non-OADS,/arxiv_data1/oa_pdf/c4/e8/JFMPC-3-404.PMC4311352.pdf
Available from: http://www.aspca.org/about-us/faq/pet- statistics.aspx [Last accessed date 2014 Nov 28].,Non-OADS,/arxiv_data1/oa_pdf/80/44/JFMPC-3-418.PMC4311355.pdf
Available from:  http://www.capcvet.org/capc-recommendations/ascarid- roundworm/ [Last updated 2012 Jul; Last cited 2014 Mar 17].,OADS,/arxiv_data1/oa_pdf/80/44/JFMPC-3-418.PMC4311355.pdf
Available from: http://www.who.int/publications/ almaata_declaration_en.pdf [Last cited on 2013 Dec 16].,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://www.ijpbs.,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://apps.who.int/medicinedocs/en/d/ Jh3011e/1.html [Last cited on 2013 Dec 16].,OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from:  http://seajme.md.chula.ac.th/articleVol5No1/SC1_S%20 Gopalakrishnan.pdf [Last cited on 2013 Nov 2].,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://www.who.int/universal_ health_coverage/en/[Last cited on 2013 Dec 6].,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://www.nice.org.uk/aboutnice/ whatwedo/aboutclinicalguidelines/about_clinical_ guidelines.jsp.,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://nrhm.gov.in/about- nrhm/ guidelines/nrhm -guidelines/standard -treatment -guidelines.,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available  from: http://www.doh.gov.za/docs/policy/2012/Standard_ treatment_guidelines_and_essential_medicines_list_2012.,Non-OADS,/arxiv_data1/oa_pdf/bf/00/JFMPC-3-424.PMC4311356.pdf
Available from: http://www.who.int/ topics/child_abuse/en/ [Last cited on 2014 Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.jaacap.com/ article/S0890-8567(09)60559-1/abstract [Last cited on 2014  Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.capmh.com/ content/7/1/22 [Last cited on 2014 Oct 01].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.indianjpsychiatry.org/temp/ IndianJPsychiatry554316-1837618_050616.pdf [Last cited  on 2014 Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available  from: http://www.childlineindia.org.in/1098/1098.htm  [Last cited on 2014 Aug 20].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available  from: http://timesofindia.indiatimes.com/india/42- of-Indian-girls-are-sexually-abused-before-19-Unicef/ articleshow/42306348.cms?,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.thehindu.com/news/cities/ bangalore/are- children -the-new-target- of-sexual -predators/ article5068905.ece [Last cited on 2014 Aug 23].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available  from: http://timesofindia.indiatimes.com/city/ bangalore/Child-abuse-cases-tumble-out -at-camps/ articleshow/40142799.cms [Last cited on 2014 Aug 23].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available  from: http://www.newindianexpress.com/cities/kochi/ article1425201.ece [Last cited on 2014 Aug 23].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.unh.edu/ccrc/factsheet/pdf/ childhoodSexualAbuseFactSheet.pdf [Last cited on 2014  Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: https://plan-international.org/./ files- fr/rapport- ghaneen -integral -anglais [Last cited on 2014  Aug 09].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from: http://www.atmph.org/article.asp?,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available from:  https://plan-international.org/learnwithoutfear/files/ india-the -campaign-to -end-violence -in-schools-english [Last  cited on 2014 Aug 04].,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/JFMPC-3-430.PMC4311357.pdf
Available  from: http://nicd.nic.in/writereaddata/linkimages/ OCT-NOV_098132922884.pdf  [Last accessed on 2014 July 01].,Non-OADS,/arxiv_data1/oa_pdf/9c/02/JFMPC-3-438.PMC4311359.pdf
Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/00046263.htm  [Last accessed on 2014 July 01].,OADS,/arxiv_data1/oa_pdf/9c/02/JFMPC-3-438.PMC4311359.pdf
Available from: http://emedicine.medscape.com/ article/776566-clinical.,Non-OADS,/arxiv_data1/oa_pdf/e4/7c/JFMPC-3-452.PMC4311364.pdf
Available from: http://www.ehealthme.com/ds/januvia/ increased -permeability+pulmonary+edema.,Non-OADS,/arxiv_data1/oa_pdf/78/25/JFMPC-3-456.PMC4311365.pdf
Available from: http://www.health.gov.,Non-OADS,/arxiv_data1/oa_pdf/72/e9/JFMPC-3-458.PMC4311366.pdf
Available from: http://www.bbc.co.uk/ethics/ euthanasia/overview/introduction.shtml.,Non-OADS,/arxiv_data1/oa_pdf/83/ce/JFMPC-3-477b.PMC4311376.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/6e/TODENTJ-8-257.PMC4311380.pdf
Clin Oral Investig 2013; Available from:  http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/5f/88/TODENTJ-8-264.PMC4311381.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/5f/88/TODENTJ-8-264.PMC4311381.pdf
[32] URL:https://www.ultradent.com/en-us/Dental-Pr oducts- Supplies/Tooth-Whitening/In-Office-Whitening/Opalescence- Boost-PF-40-percent/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/5f/88/TODENTJ-8-264.PMC4311381.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/88/TODENTJ-8-264.PMC4311381.pdf
Available at: http://earthtrends.wri.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/TOAIDJ-9-1.PMC4311383.pdf
Available at: http://femmesida.veille.inist.fr/spip.,Non-OADS,/arxiv_data1/oa_pdf/03/3d/TOAIDJ-9-1.PMC4311383.pdf
"Available at: http://www.who.int/reproductive-health/publications [25] Azemar FH, Daudin M, Bujan L. Assisted reproductive techno-logies for serodiscordant couples: desire for child and pregnancy versus the fact of illness.",Non-OADS,/arxiv_data1/oa_pdf/03/3d/TOAIDJ-9-1.PMC4311383.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/3d/TOAIDJ-9-1.PMC4311383.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/3e/TODENTJ-8-269.PMC4311385.pdf
http://www.atsdr.cdc.,Non-OADS,/arxiv_data1/oa_pdf/7c/53/CG-15-420.PMC4311387.pdf
http://www.who.int/ipcs/assessment/ public_health/  chemicals_phc/en/ (Accessed 30 September).,Non-OADS,/arxiv_data1/oa_pdf/9b/b3/CG-15-464.PMC4311390.pdf
The functional interpretations of these genes can be found via the ‘GO’ (Gene Ontology) annotations  (http://genecards.org/).,Non-OADS,/arxiv_data1/oa_pdf/c5/e1/CG-15-469.PMC4311391.pdf
"JAK1 Growth hormone receptor binding and protein tyrosine kinase  activity 1p31.3 WGS HBV [41]  JAK2 Protein kinase activity and receptor binding 9p24.1 WGS, WES HCV [30]  KHDRBS2 SH2 domain binding and protein heterodimerization activity 6q11.1 WGS, WES HCV [30]  LRP1B Low-density lipoprotein receptor activity and calcium ion binding 2q22.2  WGS HBV [41]  MLL3 Unknown 7q36.1  WGS HBV, HCV,  other causes [34, 41]  NEK8 Protein serine/threonine kinase activity and metal ion binding 17q11.2  WGS, WES HCV [30]  NFE2L2 Sequence-specific DNA binding transcription factor activity and  protein domain specific binding 2q31.2 WES alcohol [35]  NLRP1 Cysteine-type endopeptidase activator activity involved in apop- totic process and enzyme binding 17p13.2 WES HBV [37, 38]  P62(DCTN4) Protein N-terminus binding 5q33.1 WGS, WES HBV [40]  PARP4 NAD+ADP-ribosyltransferase activity and enzyme binding 13q12.12 WGS, WES HBV [39]  PAX5 DNA binding and sequence-specific DNA binding transcription  factor activity 9p13.2 BGS Unknown [42]  PROKR2 Neuropeptide Y receptor activity 20p12.3 WGS, WES alcohol [35]  RPS6KA3 Protein serine/threonine kinase activity and protein kinase activity Xp22.12 WES alcohol [35]  RTL1 Unknown 14q32.2  WES, RNA- Seq SB induced HCC [33]  SAMD9L Unknown 7q21.2 WES HBV [36]  SLC10A1 Bile acid:sodium symporter activity 14q24.2 WGS HBV [41]  SPAG17 Unknown 1p12 WES HBV [36]  ST18 DNA binding and sequence-specific DNA binding transcription  factor activity 8q11.23 RC-seq Unknown [43]  TMEM2 Unknown 9q21.13 WES HBV [36]  TMEM35 Molecular_function Xq22.1 WES HBV [36]  TP53 Identical protein binding and sequence-specific DNA binding  transcription factor activity 17p13.1 WGS, WES HBV, HCV [35, 37, 41, 44]  TRRAP Transcription coactivator activity and phosphotransferase activity,  alcohol group as acceptor 7q22.1 WGS, WES HCV [30]  VCAM1 Integrin binding and cell adhesion molecule binding 1p21.2 WES HBV [36]  WWP1 Ubiquitin-protein ligase activity and protein binding 8q21.3  WGS HBV, HCV,  other causes [34]  ZIC3 Sequence-specific DNA binding and sequence-Specific DNA  binding transcription factor activity Xq26.3  WGS HBV, HCV,  other causes [34]  ZNF226 DNA bi nding and zinc ion binding 19q13.31 WGS HBV, HCV,  other causes [34]  ZNF717 DNA bi nding and zinc ion binding 3p12.3 WGS, WES HBV [39]  BGS, Bisulfate genomic sequencing; ‘GO’, Gene Ontology (http://www.genecards.org/); HBV, hepatitis B virus; HCV, hepatitis C vi rus; RC-seq, retrotransposon capture sequencing;  RNA-seq, RNA sequencing; SB, Sleeping Beauty; WES, whole exome sequencing; WGS, whole genome sequencing.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/CG-15-469.PMC4311391.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/12/TODENTJ-8-280.PMC4311396.pdf
"Author Information Theprimary andprocessed dataused to generate the analyses can be downloaded by registered users from The Cancer Genome Atlas (https:// tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp, https://cghub.ucsc.edu/ and https:// tcga-data.nci.nih.gov/docs/publications/hnsc_2014/).",OADS,/arxiv_data1/oa_pdf/62/13/41586_2015_Article_BFnature14129.PMC4311405.pdf
Available at http://dx.doi.org/10.1016/j.ecolecon.2014.02.018.,OADS,/arxiv_data1/oa_pdf/bc/fd/ele0018-0108.PMC4311437.pdf
Available at: http://dx.doi.org/10.1016/j.ecolecon.2013.07.009.,OADS,/arxiv_data1/oa_pdf/bc/fd/ele0018-0108.PMC4311437.pdf
Available at: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/fd/ele0018-0108.PMC4311437.pdf
"Alternanthera sessilis, an annual or perennial herb native to Asia, is found throughout the Old World tropics, tropicalAfrica, south-eastern Asia, south-eastern Australia and south-eastern USA (http://www.issg.org) .It propagates from seeds or stem buds, and grows in both terrestrial and aquatic habi- tats, although A. sessilis rarely occurs in aquatic habitats in China.",Non-OADS,/arxiv_data1/oa_pdf/51/6c/ele0018-0048.PMC4311439.pdf
Meteorological data around the sites were obtained from the ofﬁcial website of The National Meteorological Center of China (http://www.nmc.gov.cn/).,OADS,/arxiv_data1/oa_pdf/51/6c/ele0018-0048.PMC4311439.pdf
"To investigate whether climate at these sites getscolder along the latitude transect from south to north, weobtained meteorological data for the past 50 years from thedatabase accessed through the ofﬁcial website of The NationalMeteorological Center of China (http://www.nmc.gov.cn/).The minimum temperature in January and annual averageminimum temperature around these sites decreased by 1.04and 0.65 °C per degree of latitude (Fig.",Non-OADS,/arxiv_data1/oa_pdf/51/6c/ele0018-0048.PMC4311439.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/.Rousseeuw, P.J.",Non-OADS,/arxiv_data1/oa_pdf/75/91/ele0018-0066.PMC4311441.pdf
http://www.phidot.org/software/mark/docs/book/.(18/11/2012).,Non-OADS,/arxiv_data1/oa_pdf/b2/f4/srep08147.PMC4311443.pdf
http://www.phidot.org/software/mark/ docs/book/.(18/11/2012).,Non-OADS,/arxiv_data1/oa_pdf/b2/f4/srep08147.PMC4311443.pdf
"http://flash.lakeheadu.ca/ ,arodgers/hre/ HRT%20Users%20Manual%20Draft%20August%2010%202011.pdf/.",Non-OADS,/arxiv_data1/oa_pdf/b2/f4/srep08147.PMC4311443.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8147 | DOI: 10.1038/srep08147 9",Non-OADS,/arxiv_data1/oa_pdf/b2/f4/srep08147.PMC4311443.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 57–63Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  57ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S7002 9Glycosylated hemoglobin as a screening test   for hyperglycemia in antipsychotic-treated  patients: a follow-up study Pauline MJ Steylen1 Frank MMA van der  Heijden1 Witte JG Hoogendijk2 Willem MA Verhoeven1,2 1Vincent van Gogh Institute for  Psychiatry, Center of Excellence  for Neuropsychiatry, Venray, the  Netherlands; 2Erasmus University  Medical Center, Department  of Psychiatry, Rotterdam, the  Netherlands Correspondence: Pauline MJ Steylen   Vincent van Gogh Institute for  Psychiatry, Center of Excellence for  Neuropsychiatry, Stationsweg 46,  5803AC Venray, the Netherlands   Tel +31 478 52 7339   Fax +31 478 52 7110   Email psteylen@vvgi.n l;   paulinesteylen@gmail.co mPurpose:  To assess the point prevalence of undetected prediabetes (preDM) and diabetes  mellitus (DM) in patients treated with antipsychotics and to compare metabolic parameters  between patients with normoglycemia (NG), preDM, and DM.",Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
Available from: http://www.nationaalkompas.nl/ gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings- en- stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/ omvang /.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
Available  from: http://www.who.int/diabetes/publications/report-hba1c_2011.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/dmso-8-057.PMC4311678.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/mder-8-095.PMC4311757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 95–102Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  95REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S5118 9Automated cyclers used in peritoneal dialysis:  technical aspects for the clinician Rafia i Chaudhry Thomas A Golper Division of Nephrology and  Hypertension, vanderbilt Center for  Kidney Disease, vanderbilt University  Medical Center, Nashville, TN, USA Correspondence: Thomas A Golper   vanderbilt University Medical Center,  S-3303 Medical Center North,   1161 21st Avenue South, Nashville,   TN 37232-2372, USA   Tel +1 615 343 2220   Email t homas.golper@vanderbilt.ed uAbstract:  Peritoneal dialysis (PD) is a widely accepted and increasingly popular form of dialysis.",Non-OADS,/arxiv_data1/oa_pdf/bc/f3/mder-8-095.PMC4311757.pdf
Available from: http://www.baxter.,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/mder-8-095.PMC4311757.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/bc/f3/mder-8-095.PMC4311757.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 207–214Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  207OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S73730aberrant spontaneous low-frequency brain activity  in male patients with severe obstructive sleep  apnea revealed by resting-state functional Mri hai-Jun li1,* Xi-Jian Dai1,2,* hong-han gong1 Xiao Nie1 Wei Zhang3 De-chang Peng1 1Department of radiology, The First  affiliated hospital of Nanchang  University, Nanchang, Jiangxi, People’s  republic of china; 2Department of  imaging and interventional radiology,   Prince of Wales hospital, The chinese  University of hong Kong, shatin,   New T erritories, hong Kong special  administrative region, People’s  republic of china; 3Department  of Pneumology, The First affiliated  hospital of Nanchang University,   Nanchang, Jiangxi, People’s republic  of china *These authors contributed equally   to this workBackground:  The majority of previous neuroimaging studies have demonstrated both structural  and functional abnormalities in obstructive sleep apnea (OSA).",Non-OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
"Keywords:  obstructive sleep apnea, amplitude of low-frequency fluctuation, functional magnetic  resonance imaging, resting state, spontaneous activity, blood oxygen-level-dependent Introduction Obstructive sleep apnea (OSA), characterized by repeated obstructions of upper  airway with intermittent hypoxic exposure, is associated with multiple detrimental  physiological and psychological consequences, in addition to being associated with  cardiorespiratory diseases, including pulmonary hypertension,1 systemic hypertension,2  cardiac arrhythmias,3 cardiac ischemia4 and cerebral ischemia.5 OSA may also cause  daytime sleepiness,6 increase the risk of a traffic accident,7 and diminish both qual - ity of life8 and work performance,9 as well as being accompanied by impairment in correspondence: De-chang Peng Department of radiology, The First  Affiliated Hospital of Nanchang  University, 17 Yongwai Zheng street,  Donghu District, Nanchang city 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 4457   email pengdcdoctor@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Li et al Running head recto: Spontaneous low-frequency brain activity in obstructive sleep apnea DOI: http://dx.doi.org/10.2147/NDT.S73730",Non-OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
"On the basis of MATLAB2010a (Mathworks, Natick, MA,  USA), the remainder of the data preprocessing was performed  by DPARSFA ( http://rfmri.org/DPARSF ) software, includ - ing DICOM form transformation, slice timing, head motion  correction, spatial normalization, smoothing with a Gaussian  kernel of 6 ×6×6 mm3 full width at half maximum (FWHM).",OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/06/ndt-11-207.PMC4311758.pdf
http://dx.doi.org/10.1111/ j.1600-065X.2008.00680.x .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1002/jmv.21237 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
J Hosp Infect 58:42– 49. http://dx.doi.org/10.1016/ j.jhin.2004.04.021 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
Food Mi-crobiol 25:871– 874. http://dx.doi.org/10.1016/j.fm.2008.06.002 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1128/AEM.01797-09 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1002/ ppap.200600217 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
J Phys D Appl Phys 44: 505201. http://dx.doi.org/10.1088/0022-3727/44/50/505201 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
J Hosp Infect 66:40 – 45. http://dx.doi.org/10.1016/j.jhin.2006.12.021 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1089/fpd.2010.0667 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
Emerg Infect Dis19:431– 438. http://dx.doi.org/10.3201/eid1903.121029 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1007/s12560-011-9072-7 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1038/nrmicro2296 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/ 10.1128/AEM.03010-10 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
Clin Plasma Med 1:36 – 44. http://dx.doi.org/10.1016/ j.cpme.2012.10.001 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1128/AEM.70.12.7179 -7184.2004 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1016/ j.watres.2007.10.029 .,OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
http://dx.doi.org/10.1128/ AEM.00583-12 .,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
Food Environ Virol 1:42– 49. http://dx.doi.org/10.1007/s12560 -008-9007-0 .Plasma Inactivates Norovirus January/February 2015 Volume 6 Issue 1 e02300-14®mbio.asm.org 5,Non-OADS,/arxiv_data1/oa_pdf/60/83/mBio.02300-14.PMC4311907.pdf
"In this article, the details of the operative technique for lapa-roscopic liver mobilization are reported along with dem-onstrations by means of videos (Supplemental Digital Content 1, http://links.lww.com/SLE/A106, Supplemental Digital Content 2, http://links.lww.com/SLE/A107).",Non-OADS,/arxiv_data1/oa_pdf/9a/28/sle-25-e21.PMC4311998.pdf
"If you start the dissection from the lateral aspect ofthe triangular ligament, an injury can occur to a diaphragmvessel or its collateral to the liver surface (Video 1, Sup- plemental Digital Content 1, http://links.lww.com/SLE/ A106), which can be prominent in some cirrhotic patients.Such an injury can be diﬃcult to control.",Non-OADS,/arxiv_data1/oa_pdf/9a/28/sle-25-e21.PMC4311998.pdf
"Right Liver Mobilization (Video 1, Supplemental Digital Content 1, http://links.lww.com/SLE/A106) The bed should be adjusted initially to place the patient in a supine position with the surgeon standing between the patient’s legs.",Non-OADS,/arxiv_data1/oa_pdf/9a/28/sle-25-e21.PMC4311998.pdf
"Left Liver Mobilization (Video 2, Supplemental Digital Content 2, http://links.lww.com/SLE/ A107) The surgeon stands on the patient’s right side.",Non-OADS,/arxiv_data1/oa_pdf/9a/28/sle-25-e21.PMC4311998.pdf
"We recommend that the SPST method should be used asa standard technique for laparoscopic liver transection (Supple-mental Digital Content 1, http://links.lww.com/SLE/A103).",Non-OADS,/arxiv_data1/oa_pdf/df/20/sle-25-e33.PMC4311999.pdf
Study to evaluate the safety and efficacy of BA058 for prevention of fracture in postmenopausal women 2013. http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/61/ed/198_2014_Article_2944.PMC4312384.pdf
http://www.clinicaltrials.gov/ct2/show/NCT01575834?term= AMG+785&rank=13A 30.,Non-OADS,/arxiv_data1/oa_pdf/61/ed/198_2014_Article_2944.PMC4312384.pdf
"EAU Guidelines on Prostate Cancer,2013.Available at: http://www.uroweb.org/guidelines/online -guidelines/.Accessed 11 March 2014 12 National Comprehensive Cancer Network.",Non-OADS,/arxiv_data1/oa_pdf/b0/28/bju0115-0041.PMC4312486.pdf
"NCCN Prostate Cancer Guidelines ,2013.Available at: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.Accessed 11 March 2014 13 Mottet N, Bellmunt J, Bolla M etal.",Non-OADS,/arxiv_data1/oa_pdf/b0/28/bju0115-0041.PMC4312486.pdf
A discussion forum for this purpose is available at: http://www.rcslt.org/news/news/2014 news archive/ijlcd discussion forum,Non-OADS,/arxiv_data1/oa_pdf/5e/a4/jlcd0049-0452.PMC4312775.pdf
Position Statement (available at: http://www.asha.org/policy).,Non-OADS,/arxiv_data1/oa_pdf/5e/a4/jlcd0049-0452.PMC4312775.pdf
Technical Report (available at: http://www.asha.org/policy).,Non-OADS,/arxiv_data1/oa_pdf/5e/a4/jlcd0049-0452.PMC4312775.pdf
(available at: http://www.dcsf.gov.uk/bercowreview).,Non-OADS,/arxiv_data1/oa_pdf/5e/a4/jlcd0049-0452.PMC4312775.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006578).,Non-OADS,/arxiv_data1/oa_pdf/f5/cb/bmjopen-2014-006578.PMC4312788.pdf
2011. http://www.cochrane-handbook.org (accessed 10 Feb 2014).,OADS,/arxiv_data1/oa_pdf/f5/cb/bmjopen-2014-006578.PMC4312788.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Extracellular matrix abnormalities in schizophrenia H Pantazopoulos et al 11 Translational Psychiatry (2015), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/22/b1/tp2014128a.PMC4312825.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)NAC improves function in an HD model DJ Wright et al 10 Translational Psychiatry (2015), 1 –10",Non-OADS,/arxiv_data1/oa_pdf/ea/41/tp2014131a.PMC4312826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Dopamine and intertemporal choice J Joutsa et al 7 Translational Psychiatry (2015), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/d9/05/tp2014133a.PMC4312827.pdf
"Multivariate analysis To complement the univariate analysis, we conducted a multivariateanalysis using a supervised machine learning technique known asGaussian Process Classi ﬁcation (GPC) as implemented in the Pattern Recognition for Neuroimaging Toolbox (PRoNTo; http://www.mlnl.cs.ucl.ac.",OADS,/arxiv_data1/oa_pdf/c9/4b/tp2014134a.PMC4312828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Treatment response predictors in UHR individuals GP Amminger et al 7 Translational Psychiatry (2015), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/c9/4b/tp2014134a.PMC4312828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Flavanol consumption is anxiolytic in mice TP Stringer et al 9 Translational Psychiatry (2015), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/b6/25/tp2014135a.PMC4312829.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)SNAP-25 gene polymorphisms and cognition D Braida et al 11 Translational Psychiatry (2015), 1 –11",Non-OADS,/arxiv_data1/oa_pdf/b9/8f/tp2014136a.PMC4312830.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Emotion regulation in bipolar disorder P Kanske et al 9 Translational Psychiatry (2015), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/27/32/tp2014137a.PMC4312831.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)BDNF heterozygosity predicts response to estradiol YWC Wu et al 10 Translational Psychiatry (2015), 1 –10",Non-OADS,/arxiv_data1/oa_pdf/23/91/tp2014143a.PMC4312832.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)CRP polymorphisms and late-life depression M-L Ancelin et al 8 Translational Psychiatry (2015), 1 –8",Non-OADS,/arxiv_data1/oa_pdf/39/5b/tp2014145a.PMC4312833.pdf
(2012) which is also available at http://www.whrc.org/mapping/pantropical/carbon_dataset.html.,Non-OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
(2011) is available at http://carbon.jpl.nasa.gov.,OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
Available at: http://www.mct.gov.br/index.php/content/view/326984html (accessed 2 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
Available at: http://www.forestemissions.org/en/Policy_Brief.aspx (accessed 2 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
Available at: http://www.obt.inpe.br/prodes/ index.html (accessed 2 May 2014) IPCC (2006) Forest land.,Non-OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
Available at: http://www.ipcc.ch/report/ar5/wg1/ (accessed 2 May 2014).,OADS,/arxiv_data1/oa_pdf/84/ee/gcb0020-2540.PMC4312855.pdf
Registration number: ISRCTN39295230 (http://www.controlled-trials.com).,Non-OADS,/arxiv_data1/oa_pdf/9c/d0/bjs0100-1739.PMC4312881.pdf
"Adverse events(AEs) were graded using the National Cancer Institute Com-mon Terminology Criteria for Adverse Events, version 3.0(http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf).",OADS,/arxiv_data1/oa_pdf/f7/7d/bjh0165-0814.PMC4312883.pdf
Available from: http://www.rcsb.org/pdb/.,Non-OADS,/arxiv_data1/oa_pdf/3e/d9/prot0082-1583.PMC4312887.pdf
Available from: http://molprobity.biochem.duke.edu/.,OADS,/arxiv_data1/oa_pdf/3e/d9/prot0082-1583.PMC4312887.pdf
"Anonymized data were entered by each hospital intothe Electronic Database for Global Education (EDGE;Clinical Informatics Research Unit, Southampton GeneralHospital, UK; http://www.edge.nhs.uk).",OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
"All analyses were undertaken using Stata ®Release 13 (StataCorp LP , College Station, T exas, USA) and R (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
IHI Innovation Series white paper; 2012. http://www.ihi.org/knowledge/Pages/ IHIWhitePapers/UsingCareBundles.aspx [accessed 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
"NICE Clinical Guideline 50; 2007. http://www.nice.org.uk/CG50 [accessed 1 March 2014].16 Levy MM, Dellinger RP, T ownsend SR, Linde-Zwirble WT, Marshall JC, Bion J et al.",Non-OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
NICE Medical T echnology Guidance 3; 2011. http://www.nice.org.uk/ guidance/MTG3 [accessed 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
http://www.nela.org.uk [accessed 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/62/20/bjs0102-0057.PMC4312892.pdf
Data Processing and Analysis Functional magnetic resonance imaging FMRI data were processed and analyzed with the FMRI Expert Analysis Tool (FEAT) of FSL software (http://www.fmrib.ox.ac.uk/fsl/feat5/index.html).,OADS,/arxiv_data1/oa_pdf/8f/79/HBM-35-4795.PMC4312897.pdf
FSL software (http://www.fmrib.ox.ac.uk/fsl/melodic/ index.html).,OADS,/arxiv_data1/oa_pdf/8f/79/HBM-35-4795.PMC4312897.pdf
"Beforethe group analysis, fMRI data were registered to the in-plan T1-weighted structural image with translation and to a high-resolution structural image with linear transforma- tion of 6 degrees-of-freedom and ﬁnally to standard spaceusing a linear registration (FLIRT: FMRIB’s Linear ImageRegistration Tool, http://www.fmrib.ox.ac.uk/fsl/ﬂirt/index.html).",OADS,/arxiv_data1/oa_pdf/8f/79/HBM-35-4795.PMC4312897.pdf
"However, splenic B220 lowCD138/H11001PCs were de - pleted in all treatment groups in all models (Figure 3).IgM- or IgG-producing splenic PCs were significantlydepleted in all treatment groups, although dual B celltherapy resulted in the highest level of depletion (Figure3) (further information is available at http://research-pub.gene.com/lin_et_al_2014).",Non-OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"FACS analysis of kidneysshowed that in spontaneous lupus, dual B cell therapycould significantly reduce renal infiltration of activatedT cells and PCs compared to the control antibody–treated group, but not compared to single agent therapy(further information is available at http://research-pub.gene.com/lin_et_al_2014).",OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"In pristane-accelerated lupus,while all therapies resulted in a reduction of BM PCs,only dual B cell therapy caused a significant reduction ofIgG1 PCs (further information is available at http://research-pub.gene.com/lin_et_al_2014).",Non-OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"Attenuation of renal pathology was most pro- nounced with dual B cell–targeted therapy, even thoughin pristane-accelerated lupus all treatment modalitiesexcept for the anti-ragweed control had similar efficacy(further information is available at http://research-pub.gene.com/lin_et_al_2014).",Non-OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"Dual Bcell therapy was comparable to BR-3-Fc but superior toanti-CD20 in reducing glomerulopathy, arteritis, andinterstitial nephritis in spontaneous lupus (further in-formation is available at http://research-pub.gene.com/lin_et_al_2014).",Non-OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"However, in IFN /H9251-accelerated lupus, combination therapy provided a greater attenuation ofoverall renal injury as compared to monotherapies(further information is available at http://research-pub.gene.com/lin_et_al_2014).",Non-OADS,/arxiv_data1/oa_pdf/da/d2/art0067-0215.PMC4312898.pdf
"wounds were obtained at 24 hours of culture, and the extent of wound closure was assessed (using the Wimasis Image Analysisplatform, available at http://www.wimasis.com), with resultsexpressed as the percentage of wounded area covered.",OADS,/arxiv_data1/oa_pdf/1e/40/art0067-0243.PMC4312903.pdf
"We also investigated the effect of rapamycin on the cellular localization of JunB, c-Jun, and JunD innormal and SSc fibroblasts (see Supplementary Figure 1,available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38897/ abstract).",Non-OADS,/arxiv_data1/oa_pdf/1e/40/art0067-0243.PMC4312903.pdf
"Correspondence to: H.F. Kildegaard Contract grant sponsor: The Novo Nordisk FoundationReceived 11 January 2014; Revision received 1 March 2014; Accepted 7 March 2014Accepted manuscript online 18 May 2014; Article ﬁrst published online 22 May 2014 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.25233/abstract).DOI 10.1002/bit.25233ARTICLE 1604 Biotechnology and Bioengineering, Vol.",Non-OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
Ends were checked for correct PCR primer using fastx_barcode_splitter (http://hannonlab.cshl.edu/fastx_toolkit/index.html).,OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
"Cas9 Target Finding Database and Web Interface CRISPy A python script, utilizing BioPython (Cock et al., 2009), was created to search through the CHO-K1 genome obtainedfrom http://www.chogenome.org (Hammond et al., 2012).",OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
"The “CRISPR Design ” (http://crispr.mit.edu/) (Hsu et al., 2013), allows the user toﬁnd targets in a given sequence and then checks for off- targets in the genome of either human, mouse, zebra ﬁsh, or C. elegans .",Non-OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
"5), we have developed a bioinformatics tool “CRISPy ”that is freely accessible at “http://staff.biosustain.dtu.dk/laeb/crispy/.",Non-OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
The tool is available at http://staff.biosustain.dtu.dk/laeb/crispy/.,OADS,/arxiv_data1/oa_pdf/2c/6f/bit0111-1604.PMC4312910.pdf
Registration number: NCT00764621(http://clinical trials.gov); EudraCT number: 2008-000583-16 (https://eudract.ema.europa.eu/).,Non-OADS,/arxiv_data1/oa_pdf/44/87/bjs0101-0613.PMC4312911.pdf
http://www.aptivsolutions.com/addpdlan-software/[accessed 24 September 2012].,OADS,/arxiv_data1/oa_pdf/44/87/bjs0101-0613.PMC4312911.pdf
"ZandstraReceived 30 July 2013; Revision received 20 October 2013; Accepted 18 November 2013Accepted manuscript online 27 November 2013; Article ﬁrst published online 16 December 2013 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.25163/abstract).DOI 10.1002/bit.25163COMMUNICATION TO THE EDITOR 1258 Biotechnology and Bioengineering, Vol.",Non-OADS,/arxiv_data1/oa_pdf/03/35/bit0111-1258.PMC4312920.pdf
Materials and Methods This study is based on breast cancer screening data providedby the Mass Screening Registry (MSR) of the Finnish CancerRegistry (http://www.cancer.ﬁ/syoparekisteri/en/).,OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
The study is based on tabular information and originates from data recorded on the mam- mography screening form (http://www.cancer.ﬁ/syoparekis-teri/joukkotarkastusrekisteri/) for every woman who was screened during that period of time.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.Table 5.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.ncbi.nlm.nih.gov/ pubmed/12169283 [Accessed May 3, 2013].",OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.aafp.org/afp/2000/0415/p2371 [Accessed May 3, 2013].",Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15575032.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/12165640.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.cancer.ﬁ/ syoparekisteri/en/mass-screening-registry/statistics/breast-cancer-screening/ﬁnland/.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.ncbi.nlm.nih.gov/pubmed/9595616 [Accessed June 7, 2013].",OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11818625.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://jama.jamanet- work.com/article.aspx?articleid 5404660 [Accessed December 31, 2012].",Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.ncbi.nlm.nih.gov/pubmed/21862730 [Accessed November 15, 2012].",OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.ncbi.nlm.nih.gov/ pubmed/23244222 [Accessed December 26,2012].",OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"Available at: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid 52361732&tool 5pmcentrez &rendertype 5abstract [Accessed December 29, 2012].",OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
Breast Cancer Res Treat 2012;131:527–40http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/da/78/ijc0136-E630.PMC4312922.pdf
"15–19However, it is also reported that metformin can drive angiogenesis and acceler- ate the in vivo growth of BRAFV600E-driven melanoma by upregulating VEGFA mRNA and protein levels.20Multiple combinations of metformin and targeted agents are currently under clinical investigation (http://www.clinicaltrials.gov/).",Non-OADS,/arxiv_data1/oa_pdf/64/39/ijc0136-1434.PMC4312923.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/8d/5c/per-33-1.PMC4312929.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 1–40www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X681981 RESEARCH  ARTICLE InTRodu CTIon The  current generic and family concepts of the Mycosphaerel­ laceae  and the Teratosphaeriaceae (Capnodiales , Dothideo ­ mycetes) can be indirectly attributed to Crous (1998), who used morphological characteristics of cultures and asexual morphs to show that Mycosphaerella was polyphyletic.",Non-OADS,/arxiv_data1/oa_pdf/8d/5c/per-33-1.PMC4312929.pdf
Phylogenetic analysis An initial alignment of the obtained sequence data was ﬁrst  done using MAFFT v. 7 (http://mafft.cbrc.jp/alignment/server/index.html; Katoh et al.,OADS,/arxiv_data1/oa_pdf/8d/5c/per-33-1.PMC4312929.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 141–154www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X684744 RESEARCH  ARTICLE INTRODUCTION Mycetoma is a chronic progressive, destructive inflammatory  disease that initially infects subcutaneous tissues and extends slowly to eventually invade the bone.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
"Morphology and physiology Morphology and growth characteristics of the species were  studied on malt extract agar (MEA, Oxoid, UK) and oatmeal agar (OA, home-made at CBS, The Netherlands, http://www.cbs.knaw.nl/index.php/food-mycology/101-mycological-media-for-food-and-indoor-fungi).",OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
"1999), and EF-983F and EF-2218R (http://www.aftol.org/pdfs/EF1primer.pdf), respectively.",Non-OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
"A combined alignment was constructed for partial sequences of LSU, SSU, TEF1, and RPB2, alignments were concatenated   using DataConvert 1.0 (https://www.bigelow.org/research/srs/david_a_mcclellan/david_mcclellan_laboratory/dataconvert/).",OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
The combined dataset was partitioned per locus and the analy-sis was done in MrBayes v. 3.1.2 implemented in the Cipres web server (http://www.phylo.org/).,OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
Version 2.75 http://mesquiteproject.org.,Non-OADS,/arxiv_data1/oa_pdf/c5/b0/per-33-141.PMC4312930.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/5a/78/per-33-155.PMC4312931.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 155–168www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X684780 RESEARCH  ARTICLE Confronting the constraints of morphological taxonomy  in the Botryosphaeriales  B. Slippers1, J. Roux2, M.J. Wingfield1, F.J.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/78/per-33-155.PMC4312931.pdf
2002) v. 5.8 (http://mafft.cbrc.jp/alignment/server/) and  manually adjusted.,Non-OADS,/arxiv_data1/oa_pdf/5a/78/per-33-155.PMC4312931.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/4e/68/per-33-169.PMC4312932.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 169–181www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X685202 RESEARCH  ARTICLE InTRodu CTIon The genus  Ustilago contains about 170 described species  (Vánky 2012).",Non-OADS,/arxiv_data1/oa_pdf/4e/68/per-33-169.PMC4312932.pdf
"Retrieved July 8, 2013, from http://nt.ars-grin.gov/fungaldatabases/.",OADS,/arxiv_data1/oa_pdf/4e/68/per-33-169.PMC4312932.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/91/b0/per-33-182.PMC4312933.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 182–211www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X685211 RESEARCH  ARTICLE InTRodu CTIon The family  Nectriaceae  includes about 20 genera of which two  major genera were monographed by Hirooka et al.",Non-OADS,/arxiv_data1/oa_pdf/91/b0/per-33-182.PMC4312933.pdf
http://sweetgum.nybg.org/ih/.,Non-OADS,/arxiv_data1/oa_pdf/91/b0/per-33-182.PMC4312933.pdf
"For 	 any 	 reuse 	 or 	 distribution, 	 you 	 must 	 make 	 clear 	 to 	 others 	 the 	 license 	 terms 	 of 	 this 	 work, 	 which 	 can 	 be 	 found 	 at 	 http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/a2/e5/per-33-212.PMC4312934.pdf
"Nothing 	 in 	 this 	 license 	 impairs 	 or 	 restricts 	 the 	 author’s 	 moral 	 rights.Persoonia 	33,	2014:	212–289 www .ingentaconnect.com/content/nhn/pimj	 http://dx.doi.org/10.3767/003158514X685680 RESEARCH  ARTICLE Fungal Planet description sheets: 281–319 P.W.",Non-OADS,/arxiv_data1/oa_pdf/a2/e5/per-33-212.PMC4312934.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/per-33-41.PMC4312936.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 41–47www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X682313 RESEARCH  ARTICLE InTRoduCTIon Basidiomycota  (Dikarya , Fungi ) contains three main phyloge - netic domains, namely the subphyla Agaricomycotina , Pucci-  niomycotina and Ustilaginomycotina (Hibbett et al.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/per-33-41.PMC4312936.pdf
"Reference species representing  Pucciniomycotina , Agaricomycotina  and currently recognised  classes of Ustilaginomycotina were selected based on se- quence availability for the six genes used in the AFTOL1 project (http://aftol.org/data.php) (Table 1).",OADS,/arxiv_data1/oa_pdf/89/c8/per-33-41.PMC4312936.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c1/1c/per-33-48.PMC4312937.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 48–60www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X683538 RESEARCH  ARTICLE INTRODUCTION Curvularia, typiﬁed by C. lunata, is a species-rich genus, which  includes numerous grass pathogens and saprobes occurring  on plant material, dung and soil (Faurel & Schotter 1965, Si-vanesan 1987, Jiang & Zhang 2007).",Non-OADS,/arxiv_data1/oa_pdf/c1/1c/per-33-48.PMC4312937.pdf
"The sequences generated  during this study and the alignments used in the phylogenetic analyses were deposited in GenBank (Table 1) and TreeBASE (submission ID http://purl.org/phylo/treebase/phylows/study/TB2:S14881), respectively.",OADS,/arxiv_data1/oa_pdf/c1/1c/per-33-48.PMC4312937.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1f/bb/per-33-61.PMC4312938.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 61–82www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X684212 RESEARCH  ARTICLE INTRODUCTION Wehmeyer (1941) gave an account of the diaporthalean genus  Prosthecium Fresen.",Non-OADS,/arxiv_data1/oa_pdf/1f/bb/per-33-61.PMC4312938.pdf
The ﬁnal matrices used for phylogenetic analyses were deposited in TreeBASE (http://www.treebase.org) and are available under http://purl.,OADS,/arxiv_data1/oa_pdf/1f/bb/per-33-61.PMC4312938.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/cd/73/per-33-83.PMC4312939.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 83–97www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X684447 RESEARCH  ARTICLE InTRodu CTIon Collet otrichum gigasporum was originally reported from healthy  leaves of Centella asiatica  in Madagascar and Stylosanthes  guianensis in Mexico, as well as from Coffea arabica in Colom - bia (Rakotonirian a et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/73/per-33-83.PMC4312939.pdf
3 sequences downloade d from NIAS GenBank (http://www.gene.affrc.go.jp/index_en.php).,OADS,/arxiv_data1/oa_pdf/cd/73/per-33-83.PMC4312939.pdf
"Sequences derived in this study were lodged in GenBank, the multi-locus alignment and tree in TreeBASE (http://www.treebase.org/treebase-web/search/studySearch.html) (S15175), and taxonomic novelties in Myco - Bank (www .MycoBank.org; Crous et al.",OADS,/arxiv_data1/oa_pdf/cd/73/per-33-83.PMC4312939.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/78/1d/per-33-98.PMC4312940.pdf
"Nothing in this license impairs or restricts the author’s moral rights.Persoonia 33, 2014: 98–140www.ingentaconnect.com/content/nhn/pimj  http://dx.doi.org/10.3767/003158514X684681 RESEARCH  ARTICLE INTRODUCTION Studies using DNA sequence data have shown that the diversity  of fungi far exceeds earlier expectations with many common species of macrofungi still to be described and named (Schmit & Mueller 2007).",Non-OADS,/arxiv_data1/oa_pdf/78/1d/per-33-98.PMC4312940.pdf
The alignment is 812 nucleotides long (in  cluding gaps) and is  available at TreeBASE under S14832  (http://www.treebase.org/treebase-web/home.html).,OADS,/arxiv_data1/oa_pdf/78/1d/per-33-98.PMC4312940.pdf
http://sweetgum.nybg.org/ih/.,Non-OADS,/arxiv_data1/oa_pdf/78/1d/per-33-98.PMC4312940.pdf
Available at:http://www.who.int/patientsafety/safesurgery/tools_resources/SSSL_Manual_ﬁnalJun08.pdf?ua=1(accessed 20 January 2009).,Non-OADS,/arxiv_data1/oa_pdf/40/35/aas0059-0205.PMC4312956.pdf
Available at: http://www.clr-online.com/CLR201213-Table-of-Critical-Limits.pdf (accessed13 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/40/35/aas0059-0205.PMC4312956.pdf
"Approval wasobtained from the University of Barcelona ethics commit-tee (Comissi /C19o de Bioe `tica de la Universitat de Barcelona; Institutional Review Board 00003099 Assurance number:FWA00004225; http://www.edu/recerca/comissiobioeti-ca.htm), and informed consent was obtained from eachparticipant, and study was conducted according to theprovisions of the Helsinki declaration.",Non-OADS,/arxiv_data1/oa_pdf/77/89/HBM-36-577.PMC4312977.pdf
Anatomical labeling of activations was performedwith reference to the Harvard-Oxford cortical and sub-cortical structural atlases (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases).,OADS,/arxiv_data1/oa_pdf/77/89/HBM-36-577.PMC4312977.pdf
"We used Network-Based Statistics (NBS) v1.2 [Zalesky et al., 2010] (http://www.nitrc.org/projects/nbs/) to iso-late the components of the 11 311 connectivity weightedrFunctional Integration of the Default ModeNetwork r r581r",OADS,/arxiv_data1/oa_pdf/77/89/HBM-36-577.PMC4312977.pdf
"Graph-computation analysis For the calculation of graph network properties, we used the Brain Connectivity Toolbox, from Rubinov andSporns [2010], (https://sites.google.com/site/bctnet/).First, we calculated the following measures of functionalsegregation for every subject: clustering, deﬁned as theinherent tendency to cluster nodes into tightly connectedneighborhoods [Onnela et al., 2005; Watts and Strogatz,1998], and local efﬁciency, deﬁned as the average of theglobal efﬁciency of the level of the local subnetworks[Latora and Marchiori, 2001]; second, we calculated meas- ures of functional integration for every subject: mean pathlength, deﬁned as the average distance (in terms of node–node connection) that must be traversed to connect onemode with another [Watts and Strogatz, 1998] and globalefﬁciency, deﬁned as a measure of how much parallelinformation can potentially be exchanged [Latora andMarchiori, 2001].",OADS,/arxiv_data1/oa_pdf/77/89/HBM-36-577.PMC4312977.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15365124.,Non-OADS,/arxiv_data1/oa_pdf/77/89/HBM-36-577.PMC4312977.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/83/srep08181.PMC4313083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8181 | DOI: 10.1038/srep08181 10",Non-OADS,/arxiv_data1/oa_pdf/fb/83/srep08181.PMC4313083.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ef/ad/srep08160.PMC4313084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8160 | DOI: 10.1038/srep08160 6",Non-OADS,/arxiv_data1/oa_pdf/ef/ad/srep08160.PMC4313084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8148 | DOI: 10.1038/srep08148 6",Non-OADS,/arxiv_data1/oa_pdf/fc/f2/srep08148.PMC4313085.pdf
1 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article © Korean Vaccine Society.,Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:1-10 http://dx.doi.org/10.7774/cevr.2015.4.1.1 pISSN 2287-3651 • eISSN 2287-366X  Thomas Grunwald*,   Sebastian Ulbert* Department of Immunology, Fraunhofer-Institute  for Cell Therapy and Immunology, Leipzig,  Germany *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
"Thomas Grunwald et al • Improvement of DNA vaccines 2 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1foreign protein, including its natural conformation and ap - propriate post-translational modifications.",OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
 Thomas Grunwald et al • Improvement of DNA vaccines 3 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1DNA studies in non-human prinates and the first human clin - ical trials were carried out without or with only little induc - tion of immune response [22-24].,OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
"Thomas Grunwald et al • Improvement of DNA vaccines 4 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1DNA encoding the fusion protein of the respiratory syncytial  virus delivered by intramuscular EP , intradermal EP , DNA- tattooing or by intramuscular injection without any adjuvants  [41].",Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
" Thomas Grunwald et al • Improvement of DNA vaccines 5 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1antigens, but rather to the lack of a direct interaction between  adjuvant and antigen before injection.",Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
"Thomas Grunwald et al • Improvement of DNA vaccines 6 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1context of cancer and autoimmune disease in humans, DNA  vaccines have also been clinically tested against infectious vi - ral diseases, most prominently HIV , hepatitis C virus, and cy - tomegalovirus (CMV).",Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
ORCID  Sebastian Ulbert http://orcid.org/0000-0001-5910-3643 Thomas Grunwald http://orcid.org/0000-0001-7593-4914,Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
 Thomas Grunwald et al • Improvement of DNA vaccines 7 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1References     1.,OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
Thomas Grunwald et al • Improvement of DNA vaccines 8 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1vaccination against infectious disease.,OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
 Thomas Grunwald et al • Improvement of DNA vaccines 9 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1hawks (Buteo jamaicensis).,OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
http://dx.doi.org/  10.1093/ofid/ofu016/.,Non-OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
Thomas Grunwald et al • Improvement of DNA vaccines 10 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.1Vaccine 2011;29:2561-7.,OADS,/arxiv_data1/oa_pdf/c8/47/cevr-4-1.PMC4313101.pdf
"107 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies, one of the most fatal zoonotic diseases, is caused by infection with the rabies  virus (RABV) of the genus Lyssavirus  (family Rhabdoviridae , order Monogegavirales ).",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
"In Korea, 33 human rabies cases and 756 animal rabies cases have  been reported since 1970 according to information provided by the KAHIS program  (http://www.kahis.go.kr) of the Animal and Plant Quarantine Agency (QIA).",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:107-113 http://dx.doi.org/10.7774/cevr.2015.4.1.107 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang1, Ha-Hyun Kim1,  Sung-Suk Choi1, Jong-Taek Kim2,  Woong-Ho Jeong3, Jae-Young Song1 1Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Anyang; 2College  of Veterinary Medicine, Kangwon National  University, Chuncheon; 3Gangwon-do Veterinary  Service Laboratory, Chuncheon, Korea  Received: December 8, 2014 Revised: December 28, 2014 Accepted: December 31, 2014 Corresponding author: Dong-Kun Yang, PhD, DVM Animal and Plant Quarantine Agency, 175 Anyang- ro, Anyang 430-757, Korea Tel: +82-31-467-1783, Fax: +82-31-467-1797 E-mail: yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
"Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 108 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.107 To prevent transmission of rabies from wild animals to do - mestic and companion animals, many countries have taken  preventive measures such as distribution of vaccine baits.",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
 Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 109 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.107Efficacy of ERAG3G strain in mice Four-week-old BALB/c mice were divided into four groups  composing four female mice.,OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 110 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.10720 19 18 17 16 15 14 13 12 11 10  1 2 3 4 5 6 7 8 9 Days after challengeBody weight (g)ERAG3G-1 Control 1ERAG3G-2 Control 2 A120 100 80 60 40 20 0  1 2 3 4 5 6 7 8 9 10 11 12 Days after challengeSurvival rate (%)ERAG3G-1 Control 1ERAG3G-2 Control 2 B Fig.,Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
" Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 111 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.107tries with the exception of Brunei, Hong Kong, Japan, Malay - sia, and Singapore, and vector hosts differ depending on the  countries [21].",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 112 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.107ORCID Dong-Kun Yang http://orcid.org/0000­0001­5765­3043 Ha-Hyun Kim http://orcid.org/0000­0001­6473­0035 Sung-Suk Choi http://orcid.org/0000­0001­5124­9736 Jong-Tack Kim http://orcid.org/0000­0002­6388­550X Woong-Ho Jeong http://orcid.org/000­0003­1776­8297 Jae-Young Song http://orcid.org/0000­0002­9554­9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
 Dong-Kun Yang et al • Oral administration of ERAG3G leads to complete protection in mice 113 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.107United States.,Non-OADS,/arxiv_data1/oa_pdf/05/7a/cevr-4-107.PMC4313102.pdf
"11 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction During nine months till the middle of December in 2014, more than 19,000 people  were infected by Ebola virus (Fig.",Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:11-16 http://dx.doi.org/10.7774/cevr.2015.4.1.11 pISSN 2287-3651 • eISSN 2287-366X  Woo Young Choi1*,   Kee-Jong Hong2*,†,   Joo Eun Hong3, Won-Ja Lee1 1Division of Arboviruses, 2Division of High-risk  Pathogen Research, Korea National Institute of  Health, 3Division of Bioterrorism Preparedness  and Response, Korea Centers for Disease Control  and Prevention, Cheongju, Korea *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
"Woo-Young Choi et al • Ebola vaccine and drug development 12 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.11nyaviridae , and Filoviridae [2]; yellow fever virus and Dengue  virus are included in Flaviviridae , and they are usually trans - mitted by mosquito as a vector.",Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
" Woo-Young Choi et al • Ebola vaccine and drug development 13 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.11Diego, CA, USA) and c2G4 and c4G7 from ZMAb (mouse mAbs  developed by DeFyrus located in Toronto, Canada) [7,8].",OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
Woo-Young Choi et al • Ebola vaccine and drug development 14 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.11cess was unpredictable step for the most potentially harmful  pathogens such as HFVs including Ebola virus.,OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
 Woo-Young Choi et al • Ebola vaccine and drug development 15 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.11Conclusion NIH keeps the vaccine research for 10 years using various  formats and announced clinical test in West Africa based on  these results last September.,Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
ORCID  Woo-Young Choi http://orcid.org/0000-0003-2507-7381 Kee-Jong Hong http://orcid.org/0000-0003-2054-7014 Joo Eun Hong http://orcid.org/0000-0002-6487-604X Won-Ja Lee http://orcid.org/0000-0002-9519-0219 References  1.,Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
Avail - able from: http://www.cdc.gov/vhf/ebola/outbreaks/2014- west africa/.,Non-OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
Woo-Young Choi et al • Ebola vaccine and drug development 16 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.112526-S1-004.,OADS,/arxiv_data1/oa_pdf/83/80/cevr-4-11.PMC4313103.pdf
114 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHBrief communication Vaccination is a key method in controlling the spread of foot-and-mouth disease (FMD)  [1].,Non-OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:114-118 http://dx.doi.org/10.7774/cevr.2015.4.1.114 pISSN 2287-3651 • eISSN 2287-366X  Rae-Hyung Kim1, Jia-Qi Chu2,  Jeong-Nam Park1, Seo-Yong Lee1,  Yeo-Joo Lee1, Mi-Kyeong Ko1,   Ji-Hyeon Hwang1, Kwang-Nyeong  Lee1, Su-Mi Kim1, Dongseob Tark1,  Young-Joon Ko1, Hyang-Sim Lee1,  Min-Goo Seo1, Min-Eun Park1,  Byounghan Kim1, Jong-Hyeon Park1 1Animal and Plant Quarantine Agency, Anyang,  Korea; 2Clinical Research Center of the Affiliated  Hospital of Guangdong Medical College,  Zhanjiang, China Received: December 27, 2014 Revised: December 30, 2014 Accepted: December 31, 2014 Corresponding author: Jong-Hyeon Park, DVM, PhD Animal and Plant Quarantine Agency, 175 Anyang- ro, Manan-gu, Anyang 430-757, Korea Tel: +82-31-467-1719, Fax: +82-31-463-4516 E-mail: parkjhvet@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
 Rae-Hyung Kim et al • Virus rescue from cDNA of FMDV O type vaccine strain 115 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.114firmed by nucleotide sequence analysis.,OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
"Rae-Hyung Kim et al • Virus rescue from cDNA of FMDV O type vaccine strain 116 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.114(Invitrogen, Grand Island, NY, USA).",OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
 Rae-Hyung Kim et al • Virus rescue from cDNA of FMDV O type vaccine strain 117 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.114length of the poly(C) tract.,OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
ORCID Rae-Hyung Kim http://orcid.org/0000-0003-3768-0399 Jia-Qi Chu http://orcid.org/0000-0002-5480-355X Jeong-Nam Park http://orcid.org/0000-0002-7070-1131 Seo-Yong Lee http://orcid.org/0000-0001-9596-6075 Yeo-Joo Lee http://orcid.org/0000-0002-7037-7300 Mi-Kyeong Ko http://orcid.org/0000-0002-9714-4232 Ji-Hyeon Hwang http://orcid.org/0000-0002-2662-9064  Kwang-Nyeong Lee http://orcid.org/0000-0002-8267-3983 Su-Mi Kim http://orcid.org/0000-0002-9242-2731  Dongseob Tark http://orcid.org/0000-0001-7499-4253 Young-Joon Ko http://orcid.org/0000-0002-3436-8175 Hyang-Sim Lee http://orcid.org/0000-0002-3393-8295 Min-Goo Seo http://orcid.org/0000-0003-1752-5105  Min-Eun Park http://orcid.org/0000-0003-0559-0997 Byounghan Kim http://orcid.org/0000-0002-7252-7763 Jong-Hyeon Park http://orcid.org/0000-0003-0824-8121 References 1.,Non-OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
Rae-Hyung Kim et al • Virus rescue from cDNA of FMDV O type vaccine strain 118 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.114vaccine against foot and mouth disease.,OADS,/arxiv_data1/oa_pdf/33/b8/cevr-4-114.PMC4313104.pdf
119 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHGuideline Pig industry have been increased during the last half century in Korea.,Non-OADS,/arxiv_data1/oa_pdf/96/db/cevr-4-119.PMC4313105.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:119-120 http://dx.doi.org/10.7774/cevr.2015.4.1.119 pISSN 2287-3651 • eISSN 2287-366X  Won Hyung Lee1, Han Sang Yoo2 1XP Bio Inc., Anseong, 2Department of Infectious  Diseases, College of Veterinary Medicine, Seoul  National University, Seoul, Korea Received: August 13, 2014 Revised: October 21, 2014 Accepted: October 24, 2014 Corresponding author: Han Sang Yoo, DVM, PhD Department of Infectious Diseases, College of  Veterinary Medicine, Seoul National University,   1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82-2-880-1263, Fax: +82-2-874-2738  E-mail: yoohs@snu.ac.kr No potential conflict of interest relevant to this  article was reported.There is no published guideline for the vaccination to pigs even though several vaccine com - panies suggested the program based on their products.",Non-OADS,/arxiv_data1/oa_pdf/96/db/cevr-4-119.PMC4313105.pdf
Won Hyung Lee et al • Suggested guidelines for vaccination of pigs in Korea 120 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.119Table 1.,Non-OADS,/arxiv_data1/oa_pdf/96/db/cevr-4-119.PMC4313105.pdf
"17 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Ebola viruses are the causative agents of Ebola hemorrhagic fever (EHF), which are  highly virulent zoonosis that affect both human and nonhuman primates.",Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:17-22 http://dx.doi.org/10.7774/cevr.2015.4.1.17 pISSN 2287-3651 • eISSN 2287-366X  Woonsung Na1,2*, Nanuri Park1,2*,  Minju Yeom1,2, Daesub Song1,2 1Viral Infectious Disease Research Center,  Korea Research Institute of Bioscience and  Biotechnology, Daejeon; 2University of Science  and Technology, Daejeon, Korea *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
18 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.17within bat populations remain unknown.,Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
19 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.17ed from bushmeat which was killed by her family in wild.,Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
20 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.17Table 4.,Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
"21 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.17virus infections although there are effort to develop vaccine  and treatment such as ZMapp and cAd-ZEBOV , early detec - tion and diagnosis of infection from animals and human are  very crucial for now.",Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
ORCID Woonsung Na http://orcid.org/0000-0002-7254-5240 Nanuri Park http://orcid.org/0000-0002-7951-0956 Minju Yeom http://orcid.org/0000-0001-8949-6361 Daesub Song http://orcid.org/0000-0002-2759-1061   References 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
22 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.17swine as a host for the Reston ebolavirus.,Non-OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
Available from: http://www.who.int/csr/don/  2014_08_27_ebola/en/.,OADS,/arxiv_data1/oa_pdf/f3/85/cevr-4-17.PMC4313106.pdf
"23 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Vaccination is among humanity’s greatest achievements for reducing death, disability,  and inequity caused by infectious diseases.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:23-45 http://dx.doi.org/10.7774/cevr.2015.4.1.23 pISSN 2287-3651 • eISSN 2287-366X  Bradford S. Powell1,   Alexander K. Andrianov2,   Peter C. Fusco1 1PharmAthene, Inc., Annapolis, MD, USA;  2Institute for Bioscience and Biotechnology  Research, University of Maryland, College Park,  MD, USA Received: November 21, 2014 Revised: November 24, 2014 Accepted: November 29, 2014 Corresponding author: Bradford S. Powell, PhD, PMP PharmAthene, Inc., One Park Place, Suite 450,  Annapolis, MD 21401, USA Tel: +1-410-269-2682, Fax: +1-410-269-2525 E-mail: bradford.powell@pharmathene.com We thank Wayne Morges for critical reading of  the manuscript and Jill Sharp for help in back - ground research.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Bradford S. Powell et al • Polyionic vaccine adjuvants 24 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23tancy of 30.4 years over the same time period [2].,OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"A, up to 1899; B,  1900 to 1949; C, 1950 to 2012; D, 2014 U.S. licensed as listed by Food  and Development Administration (FDA); E, 2014 in clinical testing as  listed by HuVax (http://www.violinet.org).",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
" Bradford S. Powell et al • Polyionic vaccine adjuvants 25 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23 Here we first look back at the origin of adjuvants, and then  focus on a few classical and recent adjuvants as examples of  the category of ionic polymers and ionic materials.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 26 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23 The last achievement listed, on the effectiveness of pre-form- ed aluminum salts compared to co-precipitation of antigen  with aluminum phosphate or alum (potassium aluminum  sulfate) before that, connects this line of development to mod - ern aluminum gels which are mostly employed today.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 27 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23tential adjuvants with new capabilities to improve vaccines.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Bradford S. Powell et al • Polyionic vaccine adjuvants 28 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23sponse generally is of short duration with no affinity matura - tion and fails to elicit immunologic memory.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 29 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23hydrogel (aluminum oxyhydroxide) saline formulation result - ed in hydrated antigen and re-established soluble-like struc - ture compared to formulation with plain Alhydrogel [85].,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"The Vaxjo web-based database tool  for vaccine adjuvant informatics (http://www.violinet.org/ vaxjo/adjuvant) lists 103 different vaccine adjuvant compounds  [92,93].",OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 30 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23few decades, an aluminum oxide sulfate or phosphate was  salted out together with antigen in creating toxoid prepara - tion.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 31 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23pensive and rapid route to improving the capability of this  adjuvant for other protein antigens [85].,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 32 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23its dependency on adjuvant, a track record of aluminum oxy - hydroxide use, and a history of differing potencies and stabil - ities by various producers.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 33 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23nanoparticulate formulations.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Bradford S. Powell et al • Polyionic vaccine adjuvants 34 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23interferences due to impurities [125].,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 35 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23creased the ability of leukocytes to kill the ingested Staphylo - coccus aureus  in a dose-dependent manner [130].,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 36 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23[139,141,143,148].",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
" Bradford S. Powell et al • Polyionic vaccine adjuvants 37 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23more, intramuscular injection of mice with PCEP induced  significant recruitment of neutrophils, macrophages, mono - cytes, DCs, and lymphocytes at the site of injection as well as  in the draining lymph nodes [155].",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 38 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23manufactured 13% of world supply, with China and India at  8% [158].",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
" Bradford S. Powell et al • Polyionic vaccine adjuvants 39 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23and technology, at the crossroads of immunology, cell biolo - gy, bioinformatics, nanotechnology and materials sciences,  public health, and several other areas of scientific knowledge  and practice.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"ORCID Bradford S. Powell http://orcid.org/ 0000-0002-5957-1890 Alexander K. Andrianov http://orcid.org/ 0000-0001-6186-6156 Peter C. Fusco http://orcid.org/ 0000-0001-9366-4890 References 1. van Panhuis WG, Grefenstette J, Jung SY, et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
"Bradford S. Powell et al • Polyionic vaccine adjuvants 40 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23censure safety surveillance for adolescent and adult tet - anus, diphtheria and acellular pertussis vaccines: 2005- 2007.",Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Avail - able from: http://www.nobelprize.org/nobel_prizes/med - icine/laureates/1901/behring-article.html.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 41 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23  48.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Bradford S. Powell et al • Polyionic vaccine adjuvants 42 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23  77.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 43 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23ture and adsorption properties of commercial calcium  phosphate adjuvant.,OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Bradford S. Powell et al • Polyionic vaccine adjuvants 44 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23Immunopharmacol 2004;4:1615-23.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
 Bradford S. Powell et al • Polyionic vaccine adjuvants 45 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.23come of rotavirus vaccination of newborn mice with vi - rus-like particles.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
Available from: http://www.vaccineseurope.,Non-OADS,/arxiv_data1/oa_pdf/9f/16/cevr-4-23.PMC4313107.pdf
46 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Infectious diseases caused by viruses have been the most challenging problem in hu - man health.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:46-53 http://dx.doi.org/10.7774/cevr.2015.4.1.46 pISSN 2287-3651 • eISSN 2287-366X  Seunghoon Han1,2 1Department of Pharmacology, College of  Medicine, The Catholic University of Korea,  Seoul; 2Department of Clinical Pharmacology and  Therapeutics, Seoul St. Mary’s Hospital, College  of Medicine, The Catholic University of Korea,  Seoul, Korea Received: November 20, 2014 Revised: December 28, 2014 Accepted: December 31, 2014 Corresponding author: Seunghoon Han, MD, PhD Department of Pharmacology, College of   Medicine, The Catholic University of Korea, 222  Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-7326, Fax: +82-2-2258-7876  E-mail: waystolove@catholic.ac.kr No potential conflict of interest relevant to this  article was reported.Vaccination is regarded as one of the biggest triumphs in the history of medicine.",Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
 Seunghoon Han • Clinical vaccine development 47 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46 This review article briefly summarizes the past and present  trends in clinical vaccine development.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Seunghoon Han • Clinical vaccine development 48 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46tion began with Good pasture’s findings of viral growth in  embryonated hens’ eggs.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
 Seunghoon Han • Clinical vaccine development 49 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46This includes the following contents: 1) identification of the  target population (mostly healthy people with particular de - mographic characteristics) and their sociocultural factors; 2)  risk assessment of the target disease and the vaccine itself; 3)  understanding of the incidence of the target disease and en - vironmental factors; 4) identification of the dose and route of  administration; 5) plans to induce herd immunity; and 6) re- gulatory strategies.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Seunghoon Han • Clinical vaccine development 50 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46III trial is much larger.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
" Seunghoon Han • Clinical vaccine development 51 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46Current Issues and Conclusion One of the most important aspects of vaccinology in the 21st  century is the extension of the target population by the devel - opment of new vaccines against emerging infections, tumors,  and chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Seunghoon Han • Clinical vaccine development 52 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46Table 3.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
ORCID Seunghoon Han http://orcid.org/0000-0002-9976-5120 References 1.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
 Seunghoon Han • Clinical vaccine development 53 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.46hepatitis B. BioDrugs 1998;10:137-58.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Available from: http://www.his - toryofvaccines.org/content/articles/vaccine-development- testing-and-regulation.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Available from: http://www.historyofvaccines.org/con - tent/articles/different-types-vaccines.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Available from: http://www.who.int/biologicals/publica - tions/trs/areas/vaccines/clinical_evaluation/en/.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
Available from:  http://www.fda.gov/BiologicsBloodVaccines/Develop - mentApprovalProcess/BiologicsLicenseApplicationsBL - AProcess/ucm133096.htm.,Non-OADS,/arxiv_data1/oa_pdf/14/ab/cevr-4-46.PMC4313108.pdf
54 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Adjuvants materials are compounds or macromolecular complexes that can enhance  the potency and longevity of antigen-specific immune response [1-4].,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:54-58 http://dx.doi.org/10.7774/cevr.2015.4.1.54 pISSN 2287-3651 • eISSN 2287-366X  Yong Taik Lim SKKU Advanced Institute of Nanotechnology,  School of Chemical Engineering, Sungkyunkwan  University, Suwon, Korea Received: December 8, 2014 Revised: December 28, 2014 Accepted: December 31, 2014 Corresponding author: Yong Taik Lim, PhD SKKU Advanced Institute of Nanotechnology,  School of Chemical Engineering, Sungkyunkwan  University, 2066 Seobu-ro, Jangan-gu, Suwon  440-746, Korea Tel: +82-31-299-4172, Fax: +82-31-299-4119 E-mail: yongtaik@skku.edu No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
" Yong Taik Lim • Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease 55 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.54Major Roles of Adjuvants When purified protein antigens were immunized, modest  antibody response with little or no T-cell response were gen - erally induced and multiple injections are required to elicit  sufficient antibody responses [2,3].",Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
Yong Taik Lim • Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease 56 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.54ia parasite.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
" Yong Taik Lim • Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease 57 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.54infectious diseases, especially viral infections [14,19-26].",Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
ORCID Yong Taik Lim http://orcid.org/0000-0001-5558-5526 References 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
Yong Taik Lim • Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease 58 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.5412.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/cevr-4-54.PMC4313109.pdf
59 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Vaccination is one of the top public health achievements in modern medicine.,Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:59-67 http://dx.doi.org/10.7774/cevr.2015.4.1.59 pISSN 2287-3651 • eISSN 2287-366X  Shee Eun Lee1,2,   Chung Truong Nguyen1,3,   Soo Young Kim1,3, Thinh Nguyen Thi1,3,   Joon Haeng Rhee1,3 1Clinical Vaccine R&D Center, Chonnam National  University Hwasun Hospital, Chonnam National  University Medical School, Hwasun; 2Department  of Pharmacology and Dental Therapeutics, School  of Dentistry, Chonnam National University, Gwangju;  3Department of Microbiology, Chonnam National  University Medical School, Gwangju, Korea Received: May 25, 2014 Revised: October 20, 2014 Accepted: October 27, 2014 Corresponding author: Joon Haeng Rhee, MD Clinical Vaccine R&D Center, Chonnam National  University Hwasun Hospital, Chonnam National  University Medical School, 322 Seoyang-ro,  Hwasun 519-763, Korea Tel: +82-61-379-8479, Fax: +82-61-379-8455 E-mail: jhrhee@chonnam.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
"Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 60 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59 Adjuvants are vaccine components that potentiate immune  responses to an antigen and may modulate them towards  more desirable directions [6,7,10,11].",Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
 Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 61 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59cultures by adding 0.4 mM isopropyl-D-thiogalactopyrano - side (IPTG).,Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 62 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59Fig.,OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
The model was constructed by the Phyre server (http://www.sbg.bio.ic.ac.uk/ phyre/) using Protein Data Bank (PDB) data sets.,OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
" Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 63 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59and blocked with 50 μL/well of a blocking buffer (1× PBS with  0.5% bovine serum albumin, 1 mM EDTA, 0.05% Tween-20)  for 1 hour at room temperature (RT).",Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 64 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59pared with FlaB (Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
 Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 65 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59result closely correlated with that of TTFC-specific antibody  titer measurement (Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 66 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59TLR5 binding capacity and it interacts with TLR5 signaling  apparatus at >2-fold higher efficiency.,OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
ORCID Shee Eun Lee http://orcid.org/0000-0002-2023-3317 Chung Truong Nguyen http://orcid.org/0000-0001-9881-0295 Soo Young Kim http://orcid.org/0000-0002-6304-0689 Thinh Nguyen Thi http://orcid.org/0000-0002-4874-3458 Joon Haeng Rhee http://orcid.org/0000-0003-4018-3203References 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
 Shee Eun Lee et al • FlaB-TTFC mucosal vaccine 67 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.59coccus pneumoniae infection in mice.,OADS,/arxiv_data1/oa_pdf/2c/88/cevr-4-59.PMC4313110.pdf
68 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies is acute viral encephalitis caused by a highly neurotropic negative sense single  stranded RNA virus belonging to the genus Lyssavirus  of the family Rhabdoviridae .,Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:68-74 http://dx.doi.org/10.7774/cevr.2015.4.1.68 pISSN 2287-3651 • eISSN 2287-366X  Manjunatha Muniswamappa  Venkataswamy,   Shampur Narayan Madhusudana,  Sampada Sudarshan Sanyal,  Shaheen Taj,   Ashwin Yajaman Belludi,   Reeta Subramaniam Mani,   Nandita Hazra Deptartment of Neurovirology, National Institute  of Mental Health and Neurosciences, Bangalore,  India Received: August 8, 2014 Revised: October 20, 2014 Accepted: October 24, 2014 Corresponding author:   Shampur Narayan Madhusudana, MD Department of Neurovirology, National Institute  of Mental Health and Neurosciences,   Bangalore-560029, India Tel: +91-80-26995129, Fax: +91-80-26564830 E-mail: mshampur@hotmail.com No potential conflict of interest relevant to this  article was reported.Purpose:  Immunization against rabies in humans induces protective neutralizing antibodies;  however, the induction of type 1 or type 2 cytokine mediated cellular immune responses fol - lowing rabies vaccination is not understood.",Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
 Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 69 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68efficacy [2-4].,Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
"Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 70 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68overlaid on Histopaque gradient (Sigma, St. Louis, MO, USA).",Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
 Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 71 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68correlation between RVNA titers and cellular cytokine respon- ses were analyzed by the Pearson’s correlation coefficient test.,OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
"Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 72 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68Rabies specific antibodies detectable at six months after  primary ID pre-exposure vaccination are enhanced by booster  vaccination The serum RVNA titers, as observed by the RFFIT assay, were  at detectable levels six months after the primary ID vaccina - tion, with all the ten individuals showing titers much higher  than the 0.5 IU/mL which is regarded by the WHO as the ad - equate level following vaccination [1].",Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
 Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 73 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68for assessing a successful vaccination has been to measure  the levels of RVNA.,Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
Manjunatha Muniswamappa Venkataswamy et al • Rabies vaccination induces type 1 and type 2 cellular cytokine responses 74 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.68vestigated.,Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
ORCID  Manjunatha Muniswamappa Venkataswamy http://orcid.org/       0000-0003-3908-7222 References 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/34/cevr-4-68.PMC4313111.pdf
"75 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Pertussis is caused by Bordetella pertussis , which exclusively infects humans, and is a  highly contagious respiratory disease.",Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:75-82 http://dx.doi.org/10.7774/cevr.2015.4.1.75 pISSN 2287-3651 • eISSN 2287-366X  Seung Beom Han1,2, Kyu Ri Kang2,  Dong Ho Huh2, Hee Chul Lee2,   Soo Young Lee1,2, Jong-Hyun Kim1,2,  Jae Kyun Hur1,2, Jin Han Kang1,2 1Department of Pediatrics, 2The Vaccine Bio  Research Institute, College of Medicine, The  Catholic University of Korea, Seoul, Korea Received: August 26, 2014 Revised: October 21, 2014 Accepted: October 24, 2014 Corresponding author: Jin Han Kang, MD, PhD Department of Pediatrics, Seoul St. Mary’s Hospi - tal, College of Medicine, The Catholic University  of Korea, 222 Banpo-daero, Seocho-gu, Seoul  137-701, Korea Tel: +82-2-2258-6183, Fax: +82-2-537-4544 E-mail: kjhan@catholic.ac.kr This trial was supported by the Green Cross  Corporation (Grant number: 5-2013-D0083-00001).",Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
Seung Beom Han et al • Tdap vaccine efficacy in mice 76 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.7590% [1-3].,Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
 Seung Beom Han et al • Tdap vaccine efficacy in mice 77 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.75Intranasal infection with B. pertussis Mice were intranasally challenged three weeks after booster  vaccination.,Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
"Seung Beom Han et al • Tdap vaccine efficacy in mice 78 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.75Th2 CMIs (IL-4, -5, and -10) After stimulation by PT, FHA, PRN, and mixed antigen, most  IL-4 levels were less than 10 pg/mL, most IL-5 levels were be - tween 10 and 30 pg/mL, and IL-10 levels were near 10 pg/mL  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
" Seung Beom Han et al • Tdap vaccine efficacy in mice 79 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.75Discussion  Although humans are the only natural host of B. pertussis ,  murine models have been accepted as a useful animal study  model evaluating pertussis vaccine immunogenicity [10-14].",Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
Seung Beom Han et al • Tdap vaccine efficacy in mice 80 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.75tection against pertussis in an aerosol challenge model.,Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
ORCID Seung Beom Han  http://orcid.org/0000-0002-1299-2137 Kyu Ri Kang  http://orcid.org/0000-0001-9135-1890 Dong Ho Huh  http://orcid.org/0000-0001-5395-7197 Hee Chul Lee  http://orcid.org/0000-0002-5715-7143 Soo Young Lee  http://orcid.org/0000-0002-5354-3135 Jong-Hyun Kim  http://orcid.org/0000-0001-8641-7904 Jae Kyun Hur  http://orcid.org/0000-0002-3978-5787 Jin Han Kang  http://orcid.org/0000-0003-1610-6742 References 1.,Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
 Seung Beom Han et al • Tdap vaccine efficacy in mice 81 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.754.,Non-OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
Seung Beom Han et al • Tdap vaccine efficacy in mice 82 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.75tion in mice is dependent on induction of cell-mediated  immunity.,OADS,/arxiv_data1/oa_pdf/da/1e/cevr-4-75.PMC4313112.pdf
"83 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCH Introduction  Bacillus Calmette–Guerin (BCG) is the only vaccine available for mass immunization  against tuberculosis (TB) with more than three billion doses administered worldwide  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:83-87 http://dx.doi.org/10.7774/cevr.2015.4.1.83 pISSN 2287-3651 • eISSN 2287-366X  Aliabbas A. Husain1,   Shubhangi R. Warke2,   Dewanand R. Kalorey2,   Hatim F. Daginawala1,   Girdhar M. Taori1,   Rajpal S. Kashyap1 1Biochemistry Research Laboratory, Central  India Institute of Medical Sciences, Nagpur;  2Department of Veterinary Microbiology and  Animal Biotechnology, Nagpur Veterinary College,  Nagpur, India  Received: August 27, 2014 Revised: October 23, 2014 Accepted: October 24, 2014 Corresponding author: Rajpal S. Kashyap Biochemistry Research Laboratory, Central India  Institute of Medical Sciences, Nagpur 440010,   India Tel: +91-712-223-3381, Fax: +91-712-223-6416 E-mail: raj_ciims@rediffmail.com No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
"Aliabbas A. Husain et al • Efficacies of Ag85B, Ag85B peptide, and BCG in mouse model 84 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.83to do better than standard intradermal BCG is the ability to  induce long-term memory immunity that is protective  against primary-disease progression and reactivation of la - tent disease [5].",Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
" Aliabbas A. Husain et al • Efficacies of Ag85B, Ag85B peptide, and BCG in mouse model 85 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.83Fig.",OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
"Aliabbas A. Husain et al • Efficacies of Ag85B, Ag85B peptide, and BCG in mouse model 86 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.83Discussion Existing BCG vaccination protocol has failed to control tuber - culosis infection.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
" Aliabbas A. Husain et al • Efficacies of Ag85B, Ag85B peptide, and BCG in mouse model 87 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.83a lot of further work is need study the mechanism of action,  use of conjugates along with MTB peptides, development of  proper disease model and also assessment of mixed Th1/Th2  response that will allow optimization of such vaccination strat - egies, and ultimately the development of improved prime  boost vaccination strategies against TB.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
ORCID  Aliabbas A. Husain  http://orcid.org/0000-0002-0765-3325 Shubhangi R. Warke  http://orcid.org/0000-0003-2831-5074 Dewanand R. Kalorey  http://orcid.org/0000-0002-4061-909X Hatim F .,Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
Daginawala  http://orcid.org/0000-0001-6081-6480 Girdhar M. Taori  http://orcid.org/0000-0001-8710-3894 Rajpal S. Kashyap  http://orcid.org/0000-0001-6643-0300 References 1.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/cevr-4-83.PMC4313113.pdf
88 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction The current most fastest and common causes of fatality worldwide are the infectious  diseases of which human hand-foot-mouth disease (HFMD) is among the most pan - demic viral infections.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:88-98 http://dx.doi.org/10.7774/cevr.2015.4.1.88 pISSN 2287-3651 • eISSN 2287-366X  Mohamed Ibrahim Saeed1, Abd Rahaman Omar2,   Mohd Zobir Hussein3,   Isam Mohamed Elkhidir4,   Zamberi Sekawi1 1Department of Microbiology and Parasitology,  University of Putra Malaysia, Medical Faculty,  Serdang; 2University of Putra Malaysia, Institute  of Biosciences, Serdang; 3University of Putra  Malaysia, Institute of Advanced Technology,  Serdang; 4Department of Microbiology and  Parasitology, University of Khartoum, Faculty of  Medicine, Sudan, Malaysia Received: September 22, 2014 Revised: December 28, 2014 Accepted: December 31, 2014 Corresponding author: Zamberi Sekawi, MD,  MPath Faculty of Medicine, Universiti Putra Malaysia,  43400 UPM Serdang, Selangor, Malaysia Tel: +60-603-8947-2502, Fax: +60-603-8947-2501 E-mail: zamberi@upm.edu.my No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
 Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 89 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88viral subtypes among the region [4].,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 90 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88ing capacity towards other viral genotypes that naturally rep - licate in a different somatic host cells such as cells on human  epithelial respiratory and digestive tracts.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
 Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 91 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88similar that of oral polio vaccine remained possible and the  issue of a vaccine safety is a priority demands before provid - ing protection.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 92 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88each 15 minutes; aliquots of 2 mL were kept and samples  used for characterization for the chemical and physical prop - erties.,OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
 Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 93 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88Adjuvant particle size  Particles size of the prepared adjuvant showed mean parti - cles distribution of 30 nm while that of commercial CaPs  were of particle size of 905 nm (Fig.,OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
"Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 94 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88liver cell is examined on HepG2 cell line monolayers after its  exposure to gradient concentrations of each adjuvant for 72  hours, the percentage of viable cell among all of the prepara - tions were either equal or above 50% which indicate for the  absence of adverse cytotoxic effect in both adjuvant, the per - centage of cell viability elevated commercial adjuvant com - pared to nao-adjuvant (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
" Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 95 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88administered intradermal nano-adsorbed vaccine (0.5 µg/ mL) and less with the intradermal micro-size adsorbed vac - cine (0.5 µg/mL) of  0.1 mL volume throughout the last 6  weeks (range, 3 to 9 weeks) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 96 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88neutralizing titer below (1:200).,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
 Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 97 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88systemic immunity in general.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
ORCID Mohamed Ibrahim Saeed http://orcid.org/0000-0002-3530-1351 Abd Rahaman Omar http://orcid.org/0000-0001-7379-0507 Mohd Zobir Hussein http://orcid.org/0000-0002-0741-261X  Isam Mohamed Elkhidir  http://orcid.org/0000-0003-1451-235X Zamberi Sekawi http://orcid.org/0000-0001-1755-2013 References 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
Mohamed Ibrahim Saeed et al • Immune response towards nano-adjuvant adsorbed HEV-71 vaccine 98 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.88ed vaccine provokes cross-protective immunity in a  mouse model of human enterovirus 71 infection.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/cevr-4-88.PMC4313114.pdf
"99 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Staphylococcus aureus  is a gram-positive bacterium, capable of causing infections in  humans, including a variety of skin infections, as well as a variety of systemic infections  such as bacteremia, osteomyelitis, ventilator-associated pneumonia, intravenous cath - eter–associated infections [1].",Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2015;4:99-106 http://dx.doi.org/10.7774/cevr.2015.4.1.99 pISSN 2287-3651 • eISSN 2287-366X  Somayeh Delfani1,   Abbas Ali Imani Fooladi2,   Ashraf Mohabati Mobarez1,  Mohammad Emaneini3,   Jafar Amani2, Hamid Sedighian2 1Department of Bacteriology, Faculty of Medical  Sciences, Tarbiat Modares University, Tehran;  2Applied Microbiology Research Center,  Baqiyatallah University of Medical Sciences,  Tehran; 3Department of Microbiology, School of  Medicine, Tehran University of Medical Sciences,  Tehran, Iran  Received: September 30, 2014 Revised: October 24, 2014 Accepted: October 27, 2014 Corresponding author: Jafar Amani, PhD  Applied Microbiology Research Center, Baqiyatal - lah University of Medical Sciences, Vanak Sq.",Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 100 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99strong immune responses in rabbit and rat models of infective  endocarditis and in a mouse model of septic arthritis [5].,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
"Multiple sequence alignments were  performed using ClustalW software of European Bioinfor -matics Institute website (http://www.ebi.ac.uk/Tools/clust - alw2), to find a common fragment in all the sequences.",OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
VaxiJen server was used  to predict the immunogenicity of each protein alone and in  combination with each other (http://www.jenner.ac.uk/Vaxi - Jen) [15].,OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
The portal  for the mfold web server is http://www.bioinfo.rpi.edu/ap - plications/mfold [16].,OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
"The physico-chemical parameters The physico-chemical parameters of the chimeric protein in - cluding molecular weight, extinction coefficient, half-life, in - stability index, theoretical isoelectric point (pI), grand aver - age of hydropathy (GRAVY) and total number of positive and  negative residues were obtained using the Expasy ProtParam  (http://us.expasy.org/tools/protparam.html/) [17].",OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
The structure was  validated to see the quality of the resulting stereochemistry of  structure by Ramachandran plot in PROCHECK software  (http://www.ebi.ac.uk/thornton-srv/software/PROCHECK).,OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
"The first, chimeric protein was analyzed for continuous  B-cell epitopes using Bcepred (http://www.imtech.res.in/ raghava/bcepred/) [20].",OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
" Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 101 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99Results Sequences, databases, and structure design The residues 500-559 in the N-terminal region of ClfA, have  been reported to be involved in polyclonal antibodies gener - ated against a ClfA recombinant protein.",OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 102 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99cated by pI value (pI<7.75).,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
We obtained predicted structural elements  using software GOR IV (http://npsa-prabi.ibcp.fr/cgi-bin/ npsa_automat.pl?page=npsa_gor4.html).,OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
 Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 103 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99sponding threshold scores.,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
"Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 104 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99our chimeric vaccine as a chimeric protein, we selected epit - opes from residues 500-559 of ClfA, amino acid residues 130  to 454 of IsdB, and the first 50 amino acid residues after Hlg  signal peptide, because polyclonal antibodies generated  against these regions.",Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
 Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 105 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99gene expression that is highly dependent on forming stable  structures by nucleotide pairing in 5’ terminus [24].,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
ORCID Somayeh Delfani  http://orcid.org/0000-0001-6707-8070 Abbas Ali Imani Fooladi  http://orcid.org/0000-0001-7339-                                                                     8257 Ashraf Mohabati Mobarez  http://orcid.org/0000-0002-1224-                                                                          6134 Mohammad Emaneini  http://orcid.org/0000-0002-0208-7264 Jafar Amani  http://orcid.org/0000-0002-5155-4738 References 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
Somayeh Delfani et al • In silico  analysis for identifying potential vaccine 106 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2015.4.1.99a protective monoclonal antibody recognizing Staphylo - coccus aureus MSCRAMM protein clumping factor A.,Non-OADS,/arxiv_data1/oa_pdf/b5/d1/cevr-4-99.PMC4313115.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/f9/srep08156.PMC4313116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8156 | DOI: 10.1038/srep08156 8",Non-OADS,/arxiv_data1/oa_pdf/e0/f9/srep08156.PMC4313116.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/5d/srep08155.PMC4313120.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/9b/ehu359.PMC4313363.pdf
: available at https://www.dcri.org/ about-us/conﬂict-of-interest/Califf-COI_2 –3–2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/9b/ehu359.PMC4313363.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ___________________________________________________________________ _________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
"28.111.14October2014http://mjiri.iums.ac.irconsidering such factors as the job d e- mands, personal health status and mental resources  how he/she will do the work (5).",Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
28.111.14October2014 http://mjiri.iums.ac.irWorkabilitymeasurement The participants’ work ability was a s- sessed using the Work Ability Index que s- tionnaire (15).,OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
28.111.14October2014http://mjiri.iums.ac.irTable 1 demonstrates the average scor es of various WAI items.,Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
28.111.14October2014 http://mjiri.iums.ac.irLogistic Regression Analysis was used for a deeper investigation of the relatio n- ship between work ability and sleep diso r- der.,Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
28.111.14October2014http://mjiri.iums.ac.irdisorder.,Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
"28.111.14October2014 http://mjiri.iums.ac.irIn a cross -sectional study on 420 workers in a petrochemical complex in Iran, Mazloumi et al.",OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
28.111.14October2014http://mjiri.iums.ac.irOccupational Health; 1994.,Non-OADS,/arxiv_data1/oa_pdf/d8/01/MJIRI-28-111.PMC4313440.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________________________________________________________________________________________ ____ 1.,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
28.127.11November 2014http://mjiri.iums.ac.irmapped on to chromosome 17q11.1 -q12 (3).,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
28.127.11November 2014  http://mjiri.iums.ac.irHAM–A and HAM -D was used to assess the severity of anxiety and depression in these disorders.,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
28.127.11November 2014http://mjiri.iums.ac.irthe anxiety group 56.67% (n= 17).,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
28.127.11November 2014 http://mjiri.iums.ac.irdifferences were observed in the genotype or allele frequencies between controls and depressed group ( p> 0.05) (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
"28.127.11November 2014http://mjiri.iums.ac.irgenotypes in the controls of the present study were 12.5%,55% and 32.5%  while Billiviers et al.",OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
28.127.11November 2014 http://mjiri.iums.ac.irimmortalized raphe cells.,Non-OADS,/arxiv_data1/oa_pdf/81/82/MJIRI-28-127.PMC4313441.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
28.117.22 October 2014http://mjiri.iums.ac.irpeak (P1) in th e ipsilateral sternocleid o- mastoid (SCM) followed by a negative peak (N1) (6).,Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
"28.117.22 October 2014  http://mjiri.iums.ac.irdistortion of the results by neck muscle f a- tigue, participants were trained to rest b e- tween trials.",Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
28.117.22 October 2014http://mjiri.iums.ac.irgroups are shown in Table 1.,OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
28.117.22 October 2014 http://mjiri.iums.ac.irvate the vestibulo -collic reflex that causes the VEMP response changed as age i n- creased.,Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
"28.117.22 October 2014http://mjiri.iums.ac.irof saccular disorders, which are represent a- tive of vestibular disease.",Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
28.117.22 October 2014 http://mjiri.iums.ac.irtine angle meningioma and schwannoma.,Non-OADS,/arxiv_data1/oa_pdf/01/93/MJIRI-28-117.PMC4313442.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________ _____________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
"28.120.26 October 2014http://mjiri.iums.ac.ira rapid release of numerous neurotransmi t- ters that include serotonin (5 -HT), dop a- mine, and norepinephrine (4).",Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014 http://mjiri.iums.ac.irdata on the effects of the A2a receptor on dose distribution for MDMA.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014 http://mjiri.iums.ac.irμm2counting frame.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
"28.120.26 October 2014  http://mjiri.iums.ac.irthermocycler (Sydney, Australia).",Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014 http://mjiri.iums.ac.irexpression significantly increased in the MDMA20+CGS group compared to the MDMA20 group (p= 0.02).,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014 http://mjiri.iums.ac.irsignificant reduction in the Purkinje ne u- rons when compared with MDMA20 group.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014http://mjiri.iums.ac.irlinking MDMA exposure to increased ly m- phocyte infiltration and inflammatory da m- age to the myocardium (39).,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
"28.120.26 October 2014 http://mjiri.iums.ac.irof the Cellular and Molecular Research Center,Iran University of Medical Scien c- es, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014http://mjiri.iums.ac.irstructural and behavioral study.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
28.120.26 October 2014 http://mjiri.iums.ac.irreceptors.,Non-OADS,/arxiv_data1/oa_pdf/01/91/MJIRI-28-120.PMC4313443.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
28.125.8 November 2014http://mjiri.iums.ac.iractional leadership is identified by a sense of duty based on reward and punishment to reach goals (3).,Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
"28.125.8 November 2014 http://mjiri.iums.ac.irhealth care services (21, 22).",Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
28.125.8 November 2014 http://mjiri.iums.ac.irassessed via a test -retest approach.,Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
"28.125.8 November 2014 http://mjiri.iums.ac.irResults KMO showed that 95% of the variance was caused by 5 underlying factors with an Eigen value larger than one: 15.31, 3.99, 2.69, 1.48, 1.38, respectively (Tables 1 and 2).",OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
"28.125.8 November 2014http://mjiri.iums.ac.irfactor 3 represented 11.77% of the e x- plained variance and was related to sincer i- ty; and finally, factor 4 accounted for 6.35% of the explained variance and was related to recognition.",OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
28.125.8 November 2014 http://mjiri.iums.ac.irHigh-quality leadership relies on attitudi- nal qualities of a leader (22).,Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
"28.125.8 November 2014http://mjiri.iums.ac.irof a healthcare or educational organization, it seems crucial to consider the integrity behaviors within a coaching role that a s u- pervisor can play in decreasing burnout among staff (32).",Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
28.125.8 November 2014 http://mjiri.iums.ac.irership and Organizational Culture.,Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
"28.125.8 November 2014http://mjiri.iums.ac.irHealth Service, National Institutes of Health, N a- tional Cancer Institute.",Non-OADS,/arxiv_data1/oa_pdf/6c/2b/MJIRI-28-125.PMC4313444.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________________ ____________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
28.122.28 October 2014http://mjiri.iums.ac.irlem and it is estimated that prevalence of opium addiction has grown up by three folds for the past 20 years and now has been estimated about 2 -2.8% according to official reports in Iranian (3) A rapid situ a- tional analysis in 2007 show ed a prevalence of 3.32 for men and 0.55 for women (more than 15 years old).,Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
"28.122.28 October 2014 http://mjiri.iums.ac.irleads if necessary) in a daily basis to assess ST segment shifts, arrhythmia, MI site,and atrioventricular or interventricular block.",Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
"28.122.28 October 2014http://mjiri.iums.ac.irtein (LDL), and high density lipoprotein (HDL), but total cholesterol levels were lower in opium ad dicted patients (intr o- duce as a known side effect of op ium).",Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
28.122.28 October 2014 http://mjiri.iums.ac.irnarcotics among educated people is one of the major concerns of many social pathologists in Iran (21 -24).,Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
"28.122.28 October 2014http://mjiri.iums.ac.irconfounding, a possibility of measurement bias in determining the actual amount and route ofopium consumption because these data were collected solely based on self - reporting.",OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
Available from: http://www.who.int/substance_ abuse/terminology/definition1/en/[cited 2013 Aug 2].,Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
Available from: http://www.who.int/substanc e_abuse/publications/a tlas_report/profiles/iran.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
"28.122.28 October 2014 http://mjiri.iums.ac.irAdmitted to Special Care Centers of Shahid Bah o- nar Hospital, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1c/67/MJIRI-28-122.PMC4313445.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________ ________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014http://mjiri.iums.ac.irstrength (3 -5).,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
"28.128.11November 2014  http://mjiri.iums.ac.irOr, )8( .1693.0)21ln(1 T TTI  Therefore, TI can be adjusted to optimize the contrast between the suppressed region of interest (e g., tissue) and its surroun d- ings.",Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
"28.128.11November 2014 http://mjiri.iums.ac.irImage Analysis: The images were pr o- cessed by the transfer of the image data from the MR scanner to a personal compu t- er, and they were then computerized by an image-processing software in an interactive data language (ID L, Research Systems, Inc.; http://www.rsinc.com).",OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014  http://mjiri.iums.ac.irEq.(3)).,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
"28.128.11November 2014 http://mjiri.iums.ac.irDiscussionThe IR sequ ences will be started with a 180-degree inversion radiofrequency pulse, and the pulse will flip the longitudinal Fig.5.Exhibits the concentration of the contrast agent versus the mean SI from the 9 innermost pixels of the vials at TI = 700ms.",Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014  http://mjiri.iums.ac.irmagnetization vector through the x -y plane and into the z-direction.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014 http://mjiri.iums.ac.ircalled T1 recovery.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014 http://mjiri.iums.ac.iralso on the time at which the readout se- quence is applied.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
28.128.11November 2014http://mjiri.iums.ac.ir2010 Feb;3:120 -6.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/MJIRI-28-128.PMC4313446.pdf
"Review Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD,PhD, GMP, Compliant Stem Cell Manufacturing Facility, Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014http://mjiri.iums.ac.irlack of internationally accepted scientific evidences, cell -based therapies offer great promise for many currently intractable conditions including neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014 http://mjiri.iums.ac.irerat$ or contus$)).tw,ot.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
28.112.14October2014http://mjiri.iums.ac.irless than 0.05 were regarded significant.,OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014 http://mjiri.iums.ac.irblind therapists to use stem cell transplant, none of the clinical trials reported alloc a- tion concealment or blinding.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014http://mjiri.iums.ac.irwas observed among them by considering ASIA-A, acute, cervical and thoracic su b- groups of patients.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
28.112.14October2014  http://mjiri.iums.ac.ircome (motor and sensory scores) might a l- so be useful in these trials.,Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
28.112.14October2014 http://mjiri.iums.ac.irwere to obtain improvement in ASIA scale.,Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014  http://mjiri.iums.ac.irled to this result because the likelihood of improvement in patients with incomplete impairment should be more than the co m- plete functional impairment (19).In addi- tion, there was homogeneity between the studies tha t included patients with ASIA -B at baseline in contrast with studies that i n- cluded ASIA –A at baseline (Fig s.3, 4).Incomparison with the cervical and lumbar segment, cell transplantation in a thoracic segment might be less likely to affect a si g- nificant outcome.",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
28.112.14October2014http://mjiri.iums.ac.irvantages and risks of treating cervical ve r- sus thoracic injuries (18).,Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
"28.112.14October2014 http://mjiri.iums.ac.irments, and this might have led to an ove r- estimation of the overall outcome (24).",Non-OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
28.112.14October2014http://mjiri.iums.ac.irStem Cells 2007;25(8):2 066-73.,OADS,/arxiv_data1/oa_pdf/59/52/MJIRI-28-112.PMC4313447.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014 http://mjiri.iums.ac.irshifting the focus from a neoplastic process to an inflammatory one.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014  http://mjiri.iums.ac.irheads of gastrochenemious were detached and posterior transverse capsulotomy was performed (Fig .2).,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014http://mjiri.iums.ac.ir2-17 years).,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014 http://mjiri.iums.ac.irOurcases had a mean age of 27 years and a female preponderance (18F: 8M).,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014http://mjiri.iums.ac.irpart of the synovium remained intact.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
"28.123.29 October 2014 http://mjiri.iums.ac.irextracellular, foamy histiocytes or mon o- nuclear cells and giant cells (3,4,11).",Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
28.123.29 October 2014http://mjiri.iums.ac.irM.T.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/MJIRI-28-123.PMC4313448.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________ _____________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
"28.124.1November 2014 http://mjiri.iums.ac.irniques have been proposed for the trea t- ment of recurrent LDH including aggre s- sive medical management, minimally inv a- sive discectomy, open conventional disce c- tomy alon e, or discectomy with instrumen t- ed fusion (12).",Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
"28.124.1November 2014 http://mjiri.iums.ac.iring of the patient on the radiolucent opera t- ing table, midline incisio n, paravertebral muscles retraction and scar tissue resection were carried out.",Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
"28.124.1November 2014http://mjiri.iums.ac.irfinally, 51 patients (30 female, 21 male) remained for evaluation.",Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
28.124.1November 2014 http://mjiri.iums.ac.ireight patients with recurrent LDH) (20).,Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
"28.124.1November 2014http://mjiri.iums.ac.irAcknowledgment s The authors thank Student Research Committee, Faculty of Medicine, Ma shhad University of Medical Sciences for its f i- nancial support.",Non-OADS,/arxiv_data1/oa_pdf/7b/44/MJIRI-28-124.PMC4313449.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
28.115.20 October 2014 http://mjiri.iums.ac.irand allegic activities.,Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
28.115.20 October 2014 http://mjiri.iums.ac.irResults The Ki-67 positive cells were experessed light to dark brown color of nuclei in basal and squamous layer of epithelium (Fig.,OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
28.115.20 October 2014http://mjiri.iums.ac.irtween lymph node involvement with e o- sinophilc cells and Ki67 positive cells counts was exist.,Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
"28.115.20 October 2014 http://mjiri.iums.ac.irty, respectively (13).",Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
28.115.20 October 2014http://mjiri.iums.ac.irvolvement on hematoxilin -eosin sections when immunohistochemical technique is not available.,Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
28.115.20 October 2014 http://mjiri.iums.ac.ir20.,Non-OADS,/arxiv_data1/oa_pdf/40/84/MJIRI-28-115.PMC4313450.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.Neonatologist, Family Health Institute, Maternal -Fetal  & Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
28.119.25 October 2014http://mjiri.iums.ac.ir-Hb level -Presence of another disease ( which r e- sult in oxygen -transportation difficulty): Pulmonary dysplasia Congenital heart disease Respiratory distress syndrome (1) In most cases transfusion is a common procedure for treating anemia of prematur i- ty or as a replacement for the blood taken from newborns (2).,Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
"28.119.25 October 2014 http://mjiri.iums.ac.irIn the first group the blood transfusion took place based on neonatologists' opi n- ion, so blood transfusion guide was applied according toneonate'sgeneral condition, symptoms and laboratory test.",Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
"28.119.25 October 2014http://mjiri.iums.ac.irboth group, %66 in the first group and %77 in the second one ( p=0.74).",Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
"28.119.25 October 2014 http://mjiri.iums.ac.irless than 1500 grams and under age of 35 weeks, number of blood infusions may have shown an increase.",Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
28.119.25 October 2014http://mjiri.iums.ac.irbe conducted to reduce the v olume of blood taken in newborns.,Non-OADS,/arxiv_data1/oa_pdf/a7/f8/MJIRI-28-119.PMC4313451.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
28.130.17 November 2014http://mjiri.iums.ac.irse problems may have significant effects on speechprocessing and communication of patients with CVA (1).,Non-OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
"28.130.17 November 2014 http://mjiri.iums.ac.irHearing assessments The instruments used in this study were immitance acoustic (Interacoustics, AZ7), two channels audiometer (Amplaid, 311), CD player with microphone input, and compact disk (CD) related to Persian ve r- sion of CST and DDT.",OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
28.130.17 November 2014http://mjiri.iums.ac.irwas statistically significant (F=0.319 & p=0.049).,OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
"28.130.17 November 2014 http://mjiri.iums.ac.irIn this test, the participants’ task is to listen and attend to the target mess age and segr e- gate it from simultaneous competing se n- tence.",Non-OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
"28.130.17 November 2014http://mjiri.iums.ac.irright hemisphere CVA represented ev i- dence of difficult ies in central auditory tests including CST and DDT, we could premise that they have problems in concurrent aud i- tory segregation and speech perception.",Non-OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
28.130.17 November 2014 http://mjiri.iums.ac.irlisteners.,Non-OADS,/arxiv_data1/oa_pdf/53/0d/MJIRI-28-130.PMC4313452.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/33/8e/MJIRI-28-121.PMC4313453.pdf
28.121.27 October 2014http://mjiri.iums.ac.irmay also lowers the cause low MCV and MCH values (6).,Non-OADS,/arxiv_data1/oa_pdf/33/8e/MJIRI-28-121.PMC4313453.pdf
28.121.27 October 2014 http://mjiri.iums.ac.irin Table 2.,Non-OADS,/arxiv_data1/oa_pdf/33/8e/MJIRI-28-121.PMC4313453.pdf
28.121.27 October 2014http://mjiri.iums.ac.irEngl J Med 2005;353:1135 -46.,Non-OADS,/arxiv_data1/oa_pdf/33/8e/MJIRI-28-121.PMC4313453.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
"28.114.18 October 2014http://mjiri.iums.ac.irencing the medical community and health system policy -makers(1,2).",Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
28.114.18 October 2014 http://mjiri.iums.ac.iranalysis method.,Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
28.114.18 October 2014http://mjiri.iums.ac.irhigher than in females (p= 0.04).,Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
28.114.18 October 2014 http://mjiri.iums.ac.irthy source of health and medical news (18).,Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
"28.114.18 October 2014http://mjiri.iums.ac.ircy and Law, 2003 ;28(5): 927 -950.",Non-OADS,/arxiv_data1/oa_pdf/61/8e/MJIRI-28-114.PMC4313454.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
28.129.15 November 2014http://mjiri.iums.ac.irstill remain a popular choice in surgical treatment of bone sarcoma.,Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irIsolation and culture of bone marrow MSC:Five male SD rats were prepared for allogenic donor, bone marrow MSC was extracted from both tibia and femur of each rat.Bone marrow cell s were taken using modified Dobson method by putting the bone in 25 mL polypropylene conical flask.",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014http://mjiri.iums.ac.irsite were identified, and temporary K -wire was removed.",OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
28.129.15 November 2014  http://mjiri.iums.ac.irBone Mechanical Strength Test The mechanical strength of bone was examined by bending test.,Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irassumed showed significant difference b e- between the radiological mean score of proximal osteotomy (PO) at week-2 to week-8(F(3,8) = 62.593, p<0.0001 ).",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irtest showed no significant difference at week-2 (p= 0.059), however, it was statisticallydifferent at week -4 (p=0.027).",OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irImmunohistochemistry of alkaline pho s- phosphatase and osteocalcin Alkaline phosphatase and osteocalcin expression of tissue showed positive resultsin group I -III and negative in group IV -V. Alkaline phosphatase expression was most commonly found in group III (80%), followed by group II (67%), and group I (33%).",OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014  http://mjiri.iums.ac.irthe graft suits individual patient (matc hing) (3,37-38).",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
28.129.15 November 2014http://mjiri.iums.ac.irhave the following three criteria (42).,Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irunderwent union with mature bone, by forming lamellar bone that surround the cortical wall.",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014http://mjiri.iums.ac.irWithout exogenous application of rhBMP-2,healingofosteotomy occurred slower(delayed union)ormight develop non-union.When the number of osteogenic cellswas sufficient ,healingofosteotomy / fracturewould still took place even without theadministration of BMP-2(58).This can be seen in some of the ratsin group I -III which had complete healingwith score 4 .",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014 http://mjiri.iums.ac.irultimate bending force as healthy bone, it required 228% greater cross -sectional area.",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
"28.129.15 November 2014http://mjiri.iums.ac.ir19.Santoni BG, Turner AS, Wheeler DL, Nich o- las RW, Anchordoquy TJ, Ehrhart N. Gene ther a- py to enhance allograft incorporation after host tissue irradiation.",Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
28.129.15 November 2014 http://mjiri.iums.ac.irBlood 2001;97:12227 -31.,Non-OADS,/arxiv_data1/oa_pdf/ce/74/MJIRI-28-129.PMC4313455.pdf
Original Article http://mjiri.iums.ac.ir MedicalJournal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________ _______________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
28.126.8 November 2014http://mjiri.iums.ac.irtection of Mycobacterium tuberculosis complex (MTC) since it requires 103to 104 organisms per ml of sputum and also needs expert specialists to report accurate diagn o- sis of TB in suspects.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
28.126.8 November 2014  http://mjiri.iums.ac.irrpm for 4 min at 4oC.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
28.126.8 November 2014http://mjiri.iums.ac.irble 1).,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
28.126.8 November 2014 http://mjiri.iums.ac.irin-house PCR would be reliable indicator and can be compared with those found in other experiments.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
"Available at: http://www.hpa.org.uk 3.PaiM,Minion J,Sohn H,Zwerling A ,Perkins MD.",Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
Available at: http://www.who.int/tb/dots/laboratory /resourcs).,OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
Available at: http://www.who.int/tb/dots/laboratory/resources ).,OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
28.126.8 November 2014http://mjiri.iums.ac.irman nucleated cells.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
[ Modified from protocols by Barker et al (1998) ] Available at: http://ccoon.myweb.usf.edu/ecoimmunology.org/Ab out_Home.html 12.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/MJIRI-28-126.PMC4313456.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/92/MJIRI-28-113.PMC4313457.pdf
"28.113.15 October 2014http://mjiri.iums.ac.irRheumatoid Factors (RF), Anti -Nuclear Antibody (ANA), and Anti -Cyclic Citrull i- nated Peptide (Anti -CCP) antibodies (2).",Non-OADS,/arxiv_data1/oa_pdf/8c/92/MJIRI-28-113.PMC4313457.pdf
28.113.15 October 2014 http://mjiri.iums.ac.irtime of hospitalization.,Non-OADS,/arxiv_data1/oa_pdf/8c/92/MJIRI-28-113.PMC4313457.pdf
"28.113.15 October 2014http://mjiri.iums.ac.irADA was calculated to be 77.5%, which means that 77.5% of the JIA negative p a- tients were ADA negative.",OADS,/arxiv_data1/oa_pdf/8c/92/MJIRI-28-113.PMC4313457.pdf
28.113.15 October 2014 http://mjiri.iums.ac.irpopulations.,Non-OADS,/arxiv_data1/oa_pdf/8c/92/MJIRI-28-113.PMC4313457.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
28.118.22October2014http://mjiri.iums.ac.irple(8).,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
"28.118.22 October 2014 http://mjiri.iums.ac.ir(difficulty of understanding words and phrases), the fit (fit and proper communica- tion with the statements of the question- naire) and uncertainty (probability of false impressions despite the failure of the mean- ings of words or phrases) were studied ,also fifteenexpertsreviewedthe items.",OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
28.118.22October2014http://mjiri.iums.ac.irand other items receivedscored 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
"28.118.22 October 2014 http://mjiri.iums.ac.irsis,patientswithscore less than 11 were considered as healthy (no stroke) and those withscore 11 and upper, suspected as stroke or TIA.",Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
28.118.22October2014http://mjiri.iums.ac.irproblems and imp aired balance in the pos- terior circulation problems (24).,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
28.118.22 October 2014 http://mjiri.iums.ac.irtechnicians’ take an appropriate training course about the importance of immediate action in the treatment of stroke and em- phasizing the role of pre -hospital emergen- cy care in the t reatment of these patients.,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
28.118.22October2014http://mjiri.iums.ac.ir28(4):563-75.,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/MJIRI-28-118.PMC4313458.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________ _____________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
28.116.21 October 2014http://mjiri.iums.ac.iraged and overweight people.,Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
"28.116.21 October 2014 http://mjiri.iums.ac.irsoftware (KNIME2.6), and we also asked two experts to evaluate these variables in order to select those which were signif i- cantly different between cirrhotic and non- cirrhotic patients with NAFLD.",Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
28.116.21 October 2014http://mjiri.iums.ac.irbe claimed that over -fitting had not o c- curred in the training phase.,Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
28.116.21 October 2014  http://mjiri.iums.ac.irrate.,Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
"28.116.21 October 2014http://mjiri.iums.ac.irConclusion The results of this study revealed that the neural network modeling is a simple, no n- invasive and accurate method of diagnosing cirrhosis only based on routine laboratory data.",Non-OADS,/arxiv_data1/oa_pdf/90/72/MJIRI-28-116.PMC4313459.pdf
Available from: http://www.shroffeye.org/wp‑content/uploads/2012/06/ Low‑vision.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/07/IJO-62-1113.PMC4313488.pdf
Available from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/db/d1/IJO-62-1121.PMC4313490.pdf
Available  from:   http://www.who.int/blindness/causes/priority/en/index  5.html.,Non-OADS,/arxiv_data1/oa_pdf/a1/fd/IJO-62-1125.PMC4313491.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs282/en/.,Non-OADS,/arxiv_data1/oa_pdf/2c/ef/IJO-62-1152.PMC4313496.pdf
Available at: http://www.epa.gov/ scipoly/sap/meetings/2013/may/052113minutes.pdf.,OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: http://www.altex.ch/resources/WR Juberg epub.pdf pii:S1868696 ×1309271X.,Non-OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Slide presentation at: http://www.epa.gov/scipoly/ oscpendo/presentations/intact male presentation 080205.ppt.,Non-OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
"Guidelines for Testing of Chemicals, Section 4: Health Effects , protocol number 440, uterotrophic bioassay in rodents: a short- term screening test for oestrogenic properties http://www.oecd- ilibrary.org/environment/test-no-440-uterotrophic-bioassay-in- rodents 9789264067417-en;jsessionid =12ic71yg7bopl.delta.",Non-OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: http://www.epa.gov/endo/pubs/female isrv4.1c.pdf.,OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Avail- able at: http://www.regulations.gov/#!documentDetail; D=EPA-HQ-OPPT-2009-0576-0009.,Non-OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: http://www.regulations .gov/#!documentDetail;D =EPA-HQ-OPPT-2009-0576-0010.,OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: <http://www.regulations.gov/#!document Detail;D =EPA-HQ-OPPT-2010-0877-0021 >.,Non-OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: http://www.epa.gov/ scipoly/oscpendo/pubs/toresources/clariﬁcationdoc.pdf.,OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
Available at: http://www.epa.gov/ scipoly/oscpendo/pubs/use oftier1data inriskassessment.pdf.,OADS,/arxiv_data1/oa_pdf/64/6d/bdrb0101-0043.PMC4313686.pdf
"Available at: http://www-lp.fmf.uni-lj.si/plestenjak/Papers/NICEGR.pdf1996,1–10.",Non-OADS,/arxiv_data1/oa_pdf/34/66/wcms0005-0096.PMC4313690.pdf
"Available at http://www.cseltehu/egres/qp/egresqp-11-07ps 2011, 1–3.",Non-OADS,/arxiv_data1/oa_pdf/34/66/wcms0005-0096.PMC4313690.pdf
"Hypothesis & Experience  Original Article Asia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.1.40 Asia Pac Allergy 2015;5:40-46Tolerance to etoricoxib in children with nonste - roidal anti-inflammatory drug hypersensitivity Wenyin Loh*, Hwee Hoon Lim, Rajeshwar Rao, Anne Goh, Lin Xin Ong, and Wen Chin Chiang Allergy Service, Department of Pediatric Medicine, KK Women’s and Children’s Hospital, Singapore 229899, Singapore Background:  Cyclooxygenase-2 (COX-2) inhibitors have been found to be safe alternatives in adults with cross-intolerant  hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs).",Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
Tolerance to etoricoxib in children 41 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.40 pathway of arachidonic acid metabolism.,Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
Asia Pacific allergy42 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.40confirmed by performing an oral provocation test in an open  procedure.,Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
"Tolerance to etoricoxib in children 43 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.40  hypersensitivity to paracetamol, diclofenac and aspirin.",Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
Asia Pacific allergy44 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.40patients were lost to follow-up.,Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
Tolerance to etoricoxib in children 45 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.40NSAID hypersensitivity was the only parameter that increased  the odds of a positive NSAID challenge in children.,Non-OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
"Asia Pacific allergy46 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.40Nunez I, Gomez F, Salas M, Rondon C, Canto MG, Blanca M. Drug  hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients.",OADS,/arxiv_data1/oa_pdf/d0/39/apa-5-40.PMC4313751.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.1.25 Asia Pac Allergy 2015;5:25-31Validation of the Korean version of the European Com - munity Respiratory Health Survey screening  question - naire for use in epidemiologic studies for adult asthma Woo-Jung Song1, So-Hee Lee1,2, Min-Gyu Kang1, Ju-Young Kim1, Mi-Young Kim3, Eun-Jung Jo4, Suh-Young Lee1,  Seung-Eun Lee4, Min-Hye Kim5, Min-Suk Yang1,6, Sae-Hoon Kim1,7, Hye-Ryun Kang1, Hye-Kyung Park4,    Heung-Woo Park1, Yoon-Seok Chang1,7, Sun-Sin Kim1,2, Jong-Myung Lee5, Kyung-Up Min1, and Sang-Heon Cho1,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul 135-984, Korea 3Department of Internal Medicine, Inje University Pusan Paik Hospital, Busan 614-735, Korea 4Department of Internal Medicine, Pusan National University School of Medicine, Busan 626-870, Korea 5Department of Internal Medicine, Kyungpook National University Medical School, Daegu 700-842, Korea 6Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul 156-707, Korea 7Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Background:  Standardized questionnaire is one of key instruments for general population surveys.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
"Asia Pacific allergy26 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.25INTRODUCTION Rapid increase in the prevalence of asthma has been the  motivation for initiating global epidemiologic studies [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
Validation of the ECRHS questionnaire in Korean27 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.25specialist physicians and 2 other bilingual persons.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
Asia Pacific allergy28 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.25minutes to complete the fill-up.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
Validation of the ECRHS questionnaire in Korean29 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.25medication’) showed high specificity (0.96–0.98).,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
SUPPLEMENTARY MATERIALS Supplementary Tables can be found via http://www.apallergy.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
Asia Pacific allergy30 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.258.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
Validation of the ECRHS questionnaire in Korean31 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.25a definition of asthma for epidemiology.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/apa-5-25.PMC4313752.pdf
EditorialAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.1.1 Asia Pac Allergy 2015;5:1-2 Copyright © 2015.,Non-OADS,/arxiv_data1/oa_pdf/d5/c1/apa-5-1.PMC4313753.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d5/c1/apa-5-1.PMC4313753.pdf
apallergy.org  Chang YSAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2015.5.1.12   Study of Asthma and Allergies in Childhood) questionnaire [6].,Non-OADS,/arxiv_data1/oa_pdf/d5/c1/apa-5-1.PMC4313753.pdf
"Case Report http://dx.doi.org/10.5415/apallergy.2015.5.1.51 Asia Pac Allergy 2015;5:51-54Oral antiplatelet agent hypersensitivity and cross- reactivity managed by successful desensitisation Nicholas Chin1,*, Kanishka Rangamuwa1, Raymond Mariasoosai1, Jonathan Carnes1, and Francis Thien1,2 1Department of Respiratory Medicine, Eastern Health, Melbourne, Victoria 3128, Australia 2Professor of Respiratory Medicine, Allergy and Immunology, Monash University, Melbourne, Victoria 3145, Australia Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including  coronary stent thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
Asia Pacific allergy52 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.51CASE REPORT A 57-year-old man with significant history of ischaemic heart  disease underwent elective percutaneous coronary intervention  to the proximal left anterior descending artery with insertion of  two drug-eluting stents in February 2014.,Non-OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
"Antiplatelet cross-reactivity and desensitisation53 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.51side effects of diarrhoea, neutropenia and thrombocytopenic  purpura.",Non-OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
Asia Pacific allergy54 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.51(Table 1) and performed in a high dependency unit under close  supervision with cardiac monitoring.,OADS,/arxiv_data1/oa_pdf/c7/09/apa-5-51.PMC4313754.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.1.3 Asia Pac Allergy 2015;5:3-16Tick-induced allergies: mammalian meat allergy,  tick anaphylaxis and their significance Sheryl van Nunen* Department of Clinical Immunology and Allergy, Royal North Shore Hospital and  Sydney Medical School-Northern, St Leonards NSW 2065, Australia Serious tick-induced allergies comprise mammalian meat allergy following tick bites and tick anaphylaxis.",Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
van Nunen S Asia Pacific allergy4 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3The more severe tick-induced allergies are mammalian meat  anaphylaxis and allergy or anaphylaxis following tick bites and  tick anaphylaxis.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Mammalian meat allergy and tick anaphylaxis5 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3and genitals or where infection would have more deleterious  consequences e.g.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
"van Nunen S Asia Pacific allergy6 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3people which includes the tick endemic areas nearby, and she  currently diagnoses one-two new patients with this complaint  each week [9].",Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Mammalian meat allergy and tick anaphylaxis7 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3mammalian meat allergy.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
"van Nunen S Asia Pacific allergy8 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3As far as the author is aware, no cases have yet been reported  from South America, however, Ixodidae ticks are known to be  present and 3 species frequently parasitise humans: Arvicanthis  neumanni in 46 known localities in Argentina, Amblyomma triste    in 21 known sites in Uruguay and Amblyomma parvum  in 27  known areas in Argentina-Brazil, with human infestation by Ixodes  spp.",Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
"Mammalian meat allergy and tick anaphylaxis9 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3Confirmation of a diagnosis of mammalian meat  allergy following tick bites Confirmation of a diagnosis of an allergic reaction due to  mammalian meat involves serological testing for α-Gal  specific- IgE and mammalian meat specific-IgE [8, 24, 27 , 31]  or cetuximab  skin testing [20, 24, 29, 30] or skin prick testing by prick-prick tests  with fresh, raw, organic meat or extracts thereof [3,  8, 21, 24].",Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
"van Nunen S Asia Pacific allergy10 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3meat allergic patients of the risks inherent in taking cetuximab  [5, 15] as fatal reactions have occurred with its use [15].",Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Mammalian meat allergy and tick anaphylaxis11 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3erythrocytes during the red cell ageing process [47].,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
van Nunen S Asia Pacific allergy12 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3aimed at limiting transmission of infection and is not suitable for  preventing allergic reactions to ticks.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Mammalian meat allergy and tick anaphylaxis13 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3promotion of such a profile in the mouse following successive  tick infestations with  Rhipicephalus sangueineus .,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
van Nunen S Asia Pacific allergy14 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.35.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Mammalian meat allergy and tick anaphylaxis15 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.3Hautarzt	2012;63:299-306.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
Available	from:	http://www.tiara.org.au/.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
van Nunen S Asia Pacific allergy16 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.3venom.,Non-OADS,/arxiv_data1/oa_pdf/ab/51/apa-5-3.PMC4313755.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.1.17 Asia Pac Allergy 2015;5:17-24Carbohydrates as food allergens Jian Yi Soh1,2, Chiung Hui Huang1,2, and  Bee Wah Lee1,2,* 1Department of Paediatrics, Khoo Teck Puat National Children’s Medical Institute, National University Hospital, Singapore 119228 , Singapore 2Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore  119 077, Singapore The literature supports the notion that carbohydrate epitopes, on their own, do not contribute significantly to the induction of  allergic reactions.",Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Soh JY, et al.Asia Pacific allergy18 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.17to form glycoproteins.",OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
Carbohydrates as food allergens19 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.17of blocking antibodies of the IgG4 type.,Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Soh JY, et al.Asia Pacific allergy20 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.17significance has been increasingly challenged in recent years.",Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Carbohydrates as food allergens21 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.17in Hiroshima, Japan [55] who drank a lactic acid beverage  in November 1991.",Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Soh JY, et al.Asia Pacific allergy22 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.17ACKNOWLEDGEMENTS This study was funded by a grant (CIRG12nov060) from the  National Medical Research Council, Singapore .",Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
Carbohydrates as food allergens23 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.17Allergy Immunol 2007;142:99-115.,Non-OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Soh JY, et al.Asia Pacific allergy24 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.17G.",OADS,/arxiv_data1/oa_pdf/52/ad/apa-5-17.PMC4313756.pdf
"Case Report http://dx.doi.org/10.5415/apallergy.2015.5.1.55 Asia Pac Allergy 2015;5:55-56Anaphylaxis due to caffeine Kumiya Sugiyama1,2,*, Tatsurai Cho3, Masamitsu Tatewaki1,2, Shogo Onishi2, Tatsuya Yokoyama2, Naruo Yoshida1,2,  Takayoshi Fujimatsu1,2, Hirokuni Hirata2, Takeshi Fukuda2, and Yasutsugu Fukushima1,2 1Department of Respiratory Medicine, Dokkyo Medical University Koshigaya Hospital, Koshigaya 343-8555, Japan 2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University,  Mibu 321-0293, Japan  3Moka-Seibu Clinic, Moka 321-4364, Japan We report a rare case of anaphylaxis due to caffeine intake.",Non-OADS,/arxiv_data1/oa_pdf/ea/9c/apa-5-55.PMC4313757.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/9c/apa-5-55.PMC4313757.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ea/9c/apa-5-55.PMC4313757.pdf
Asia Pacific allergy56 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.55episode.,OADS,/arxiv_data1/oa_pdf/ea/9c/apa-5-55.PMC4313757.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · e ISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.1.32 Asia Pac Allergy 2015;5:32-39Reduced severity and improved control of self- reported asthma in Finland during 2001–2010 Paula Kauppi1,*, Sirpa Peura2, Johanna Salimäki2, Salme Järvenpää3, Miika Linna4, and Tari Haahtela1  1Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki 00250, Finland 2Association of Finnish Pharmacies, Helsinki 00500, Finland 3MedCare Ltd., Äänekoski 44100, Finland 4The Institute of Healthcare Engineering, Management and Architecture, Aalto 00076, Finland Background:  Asthma and allergies are common and cause substantial burden in symptoms and suffering, hospitalizations and  medication costs.",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Asthma in Finland 2001–201033 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.32 mortality decreased, as well as hospitalizations, despite the  increase in total number of patients [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Asia Pacific allergy34 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.32almost daily, and daily.",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Asthma in Finland 2001–201035 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.32 determinants for severe asthma in 2010, the relevant data was  dichotomized to reflect severe (score 6–10, n = 243, 40%), or mild asthma (score 0–5, n = 365, 60%).",OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Asia Pacific allergy36 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.32need for hospitalizations are in line with previous observations  [2, 13], and are objective evidence of decreasing asthma burden.",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
Asthma in Finland 2001–201037 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.32for more severe asthma [1 1].,Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
Asia Pacific allergy38 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.32in 2001 and autumn in 2010 which may have had an impact on  those purchasing asthma medication.,Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Asthma in Finland 2001–201039 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.32SD, Wenzel SE, Zar HJ.",Non-OADS,/arxiv_data1/oa_pdf/3e/3f/apa-5-32.PMC4313758.pdf
"Educational & Teaching Material  Case Report http://dx.doi.org/10.5415/apallergy.2015.5.1.47 Asia Pac Allergy 2015;5:47-50Refractory intraoperative hypotension with    elevated serum tryptase Juraj Sprung1,*, Kelly J. Larson1, Rohit D. Divekar2, Joseph H. Butterfield3, Lawrence B. Schwartz4, and    Toby N. Weingarten1 1Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA 2Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA 3Department of Internal Medicine, Mayo Clinic Program for the Study of Mast Cell and Eosinophil Disorders, Mayo Clinic, Rochester, MN 55905,  USA 4Division of Rheumatology, Allergy & Immunology, Virginia Commonwealth University, Richmond, VA 23298, USA  Severe intraoperative hypotension has been reported in patients on angiotensin-converting enzyme inhibitors and angiotensin  II receptor subtype 1 antagonists.",Non-OADS,/arxiv_data1/oa_pdf/87/ce/apa-5-47.PMC4313759.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/87/ce/apa-5-47.PMC4313759.pdf
"Asia Pacific allergy48 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.47developed hypotension recalcitrant to treatment with intravenous  crystalloids, ephedrine, phenylephrine and vasopressin and  bradycardia recalcitrant to ephedrine and glycopyrrolate.",Non-OADS,/arxiv_data1/oa_pdf/87/ce/apa-5-47.PMC4313759.pdf
Refractory hypotension with elevated tryptase49 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.1.47[3].,Non-OADS,/arxiv_data1/oa_pdf/87/ce/apa-5-47.PMC4313759.pdf
"Asia Pacific allergy50 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.1.47Elberink JN, de Monchy JG.",Non-OADS,/arxiv_data1/oa_pdf/87/ce/apa-5-47.PMC4313759.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/f4/main.PMC4313763.pdf
"Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63571Genomics Data 3 (2015) 112 –115 Speci ﬁcations Organism/cell line/tissue Homo sapiens Sequencer or array type Affymetrix Human Exon 1.0 ST ArrayData format Raw data: .CEL ﬁles, processed data: .chp ﬁles Experimental factors Gene expression pro ﬁling in lung cancer tissues vs. normal controls Experimental features The gene expression patterns of lung cancer covering four subtypes (adenocarcinoma, large cell carcinoma,stromal sarcoma, and synovial sarcoma) and normalcontrol were compared and analyzed.",OADS,/arxiv_data1/oa_pdf/25/f4/main.PMC4313763.pdf
http://dx.doi.org/10.1016/j.gdata.2014.12.004 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/f4/main.PMC4313763.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/f4/main.PMC4313763.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/25/f4/main.PMC4313763.pdf
http://dx.doi.org/10.1056/NEJM199808203390806 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1097/ INF.0b013e3182a5c30d .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1086/591698 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
Clin Microbiol Rev 23:616 – 687. http://dx.doi.org/ 10.1128/CMR.00081-09 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1016/S0140-6736(09)61999-1 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1007/s00281-011-0293-5 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
J Exp Med 12:67– 81. http://dx.doi.org/10.1084/ jem.12.1.67 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1136/bmj.2.5350.149 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1111/j.1749-6632.1965.tb11644.x .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1111/j.1365 -2958.1994.tb00304.x .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1128/AAC.00096-06 .13.Kernodle DS.,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1093/infdis/jir141 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
N Engl J Med 346: 491– 496. http://dx.doi.org/10.1056/NEJMoa011297 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1126/science.1081147 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1001/ jama.2013.3010 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1016/ j.mib.2011.10.012 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1093/infdis/jis462 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1093/cid/cit123 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
BMC Microbiol 14:63.http://dx.doi.org/10.1186/1471-2180-14 -63.,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1084/jem.20141404 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1111/j.1749-6632.1974.tb41496.x .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1084/jem.20020552 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1073/ pnas.0404382101 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1084/ jem.20092514 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1128/IAI.00230-12 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1128/mBio.00575-13 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1128/IAI.74.4.2215-2223.2006 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1093/cid/cis033 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1111/j.1699-0463.1972.tb00180.x .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1016/S0140-6736(06)68231-7 .,OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1126/science.285.5428.760 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1073/ pnas.96.22.12424 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1371/journal.pone.0039298 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1096/fj.11-187963 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1128/IAI.00442-12 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
Vaccine 22: 880 – 887. http://dx.doi.org/10.1016/j.vaccine.2003.11.034 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
Vaccine 28: 6382– 6392. http://dx.doi.org/10.1016/j.vaccine.2010.02.097 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1073/pnas.1222878110 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1055/s-0029-1207589 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/ 10.1093/infdis/166.2.393 .,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1016/S0022 -2836(83)80284-8 .Staphylococcal Immune Suppression in Guinea Pigs January/February 2015 Volume 6 Issue 1 e02369-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/70/74/mBio.02369-14.PMC4313907.pdf
http://dx.doi.org/10.1038/ nrmicro2548 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/JVI.74.5.2451-2454.2000 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1038/nm0602-594 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/JVI.05580 -11.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
J Virol 79:841– 852. http://dx.doi.org/10.1128/JVI.79.2.841 -852.2005 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
J Virol 83:6664 – 6672. http://dx.doi.org/10.1128/JVI.00195 -09.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/ JVI.00572-06 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/JVI.00381-10 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/JVI.03245-12 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/ mBio.00290-11 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1016/S1097 -2765(02)00465-3 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/JVI.00575-07 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1371/journal.ppat.1004309 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
Bio-chemistry 33:4730 – 4737. http://dx.doi.org/10.1021/bi00181a604 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1016/S0969-2126(96)00036-6 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1038/nchembio.521 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/ 10.1016/j.virol.2011.04.003 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1016/j.virol.2012.10.039 .,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/ JVI.01700-10 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1128/ JVI.77.13.7655-7662.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/ 10.1006/viro.2001.1141 .,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
J Virol 84:8664 – 8672. http://dx.doi.org/10.1128/ JVI.01039-10 .Rowe et al.,OADS,/arxiv_data1/oa_pdf/2c/c1/mBio.02285-14.PMC4313908.pdf
http://dx.doi.org/10.1016/ j.coph.2004.12.006 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.toxicon.2012.12.004 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/S0072-9752(07)01511-4 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1093/infdis/jit450 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1038/nrmicro3295 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1038/2338 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Structural analysis of the cata- lytic and binding sites of Clostridium botulinum neurotoxin B. Nat StructBiol7:693– 699. http://dx.doi.org/10.1038/78005 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Annu Rev Biochem 79:591– 617. http://dx.doi.org/10.1146/ annurev.biochem.051908.125345 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/ 10.1074/jbc.M703619200 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/ j.febslet.2012.11.007 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.celrep.2014.08.017 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1007/978-3-642-33570-9_7 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Cell Mol Life Sci 71: 793– 811. http://dx.doi.org/10.1007/s00018-013-1380-7 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Nature 372:415– 416. http://dx.doi.org/10.1038/372415a0 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/ j.toxicon.2008.12.027 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1007/978-3-642 -33570-9_1 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1021/bi200290p .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/ j.febslet.2013.10.010 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Trends Mol Med 20:602– 603. http://dx.doi.org/ 10.1016/j.molmed.2014.09.005 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1128/EC.00308 -07.,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Clin Toxicol (Phila) 48:880 – 895. http://dx.doi.org/10.3109/15563650.2010.526943 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1266/ jjg.66.367 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.febslet.2011.11.033 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/ j.toxicon.2013.12.012 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/ 10.1016/j.febslet.2010.11.045 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/ 10.1128/IAI.00536-13 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1371/journal.pone.0090252 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1007/978-3-642-33570-9_3 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/ 10.1126/science.1214270 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Trends Immunol 27: 434 – 440. http://dx.doi.org/10.1016/j.it.2006.07.002 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1007/s00018-009-9053-2 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1371/journal.pone.0109846 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.toxicon.2013.02.014 .47.Rummel A.,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1007/978-3-642-33570-9_4 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1038/nsb879 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/ 10.1111/j.1462-5822.2011.01654.x .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.chom.2011.06.012 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1002/mds.20010 .,Non-OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
Neuroscience 139: 629 – 637. http://dx.doi.org/10.1016/ j.neuroscience.2005.12.029 .,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/j.toxicon.2013.05.004 .Perspective 6®mbio.asm.org January/February 2015 Volume 6 Issue 1 e02131-14,OADS,/arxiv_data1/oa_pdf/18/d1/mBio.02131-14.PMC4313909.pdf
http://dx.doi.org/10.1016/S0140 -6736(09)61204-6 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1016/S1473-3099(04)00938-7 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1084/jem.20011576 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1172/JCI36731 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1164/ rccm.200207-698OC .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1172/JCI57761 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
J Biol Chem 278: 8869 – 8872. http://dx.doi.org/10.1074/jbc.C200651200 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
J Biol Chem 276: 4812– 4818. http://dx.doi.org/ 10.1074/jbc.M008072200 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
"http://dx.doi.org/10.1371/journal.ppat.1000241 .13.Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser JN.",OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1111/j.1462 -5822.2006.00878.x .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1016/0882-4010(90)90091 -4.,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1128/IAI.00579-13 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1074/ jbc.M511431200 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.4049/ jimmunol.1400133 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
Infect Immun 73:6199 – 6209. http://dx.doi.org/ 10.1128/IAI.73.10.6199-6209.2005 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1016/S0092 -8674(01)00198-2 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1084/jem.167.4.1459 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1128/mBio.01710-14 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
J Immunol 169: 6985– 6991. http://dx.doi.org/10.4049/ jimmunol.169.12.6985 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
The innate immunity role of cathepsin-D is linked to Trp-491 and Trp-492 residues of listeriolysin O. Mol Microbiol72:668 – 682. http://dx.doi.org/10.1111/j.1365-2958.2009.06673.x .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1128/mBio.00016-11 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
J Immunol 187:434 – 440. http://dx.doi.org/ 10.4049/jimmunol.1003143 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1074/ jbc.C114.548982 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1093/intimm/dxn071 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1016/ j.chom.2009.06.007 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
J Immunol 180: 6246 – 6254. http://dx.doi.org/10.4049/jimmunol.180.9.6246 .,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/ 10.1128/AEM.67.11.5190-5196.2001 .,OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1099/jmm.0.47661-0 .Lemon and Weiser 10®mbio.asm.org January/February 2015 Volume 6 Issue 1 e02110-14,Non-OADS,/arxiv_data1/oa_pdf/e1/33/mBio.02110-14.PMC4313911.pdf
http://dx.doi.org/10.1016/j.bbapap.2014.04.019 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nature 366: 469 – 472. http://dx.doi.org/10.1038/366469a0 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1007/s00430-009-0116-7 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1574-6976.2012.00347.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1093/emboj/17.13.3512 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/j.abb.2012.04.023 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/j.tibtech.2014.03.001 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1146/annurev -biochem-063011-092449 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nat Biotechnol 21:77– 80. http://dx.doi.org/10.1038/ nbt772 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1038/nsmb.2180 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nat Commun 4:2660. http://dx.doi.org/10.1038/ncomms3660 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1074/mcp.M700342-MCP200 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1365 -313X.2009.03982.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nat Cell Biol 14:640 – 648. http://dx.doi.org/ 10.1038/ncb2487 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/ j.cell.2005.02.026 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/j.cub.2009.06.033 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1126/ science.1175685 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1101/cshperspect.a000422 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Trends Cell Biol 22:662– 670. http://dx.doi.org/10.1016/j.tcb.2012.07.002 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1146/ annurev.biophys.050708.133652 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1371/ journal.pone.0033342 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/j.jbiotec.2012.09.002 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Annu Rev Microbiol 64:391– 408. http://dx.doi.org/10.1146/ annurev.micro.112408.134211 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1016/j.cell.2012.08.040 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07202.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nature441:248. http://dx.doi.org/10.1038/nature04777 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Chem Rev 108:4875– 4898. http://dx.doi.org/10.1021/cr078258w .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Appl Environ Microbiol 77:6165– 6171. http://dx.doi.org/ 10.1128/AEM.05282-11 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nat Com-mun 5:5398. http://dx.doi.org/10.1038/ncomms6398 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Mol Microbiol 61: 407– 417. http://dx.doi.org/10.1111/j.1365-2958.2006.05250.x .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1126/science.8456299 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2003.03716.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Mol Microbiol 82:818 – 835. http://dx.doi.org/ 10.1111/j.1365-2958.2011.07863.x .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nat Methods 3:887– 889. http://dx.doi.org/10.1038/nmeth953 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
ApplEnviron Microbiol 74:4944 – 4953. http://dx.doi.org/10.1128/AEM.00231 -08.,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1128/ AEM.70.2.1040-1050.2004 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1128/AEM.01640-09 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1128/ AEM.00192-14 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1128/ AEM.02143-13 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1146/annurev.micro.62.081307.162908 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07874.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Biochemistry 48: 6975– 6987. http://dx.doi.org/10.1021/bi900641c .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Proc Natl Acad Sc iUSA 105:6403– 6408. http://dx.doi.org/10.1073/ pnas.0710611105 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1002/art.21827 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1038/nbt.2461 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
J Mol Biol 374: 641– 654. http://dx.doi.org/10.1016/j.jmb.2007.09.053 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
MolMicrobiol 63:404 – 416. http://dx.doi.org/10.1111/j.1365 -2958.2006.05523.x .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2006.05183.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1462 -2920.2010.02401.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1038/nbt.2509 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1038/nbt.2549 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1007/s00253-002-1219-x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1128/AEM.70.6.3624-3631.2004 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.1038/nprot.2007.132 .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Appl Environ Mi- crobiol 80:4323– 4330. http://dx.doi.org/10.1128/AEM.00588-14 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/10.1111/j.1574-6968.1995.tb07823.x .,Non-OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
Nature 227: 680 – 685. http://dx.doi.org/ 10.1038/227680a0 .,OADS,/arxiv_data1/oa_pdf/f7/b6/mBio.02117-14.PMC4313912.pdf
http://dx.doi.org/ 10.3390/ijerph7010089 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/ IAI.71.1.536-540.2003 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/ 10.1023/A:1022854902700 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/mBio.01460-14 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2006.05255.x .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/AAC.00569-06 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/IAI.01333-08 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1371/ journal.pone.0029481 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1371/ journal.pone.0004232 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1371/ journal.pone.0029481 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/genomeA.00026-13 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
Immun.81:838 – 849. http://dx.doi.org/10.1128/IAI.00585-12 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/ JB.01726-06 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1038/279778a0 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
529: 78 – 85. http://dx.doi.org/10.1016/S0014- 5793(02)03185-X .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1016/S0065-2164(02)51000-5 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1073/ pnas.0737682100 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/IAI.70.9.5335-5337.2002 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1128/ IAI.70.12.7156-7160.2002 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/ 10.1016/j.vetmic.2013.05.004 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/clinids/ 9.Supplement_5.S517 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1046/j.1365-2958.1996.6461357.x .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
81:838 – 849. http://dx.doi.org/ 10.1128/IAI.00585-12 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1016/S1286- 4579(01)01412-5 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1111/j.1574- 6968.2000.tb08973.x .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
196: 57– 60. http://dx.doi.org/10.1111/j.1574- 6968.2001.tb10540.x .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
189: 8746 – 8749. http://dx.doi.org/ 10.1128/JB.01368-07 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/nar/gkg148 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/nar/ gkg312 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
IslandViewer: an integrated interface for computational identiﬁcation and visualization of genomic islands.Bioinformatics 25:664 – 665. http://dx.doi.org/10.1093/bioinformatics/ btp030 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/bioinformatics/btn529 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1101/gr.2289704 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/ bioinformatics/btr451 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1093/nar/25.17.3389 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
215: 403– 410. http://dx.doi.org/ 10.1016/S0022-2836(05)80360-2 .,OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
http://dx.doi.org/10.1080/10635150390235520 .,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
BMCGenomics 12:402. http://dx.doi.org/10.1186/1471-2164-12-402 .Genomic Avenue to Avian Colisepticemia January/February 2015 Volume 6 Issue 1 e01681-14®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/a9/1c/mBio.01681-14.PMC4313913.pdf
"As of8 January 2015, the mean lethality in this outbreak, caused byEbola virus (EBOV), reached 39.4% ( http://www.who.int/csr/don /archive/disease/ebola/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/ 10.1056/NEJMoa1404505 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1136/ bmj.g5089 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
N Engl J Med371:1481–1495 http://dx.doi.org/10.1056/NEJMoa1411100 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
CMAJ 186:E527–E528 http://dx.doi.org/10.1503/cmaj.109-4893 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1136/ bmj.g5161 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1016/S0140-6736(10)60357 -1.,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1038/nm.2202 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
Sci Rep3:3365. http://dx.doi.org/10.1038/srep03365 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1126/scitranslmed.3006608 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
Nature 514: 47–53 http://dx.doi.org/10.1038/ nature13777 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
Antimicrob Agents Chemother 58:6639 – 6647. http://dx.doi.org/10.1128/AAC.03442-14 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.3390/v6093663 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1007/s00705-012-1454-0 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1016/ j.clim.2011.08.008 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1126/ science.287.5458.1664 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1126/ science.1259657 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
Viruses 6:4760 – 4799. http://dx.doi.org/10.3390/v6114760 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1016/ j.virol.2004.10.048 .,OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
http://dx.doi.org/10.1128/AAC.00936-08 .,Non-OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
"http://dx.doi.org/10.1086/504267 .Kugelman, et al.",OADS,/arxiv_data1/oa_pdf/06/7b/mBio.02227-14.PMC4313914.pdf
"Paired-end reads were ﬁltered by calculation of quality scores with Sickle 1.210 (Bioinformatics Core, University of Cali-fornia, Davis [ https://github.com/najoshi/sickle ]) and the ﬁltered reads iteratively assembled de novo with Ray 2.0-rc8 using odd k-mer values (from 19 to 31) on 32 Inﬁniband QDR-connected Intel Xeon nodes (256Nehalem X5560 processing cores at 2.8 GHz).",OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
"Transmembrane domain searches and hydrophobicityanalyses were performed with TMHMM 2.0 (53), TopPred 2 (54), andTMpred (55) as implemented on the CBS ( http://www.cbs.dtu.dk/ services/ ), Institut Pasteur ( http://mobyle.pasteur.fr /), and Expasy (http://www.expasy.org/ ) web portals, respectively.",OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
"For phylogenomic inferences, the microspo- ridian protein sequences were retrieved from the MicrosporidiaDB (62),SilkPathDB ( http://silkpathdb.swu.edu.cn/silkpathdb/ ), and GenBank databases.",OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1146/annurev.micro.56.012302.160854 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1016/j.pt.2004.04.009 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1016/j.ijpara.2005.04.003 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1111/ jeu.12030 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Nature 414: 450 – 453. http://dx.doi.org/10.1038/ 35106579 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/ bfgp/elq032 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Res Microbiol 162:598 – 606. http://dx.doi.org/ 10.1016/j.resmic.2011.03.004 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Eur J Protistol 33:432– 443. http://dx.doi.org/10.1016/S0932 -4739(97)80055-7 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://www.ncbi.nlm.nih.gov/books/NBK2036/ .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Am Nat 156:459 – 477. http://dx.doi.org/ 10.1086/303404 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
mBio 4:-13. http://dx.doi.org/10.1128/mBio.00542-13 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.14411/ fp.2005.017 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1890/0012-9658(2001)082[3417:TASDOP]2.0.CO;2 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1003676 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000466 .24.,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002979 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
BMC Genomics 14:186. http://dx.doi.org/ 10.1186/1471-2164-14-186 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1128/ IAI.01205-09 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1126/science.1197761 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1128/EC.00307-12 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004009 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1128/mBio.00005-11 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1038/nature06903 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1016/ j.cub.2011.06.017 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Curr Opin Microbiol20:42– 48. http://dx.doi.org/10.1016/j.mib.2014.04.004 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1371/journal.pone.0013799 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1111/j.1420-9101.2007.01307.x .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://www.bioinformatics.babraham.ac.uk/projects/ fastqc/ .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
J Mol Biol 215:403– 410. http://dx.doi.org/10.1016/ S0022-2836(05)80360-2 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1101/ gr.8.3.195 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1186/gb-2009-10-3-r25 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/25.5.955 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/ nar/gkm160 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/bioinformatics/ 16.10.944 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/molbev/mst010 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
Identiﬁcation of transcriptional signals in Encephalitozoon cuniculi widespread among mi- crosporidia phylum: support for accurate structural genome annotation.BMC Genomics 10:607. http://dx.doi.org/10.1186/1471-2164-10-607 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/ gks1005 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1093/nar/gkt1140 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/gkt1223 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/bioinformatics/btu031 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.6026/97320630003282 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1038/nmeth.1701 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1006/jmbi.2000.4315 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1016/B978-0-12-381270-4.00019-6 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/gkh468 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/25.17.3389 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/nar/gkr948 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/ 10.1093/nar/gkp941 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1093/sysbio/syq010 .,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1371/journal.pone.0022594 .,Non-OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
http://dx.doi.org/10.1101/ gr.092759.109 .The Ordospora colligata Genome; of Reduction and HGT January/February 2015 Volume 6 Issue 1 e02400-14®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/20/42/mBio.02400-14.PMC4313915.pdf
"Policy makers, ethicists, cognitive scientists, epidemiologists, public health experts, biosafety experts, bioterror experts, mathe-matical modelers, principal investigators, and others have ex-pressed their opinions in multiple forums, including at a recentmeeting hosted by the National Academy of Sciences (15 to 16 De-cember 2014 [ http://bit.ly/16o0J5y ]).",Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
"As a “reward,” I included a link to my “How To Find a PostdoctoralFellowship” tutorial, which students at UT Southwestern havefound helpful ( http://bit.ly/1GsK7X5 ).",Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
"The poll was advertised via Twitter ( http://bit.ly/1BYCIMF and http://bit.ly/1qZYyya ), the American Society for Virology Facebook page ( http://on.fb.me/ 16tkKaU ), and forwarded e-mails.",Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
"The poll ( https://www.surveymonkey.com/s/B3XJP5B ) had ﬁve questions about the respondent’s background and re-search interests, with one question assessing knowledge level/awareness about the debate.",Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
Complete poll results from 13 December 2014 to 17 December 2014 are available at the following URLs: http://bit.ly/1GuS5Px (summary of responses) and http://bit.ly/1C2tRMG (all individ- ual responses/comments).,Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
Nat Rev Microbiol13:-58 – 64. http://dx.doi.org/10.1038/nrmicro3405 .,OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
http://dx.doi.org/ 10.1128/mBio.02292-14 .,Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
http://dx.doi.org/10.1128/mBio.02434-14 .,Non-OADS,/arxiv_data1/oa_pdf/c9/73/mBio.02525-14.PMC4313916.pdf
http://dx.doi.org/10.3201/eid1806.120116 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1038/382180a0 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
Nature 306:476 – 478. http://dx.doi.org/10.1038/306476a0 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1016/0092- 8674(83)90168-X .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
Chem Biol2:807– 817. http://dx.doi.org/10.1016/1074-5521(95)90087-X .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1038/nature03989 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1038/nsmb.2035 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
Bio-chemistry 50:4479 – 4490. http://dx.doi.org/10.1021/bi2003907 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1007/s00401-012-1002-8 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1073/ pnas.0710152105 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1371/ journal.ppat.1001217 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.4161/pri.5.3.16893 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
Acta Neuropathol Commun 1:44. http://dx.doi.org/ 10.1186/2051-5960-1-44 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/ 10.1038/nm.2294 .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1002/ ana.23589 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1371/journal.pone.0054915 .,Non-OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1056/NEJMoa1315200 .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
Ann Neurol 70:437– 444. http://dx.doi.org/ 10.1002/ana.22454 .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
http://dx.doi.org/10.1086/673986 .,OADS,/arxiv_data1/oa_pdf/83/9b/mBio.02451-14.PMC4313917.pdf
"A plasmid-cured version of USA300 Lac (JE2), and mutantsin this background, /H9004graR and/H9004vraR , were retrieved from The Nebraska Transposon Mutant Library ( http://www.narsa.net ).",OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
Signiﬁcance levels for overlapping genes to VISA strains were deter- mined by calculation of the representation factor using the software at http://nemates.org/MA/progs/representation.stats.html .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1086/595011 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
Methods Mol Biol 532:397– 411. http://dx.doi.org/ 10.1007/978-1-60327-853-9_23 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.2217/fmb.12.63 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1056/NEJM199808203390806 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
Lancet 368: 874 – 885. http://dx.doi.org/10.1016/ S0140-6736(06)68853-3 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1093/jac/ 21.suppl_A.1 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/ CMR.00042-09 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/JB.188.3.1120-1133.2006 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
Mol Microbiol 49:807– 821. http://dx.doi.org/10.1046/j.1365-2958.2003.03599.x .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1371/ journal.pone.0021323 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/ 10.1128/AAC.05054-11 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
Biochem Biophys Res Commun 269:485– 490. http://dx.doi.org/ 10.1006/bbrc.2000.2277 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/ 10.1093/jac/14.suppl_D.7 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
J Biol Chem274:8405– 8410. http://dx.doi.org/10.1074/jbc.274.13.8405 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1084/jem.193.9.1067 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/JB.00555-06 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1099/mic.0.26575-0 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.01173-08 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.01139-12 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/ 10.1128/AAC.48.10.3749-3757.2004 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/ AAC.00209-07 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/JB.185.24.7103-7110.2003 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.46.5.1492-1502.2002 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1093/cid/cir935 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1016/ j.ijantimicag.2012.04.003 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1016/j.jinf.2008.04.003 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1086/ 668433 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/ 10.1016/j.ijantimicag.2012.07.023 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1086/381202 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.47.4.1262-1266.2003 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1086/518452 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.00113-08 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/JCM.00448-13 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1128/AAC.00122-10 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1101/gad.943401 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1016/S1046-2023(03)00155-5 .,OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.2202/1544-6115.1027 .,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
http://dx.doi.org/10.1093/ bioinformatics/bth349 .Colistin Induces a Reversible VISA Phenotype in MRSA January/February 2015 Volume 6 Issue 1 e02268-14®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/72/a8/mBio.02268-14.PMC4313918.pdf
"Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2 /H11542)-Ia Georgina Cox,aPeter J. Stogios,b,cAlexei Savchenko,b,cGerard D. Wrighta Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilto n, Ontario, Canadaa; Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canadab; Center for Structural Genomics of Infectious Diseases (CSGID)c‡ ‡ For this virtual institution, see http://www.csgid.org .",Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
"The structures presented were solved by the Center for Struc-tural Genomics of Infectious Diseases (CSGID; http://csgid.org ); this project was funded in whole or in part with U.S. federal funds from theNational Institute of Allergy and Infectious Diseases, National Institutesof Health, Department of Health and Human Services, under contractno.",OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Proc Soc Exp Biol Med 55:66 – 69. http://dx.doi.org/10.3181/ 00379727-55-14461 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.2105/AJPH.34.4.358 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
EMBO J 17:6437– 6448. http://dx.doi.org/ 10.1093/emboj/17.22.6437 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1093/nar/gki862 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Chem Commun 47:4055– 4061. http://dx.doi.org/10.1039/c0cc05111j .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/ j.drup.2010.08.003 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1042/ BJ20130317 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.4155/ fmc.13.80 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/j.chembiol.2011.10.018 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
J Mol Biol 410: 411– 423. http://dx.doi.org/ 10.1016/j.jmb.2011.04.076 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Nat StructBiol9:653– 658. http://dx.doi.org/10.1038/nsb830 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/S0969-2126(99)80066-5 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Protein Sci 12:426 – 437. http://dx.doi.org/10.1110/ ps.0233503 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1107/S0907444905021487 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1021/ bi00041a005 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/0014-5793(71)80282-X .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/ 10.1128/AAC.28.2.282 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1093/clinids/ 24.Supplement_1.S46 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1086/595011 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1021/bi00410a045 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Antimicrob Agents Chemother 53:4504 – 4507. http://dx.doi.org/ 10.1128/AAC.00556-09 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1021/ bi002827b .Cox et al.,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
J Infect Dis 129:391– 401. http://dx.doi.org/ 10.1093/infdis/129.4.391 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/ 10.1021/bi050797c .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/ j.pep.2004.02.003 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1093/nar/gkp854 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/ j.str.2009.10.013 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/ j.str.2006.01.011 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/0092-8674(94)90388-3 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/S0968-0004(00)89071-4 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1016/ j.jmb.2007.05.022 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
Acta Crystallogr D BiolCrystallogr 62:859 – 866. http://dx.doi.org/10.1107/S0907444906019949 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1107/ S0907444909052925 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1107/ S0907444904026460 .,Non-OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
http://dx.doi.org/10.1093/nar/ gkq366 .,OADS,/arxiv_data1/oa_pdf/2a/09/mBio.02180-14.PMC4313920.pdf
"Moreover, we did observethe same synteny and three MAT genes also in the Pneumocys- tis murina genome, but our data are unpublishable because this genome sequence was released prior to publication under speciﬁcterms (see Pneumocystis murina Sequencing Project, Broad Insti- tute of Harvard and MIT, http://www.broadinstitute.org/).",OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
"The annotated genome sequences of P. jirovecii and T. defor- mans were obtained from the European Nucleotide Archive (38) (CAKM00000000 and CAHR00000000, last accessed on 14 May 2013).The P. jirovecii transcriptome assembly (HAAA01000001 to HAAA01003261) was downloaded from EBI (http://www.ebi.ac.uk,last accessed 11 November 2013).",OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
"carinii assembled contigs were downloaded from the project site (http://pgp.cchmc.org/, last accessed 14 April 2013) and correspond todata published by Slaven et al.",OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
"The S. pombe protein sequences were obtained from the annotated proteome present in UniProt (http://www.uniprot.org, last accessed 30 July 2014) and correspond to the datapublished previously (40).",OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Curated annotations and scripts are in the folder Pneumocystis _Mating available from GitHub (https://github.com/ocisse/ Pneumocystis_comparative).,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1126/scitranslmed.3004404 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1371/ journal.pone.0015152 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1128/ mBio.00428-12 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1371/journal.pone.0000423 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Annu Rev Microbiol 64:431– 452. http://dx.doi.org/10.1146/annurev.micro.112408.134335 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004425 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Mem Inst Oswaldo Cruz 104:419 – 426. http://dx.doi.org/10.1590/S0074-02762009000300004 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Sporogony in Pneumocystis carinii : syn- aptonemal complexes and meiotic nuclear divisions observed in precysts.J Protozool 31:420 – 428. http://dx.doi.org/10.1111/j.1550- 7408.1984.tb02989.x .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1111/j.1550- 7408.2001.tb00485.x .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1016/j.bbrc.2004.04.154 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1371/journal.pone.0020935 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1371/ journal.pone.0079958 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1371/journal.pone.0008524 .16.,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Annu Rev Genet 45:405– 430. http://dx.doi.org/10.1146/annurev-genet- 110410-132536 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1126/science.1203357 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1016/S0014-5793(03)00914-1 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1152/ajplung.00191.2009 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1086/657414 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
mBio 4(3):e00055- 13.http://dx.doi.org/10.1128/mBio.00055-13 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Nature 459:657– 662. http://dx.doi.org/10.1038/nature08064 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1038/nature03448 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Nature 460: 890 – 893. http://dx.doi.org/10.1038/nature08252 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Curr Biol 19:891– 899. http://dx.doi.org/10.1016/j.cub.2009.04.058 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1038/nature12891 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.2307/ 3756013 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1016/j.chom.2010.06.011 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1534/ genetics.114.170472 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1093/nar/gkt1206 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1111/j.1550-7408.2006.00184.x .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
Nature 415: 871– 880. http://dx.doi.org/ 10.1038/nature724 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1093/nar/gkt376 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/ 10.1093/nar/gks1118 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
BMC Bioin- formatics 10:421. http://dx.doi.org/10.1186/1471-2105-10-421 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1101/ gr.10.4.547 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1093/molbev/mst197 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1006/jmbi.2000.4042 .,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1093/bioinformatics/8.3.275 .,Non-OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
http://dx.doi.org/10.1093/bioinformatics/bti553 .Almeida et al.,OADS,/arxiv_data1/oa_pdf/e8/9f/mBio.02250-14.PMC4313921.pdf
"Copyright © 2014 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9 http://e-eht.org/ Introduction Nanomaterials have attracted considerable attention due to  their excellent electrical, optical, magnetic, and catalytic proper - ties [1].",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"A variety of nZVI tox - icity mechanisms toward organisms have been investigated and  the results indicate that toxicity might be caused by 1) direct  nZVI association with biological components [6], 2) oxidative  stress compounds generated by nZVI in the aqueous phase [7] or Potential environmental implications of nanoscale  zero-valent iron particles for environmental  remediation Min-Hee Jang, Myunghee Lim, Yu Sik Hwang Future Environmental Research Center, Korea Institute of T oxicology, Jinju, Korea• Special TopicOpen Access Environmental Health and Toxicology Volume: 29, Article ID: e2014022, 9 pages http://dx.doi.org/10.5620/eht.e2014022 eISSN: 2233-6567  Objectives  Nanoscale zero-valent iron (nZVI) particles are widely used in the field of  various environmental contaminant remediation.",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"Keywords  Ecotoxicity, Environmental fate, Environmental remediation, Nanoscale zero- valent iron particles Correspondence: Yu Sik Hwang, PhD     17 Jegok-gil, Munsan-eup, Jinju 660-844,  Korea Tel: +82-55-750-3834 Fax: +82-55-750-3799 E-mail: yshwang@kitox.re.kr Received:  October 30, 2014 Accepted:  November 18, 2014 Published online:  December 18, 2014 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
http://e-eht.org/ Page 2 of 9Environmental Health and Toxicology    2014;29:e2014022 3) ferrous ion released from nZVI followed by the fenton reac - tion [8].,Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 3 of 9M-H Jang, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
http://e-eht.org/ Page 4 of 9Environmental Health and Toxicology    2014;29:e2014022 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 5 of 9M-H Jang, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 6 of 9Environmental Health and Toxicology    2014;29:e2014022 Test organism Nanoparticle type Exposure method Observed effects Reference Fishes E mbryo-larval of medaka fish  (Oryzias latipes )C MC coated nZVI: synthesized by  borohydride method,    27.1 nm7 d exposure of 25-   200 mg/L nZVIC MC-nZVI had acute mortality and developmental toxic  effects in embryos A cute lethality - LC 50 = 200 mg/L O xidative stress response - ROS increase (> 25 mg/L) Developmental toxicity:    Reduction in heart rate (> 25 mg/L)    Reduction in eye size (> 100 mg/L)    Reduction in hatching rate (> 200 mg/L)[36] L arvae of medaka fish ( Oryzias  latipes ), 7 d oldC MC coated nZVI: synthesized by  borohydride method,   49.3 nm1 4 d exposure of  1-100 mg/L nZVI,   daily renewednZVI decreased dissolved oxygen and generated ROS n ZVI caused acute lethally and sublethally toxic effects in  medaka larvae (intestinal damage, catalase expression  inhibition).",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 7 of 9M-H Jang, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 8 of 9Environmental Health and Toxicology    2014;29:e2014022 ing) and environmental conditions (e.g., oxygen level, pH, ionic  strength, and organic content).",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"http://e-eht.org/ Page 9 of 9M-H Jang, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/45/eht-29-e2014022.PMC4313931.pdf
"Copyright © 2014 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4 http://e-eht.org/ Introduction Continuous monitoring of chemical residues in agricultural  and food products has been performed by government bodies in  various countries and by related government bodies in South  Korea.",Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
"Furthermore, in 2014, an integrated safety information net - work was created where related food safety information as well as  information related to regulations are systematically shared  through a unified management and support system, which has  propelled the project to change food safety management from Construction of a risk assessment system for  chemical residues in agricultural products Shinai Choi1, Jiyeon Hong1, Dayeon Lee1, Minkyoung Paik2 1Enterprise Risk Service Deloitte Anjin, LLC, Seoul; 2Department of Crop Life Safety, National Academy of Agricultural  Sciences, Wanju, Korea • Brief ReportOpen Access Environmental Health and Toxicology Volume: 29, Article ID: e2014023, 4 pages http://dx.doi.org/10.5620/eht.e2014023 eISSN: 2233-6567  Objectives  Continuous monitoring of chemical residues in agricultural and food products  has been performed by various government bodies in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
"Keywords  Chemical residues, Database system, Food consumption rate, Risk assessment  systemCorrespondence: Shinai Choi, MS 10 Gukjegeumyung-ro, Youngdeungpo-gu,  Seoul, Korea Tel: 82-2-6676-1000 Fax: 82-2-6674-9900 E-mail: shchoi@deloitte.com Received:  November 14, 2014 Accepted:  December 13, 2014 Published online:  December 30, 2014 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
http://e-eht.org/ Page 2 of 4Environmental Health and Toxicology    2014;29:e2014023 region-based autonomy to a unified country-based center.,Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
"http://e-eht.org/ Page 3 of 4S Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
http://e-eht.org/ Page 4 of 4Environmental Health and Toxicology    2014;29:e2014023 data as food consumption data and is constructed on data from  2012.,OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
Available from:  http://www.epa.gov/pesticides/science/deem/deem-user-guide- sep30-14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
Available from:  http://www.ilsi.org/researchfoundation/documents/cares/cares - v3userguide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
Available from: http://www.thelifelinegroup.org/life - line/documents/v4.4_UserManual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
Available from:  http://www.inchem.org/documents/ehc/ehc/ehc240_index.,OADS,/arxiv_data1/oa_pdf/8d/f2/eht-29-e2014023.PMC4313932.pdf
"Copyright © 2014 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6 http://e-eht.org/ Introduction Cervical cancer shows the seventh highest incidence rate of  malignant cancers in Korean women.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"However, adverse effects of Sub-acute toxicity study in female ICR mice  following repetitive intramuscular injection of  cervical cancer vaccines Seol-Hee Moon1, Du-Y eol Kim1, Jung-Min Lee1, Hee-Won Park1, Hye-Y eong Lee1, Y ong- Hoon Lee1, Jaesung Lee2, Jiwon Jung2, Min-Ju Kim2, Kyoung-Baek Choi2, Yu-Kyoung Oh3,  Y oung-Bong Kim4, Sujeong Kim2,  Seung Min Oh5 1Biotoxtech Co. Ltd., Ochang Scientific Industrial Complex, Cheongju; 2Institute of Bioinnovation Research, R &D Center,  Kolon Life Science Inc., Seoul; 3College of Pharmacy, Seoul National University, Seoul; 4Department of Animal Biotechnology,  Konkuk University, Seoul; 5Department of Nanofusion T echnology, Hoseo University, Asan,  Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 29, Article ID: e2014024, 6 pages http://dx.doi.org/10.5620/eht.e2014024 eISSN: 2233-6567  Objectives  The sub-acute toxic effects following repetitive intramuscular injection of two  cervical cancer vaccines newly developed against human papillomaviruse (HPV)16/58/18  and HPV16 were investigated in female ICR (CrljOri: CD1) mice, and the no-observed- adverse-effect-level (NOAEL) of the cervical cancer vaccines was estimated.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"Correspondence: Seung Min Oh, PhD  20 Hoseo-ro 79beon-gil, Baebang-eup,  Asan 336-795, Korea Tel: +82-41-540-9697 Fax: +82-41-540-9697 E-mail: ohsm0403@hoseo.edu Received:  October 14, 2014 Accepted:  December 15, 2014 Published online:  December 30, 2014 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"http://e-eht.org/ Page 2 of 6Environmental Health and Toxicology    2014;29:e2014024 HPV vaccines, such as vasovagal syncope, venous thrombosis,  pulmonary embolism, and amyotrophic lateral sclerosis, have  been reported in several studies, although it is difficult to infer  clear causal associations between HPV vaccines and adverse ef - fects [15,16].",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"http://e-eht.org/ Page 3 of 6S-H Moon, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"http://e-eht.org/ Page 4 of 6Environmental Health and Toxicology    2014;29:e2014024 pathological effects, including cystic tubules in the kidney, ecto - pic thymus in the parathyroid gland, cell infiltration in the sali - vary gland, and extramedullary hematopoiesis in the spleen.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"http://e-eht.org/ Page 5 of 6S-H Moon, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"In particular, a decrease in the A/G ratio due to in -creased globulin can be induced by some inflammatory diseas - es, multiple myeloma, collagen disease, and rheumatoid arthritis  (http://labtestsonline.org/understanding/analytes/tp/tab/ test/).",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"http://e-eht.org/ Page 6 of 6Environmental Health and Toxicology    2014;29:e2014024 can be caused by pathologic processes, such as pulmonary my - elofibrosis.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
Available from: http://www.cdc.gov/std/hpv/hpv - supplement99.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/eht-29-e2014024.PMC4313933.pdf
"Fort Washington, Pennsylvania: National Comprehensive Cancer Network; Available at: http://www.nccn.org/professionals/physician_gls/ pdf/infections.pdf .",Non-OADS,/arxiv_data1/oa_pdf/b6/f3/cad-26-359.PMC4314102.pdf
"Cells 2015; 38(1): 75-80  http://dx.doi.org/10.14348/molcells.2015.2241                    MicroRNA-26a Regulates RANKL-Induced  Osteoclast Formation     Kabsun Kim, Jung Ha Kim, Inyoung Kim, Jongwon Lee, Semun Seong, Yong-Wook Park1, and Nacksung Kim*      Osteoclasts are unique cells responsible for the resorption  of bone matrix.",OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
"In this study, we investigated miRNA expression profiles dur- ing osteoclastogenesis and identified miR-26a as a negative  regulator of osteoclast forma tion and function by inhibiting Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
Cells http://molcells.org     CTGF at the post-transcriptional level.,Non-OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
Cells http://molcells.org      A                    B                           C                    D                           Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
"Cells http://molcells.org     we used a bioinformatics approach including Pictar, Targetscan  and miRanda.",OADS,/arxiv_data1/oa_pdf/cc/5b/molcell-38-1-75.PMC4314121.pdf
"Cells 2015; 38(1): 51-57  http://dx.doi.org/10.14348/molcells.2015.2202                    A Role for Peroxidasin PXN-1 in Aspects of  C. elegans  Development     Juyeon Lee2,5, Jaya Bandyopadhyay3,5, Jin Il Lee4, Injeong Cho1, Daeho Park2, and Jeong Hoon Cho1,*      The Caenorhabditis elegans  peroxidasins, PXN-1 and PXN- 2, are extracellular peroxidases; pxn-2 is involved in muscle- epidermal attachment during embryonic morphogenesis  and in specific axon guidance.",OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
"For severe 30 °C heat stress (HS) experiments, wild-   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
"Cells http://molcells.org      A                                 B                                          C         D               type and pxn-1 (ok785 ) worms were incubated at 20 °C as the  baseline condition and were then subjected to heat stress at  30°C for 1 h every 12 h.   Constructs and transformation  To prepare the transcriptional fusion constructs, approximately  3 kb of the 5 ′-upstream region of pxn-1  and 2.2 kb of pxn-2   were amplified by polymerase chain reaction and then inserted  into a promoterless green fluorescent protein (GFP) vector  pPD95.77, yielding Ppxn-1:: GFP and Ppxn-2:: GFP .",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
Cells http://molcells.org      A                    B                C                    D         E                    F         G                    H           Fig.3.,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
"Cells http://molcells.org      A                                      B                          C                                    D                          These results are consistent with the rescue experiments re- ported earlier, wherein a peroxidase domain of pxn-1 was una- ble to rescue  pxn- 2 mutant phenotypes (Gotenstein et al.,  2010).",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/molcell-38-1-51.PMC4314122.pdf
"Cells 2015; 38(1): 89-94  http://dx.doi.org/10.14348/molcells.2015.2285                     The Mitochondrial Fusion-Re lated Proteins Mfn2   and OPA1 are Transcriptionally Induced during Differentiation of Bone Marrow Progenitors to Immature Dendritic Cells    Seung-Wook Ryu1,2,4,*, Eun Chun Han3,4, Jonghee Yoon1, and Chulhee Choi1,2,3,*      The shape and activity of mitoc hondria are tightly regulated  by fusion and fission processes that are essential for main-taining normal cellular function.",Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
"A recent  study reported that proteins of the PGC-1 family, especially  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
"Cells http://molcells.org     PGC-1β, directly increase the transcriptional level of Mfn2 and  induce mitochondrial fusion in muscles (Liesa et al., 2008; Zorzano et al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
Cells http://molcells.org      A             B                       C                        Expression levels were normaliz ed against an endogenous control: mouse GAPDH.,Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
"Cells http://molcells.org     REFERENCES    Aihara, T., Nakamura, N., Honda, S., and Hirose, S. (2009).",OADS,/arxiv_data1/oa_pdf/58/74/molcell-38-1-89.PMC4314123.pdf
"Cells 2015; 38(1): 81-88  http://dx.doi.org/10.14348/molcells.2015.2254                    Casein Kinases I and 2 α Phosphorylate Oryza   Sativa Pseudo-Response Regulator 37 (OsPRR37)  in Photoperiodic Flowering in Rice    Choon-Tak Kwon1, Bon-Hyuk Koo1, Dami Kim1, Soo-Cheul Yoo2, and Nam-Chon Paek1,*      Flowering time (or heading date) is controlled by intrinsic  genetic programs in response to environmental cues, such as photoperiod and temperature.",OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"Recent work has identified several genes up- stream of Hd1 and Ehd1 ; for example, Hd17 /OsELF3 , the rice  ortholog of Arabidopsis  ELF3 , functions as a floral inducer by  downregulating Ghd7 expression (Matsubara et al., 2012; Saito  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"Cells http://molcells.org     et al., 2012; Yang et al., 2013; Zhao et al., 2012).",OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
Cells http://molcells.org      A                          B                                             Fig.,Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"To determine the phosphorylation sites in PRR37, we first  examined the PRR37 sequence with a casein kinase-specific  phosphorylation site prediction algorithm, KinasePhos 2.0 (http://kinasephos2.mbc.nctu.edu .tw/).",OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
Cells http://molcells.org                                             Fig.,Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"Cells http://molcells.org     Murakami, M., Tago, Y., Yamashino, T., and Mizuno, T. (2007).",OADS,/arxiv_data1/oa_pdf/05/50/molcell-38-1-81.PMC4314124.pdf
"Cells 2015; 38(1): 20-25  http://dx.doi.org/10.14348/molcells.2015.2120                    Itch E3 Ubiquitin Ligase Positively Regulates  TGF-β Signaling to EMT via Smad7 Ubiquitination    Su-hyun Park, Eun-Ho Jung, Geun-Young Kim1, Byung-Chul Kim2, Jae Hyang Lim3,*, and Chang-Hoon Woo*      TGF-β regulates pleiotropic cellular responses including cell  growth, differentiation, migrat ion, apoptosis, extracellular  matrix production, and many  other biological processes.",OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
"In contrast,  Lallemand and colleagues reported that Itch negatively regu- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
"Cells http://molcells.org      A                                              B                          C                                              D                   tk, plus scrambled RNA or siRNA against Itch (20 pM).",OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
"Cells http://molcells.org      A                               B                             C                     D                               E                             F                 48 h. The expression levels of EMT-relate d genes, that is, N-cadherin, Snail, and Occl udin were determined using specific antib odies as indi- cated.",OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/b0/ed/molcell-38-1-20.PMC4314125.pdf
"Cells 2015; 38(1): 1-13  http://dx.doi.org/10.14348/molcells.2015.2261                    Neuropeptide Regulation of Signaling and Behavior  in the BNST    Thomas L. Kash*, Kristen E. Pleil, Ca therine A. Marcinkiewcz, Emily G.  Lowery-Gionta, Nicole Crowley,  Christopher Mazzone, Jonathan  Sugam, J. Andrew Hardaway, and Zoe A. McElligott      Recent technical developments have transformed how neu-roscientists can probe brai n function.",OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
The BNST mediates stress-    Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"Cells http://molcells.org     induced relapse to drug seeking (Erb et al., 2001).",OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"Cells http://molcells.org     Thus, although CRF actions in the BNST are principally in- volved in the anxiety-provoking aspects of ethanol withdrawal, the transition to dependence marked by enhanced ethanol  seeking behavior may involves a complex interplay between  CRF systems in the BNST and CeA that involve direct or indi-rect crosstalk between the two.",Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
Cells http://molcells.org     2014).,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
Cells http://molcells.org     samples.,OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"Cells http://molcells.org     Yamamoto, K., Matsuda, T., Mizuno, N., Nagata, S., and Baba,  A.",OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"Cells http://molcells.org     Morin, S.M., Ling, N., Liu, X.J., Kahl, S.D., and Gehlert, D.R.",OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/39/8a/molcell-38-1-1.PMC4314126.pdf
"Cells 2015; 38(1): 65-74  http://dx.doi.org/10.14348/molcells.2015.2240                    Comparative N-Linked Glycan Analysis of Wild-Type  and α1,3-Galactosyltransferase Gene Knock-Out  Pig Fibroblasts Usin g Mass Spectrometry  Approaches     Hae-Min Park2, Yoon-Woo Kim1, Kyoung-Jin Kim1, Young June Kim3, Yung-Hun Yang4, Jang Mi Jin5,  Young Hwan Kim5,6, Byung-Gee Kim2, Hosup Shim3,*, and Yun-Gon Kim1,*      Carbohydrate antigens expressed on pig cells are consid-ered to be major barriers in pig-to-human xenotransplanta- tion.",Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
Recent studies on  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
"Cells http://molcells.org     GalT-KO pigs reported glycolipid analysis of pig tissues and  cells using an LC-MS instrument, demonstrating that such a tool allowed researchers to characterize the glycolipid-derived  glycan structures (Diswall et al., 2010; Puga Yung et al., 2012).",OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
Cells http://molcells.org        A                       B                          A                               B                            C                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
Cells http://molcells.org      A                                             C                        B                                             D                    Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
"Cells http://molcells.org     J., Park, C.G., Harvey, D.J., and Kim, B.G.",OADS,/arxiv_data1/oa_pdf/01/af/molcell-38-1-65.PMC4314127.pdf
"Cells 2015; 38(1): 14-19  http://dx.doi.org/10.14348/molcells.2015.2116                       EphB/ephrinB Signaling in Cell Adhesion and  Migration    Inji Park, and Hyun-Shik Lee*     Eph receptors and their ligands, ephrins, represent the  largest group of the receptor tyrosine kinase (RTK) family,  and they mediate numerous developmental processes in a variety of organisms.",OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
"The interaction  domains of EphB receptors and ligands join, forming heterodi- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
EphrinB1 Signaling  Inji Park & Hyun-Shik Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
"Cells http://molcells.org     Phosphorylation-independent signaling begins with unpho- sphorylated ephrinB, which interacts with protein complexes; this protein complex produces a signal affecting cell-cell interac- tions, and the signal is maintained until tyrosine phosphoryla- tion of ephrinB occurs.",Non-OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
EphrinB1 Signaling  Inji Park & Hyun-Shik Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
"Cells http://molcells.org     Adams, R.H, Diella, F., Hennig, S., Helmbacher, F., Deutsch, U.,  and Klein, R. (2001).",OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
EphrinB1 Signaling  Inji Park & Hyun-Shik Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/42/87/molcell-38-1-14.PMC4314128.pdf
"Cells 2015; 38(1): 26-32  http://dx.doi.org/10.14348/molcells.2015.2136                    The Early Induction of Suppressor of Cytokine Signaling  1 and the Downregulation of Toll-like Receptors 7 and 9 Induce Tolerance in Costimulated Macrophages    Hyo-Ji Lee1,2, Keun-Cheol Kim2, Jeong A Han3, Sun Shim Choi4, and Yu-Jin Jung1,2,*      Toll-like receptors (TLR) 7 and 9 transduce a cellular signal  through the MyD88-dependent pathway and induce the production of inflammatory mediators against microbial  nucleotide components.",OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
"The costimulation or restimulation of mouse macro-  phages with gardiquimod (GDQ, TLR7 agonist) and CpG   oligodeoxynucleotide 1826 (ODN1826, TLR9 agonist) reduced  the levels of proinflammatory cytokines TNF- α and IL-6, but the Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
"Cells http://molcells.org      TLR9 or both for 4 or 16 h, followed by fixation and permeabili-  zation with 4% paraformaldehyde and 0.1% saponin.",Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
Cells http://molcells.org      A          B                    C                   A                                     B                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
"Cells http://molcells.org     universally decreased in all HIV-1-infected individuals (Chang  et al., 2012).",OADS,/arxiv_data1/oa_pdf/50/bf/molcell-38-1-26.PMC4314129.pdf
"Cells 2015; 38(1): 33-39  http://dx.doi.org/10.14348/molcells.2015.2163                    Stimulation of Oligonucleotide-Directed Gene  Correction by Red β Expression and MSH2  Depletion in Human HT1080 Cells     Ke Xu1,3,*, A. Francis Stewart2, and Andrew C.G.",Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
To exploit the Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
Cells http://molcells.org     latter observation it is important to show that transient depletion  of MSH2 also stimulates ssOR.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
"Cells http://molcells.org      A                              C              B                              D                      E            were grown with or without Tet, as indicated.",Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
Cells http://molcells.org     (2006).,OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/molcell-38-1-33.PMC4314130.pdf
"Cells 2015; 38(1): 40-50  http://dx.doi.org/10.14348/molcells.2015.2165                    Pathogen Associated Molecular Pattern (PAMP)-  Triggered Immunity Is Compromised under C-Limited Growth    Hyeong Cheol Park1,2,7,*, Shinyoung Lee1,3,7, Bokyung Park1,7, Wonkyun Choi1,2, Chanmin Kim1, Sanghun Lee4,  Woo Sik Chung1, Sang Yeol Lee1, Jamal Sabir5, Ray A. Bressan1,3,5, Hans J. Bohnert1,5,6, Tesfaye Mengiste4, and  Dae-Jin Yun1,*      In the interaction between plants and pathogens, carbon (C) resources provide energy and C skeletons to maintain,  among many functions, the plant immune system.",Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"Recent meta-analyses based on microarray data clearly  show that genes related to the OPP pathway, aerobic respira- tion [tricarboxylic acid (TCA) cycle and mitochondrial electron transfer], and ATP biosynthesis are generally up-regulated after  biotic stress treatments (Less et al., 2011).Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
Cells http://molcells.org      A                          B                        9).,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"Cells http://molcells.org                                                                     (WT_con), WT treated with 1 μM flg22 in 10 mM MgCl 2  (WT_flg), ss4_flg, pgm1 _flg, and sex1_flg.",Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
Cells http://molcells.org      A                      B                    C                    same sample set used for microarray analyses (Fig.,OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"Cells http://molcells.org                                       Lee et al., 2012; Oh et al., 1997; Yang et al., 2011).",OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"Cells http://molcells.org     Herbers, K., Meuwly, P., Frommer, W.B., Metraux, J.P., and  Sonnewald, U.",OADS,/arxiv_data1/oa_pdf/58/8d/molcell-38-1-40.PMC4314131.pdf
"Cells 2015; 38(1): 58-64  http://dx.doi.org/10.14348/molcells.2015.2231                    TLR4 Mediates Pneumolysin-Induced ATF3  Expression through the JNK/p38 Pathway in Streptococcus pneumoniae -Infected RAW 264.7 Cells    Cuong Thach Nguyen, Eun-Hye Kim, Truc Thanh Luong, Suhkneung Pyo, and Dong-Kwon Rhee*      Activating transcription factor -3 (ATF3) acts as a negative  regulator of cytokine producti on during Gram-negative bac- terial infection.",Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
"Similarly, TLR4 recognizes  pneumolysin (PLY) and activates protective signals against S.  pneumoniae;  therefore, TLR4-deficient mice were more sus- ceptible to pneumoc occal infections co mpared with wild-type  mice (Malley et al., 2003).Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
"Cells http://molcells.org      A                        B                        C                D                 (siTLR4), TLR4 expression was impaired, and the expression  of ATF3 and TNF- α was subsequently checked during the  infection.",Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
Cells http://molcells.org      A                  B                    C                   D                        plementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
Cells http://molcells.org     ACKNOWLEDGMENTS   This work was supported by the Korea Health Industry Devel- opment Institute (KHIDI A08483609-02-0000-100).,Non-OADS,/arxiv_data1/oa_pdf/ba/87/molcell-38-1-58.PMC4314132.pdf
"CDC 24/7 Saving  Lives, Protecting People, 2011. http://www.cdc.gov/Features/ LiveLonger/; Access date: 12.08.2013.",Non-OADS,/arxiv_data1/oa_pdf/50/40/MSM-26-372.PMC4314159.pdf
"Ölüm Nedeni İstatistikleri, 2013,  No: 16162. http://www.tuik.gov.tr/PreHaberBultenleri.",Non-OADS,/arxiv_data1/oa_pdf/50/40/MSM-26-372.PMC4314159.pdf
3. http:/ /hr.wikipedia.org/wiki/Predlo%C5%BEak:Medicinski_fakulteti_u_Hrvatskoj 4. http://www.mef.unizg.hr/meddb/slike/pisac40/file4959p40.pdf 5. www.mf.unsa.ba/ 6. http://www.edufair.rs/fakulteti/ 7. http://www.medical.uns.ac.rs/userfiles/file/Specijalizacije/pravilnik-specijalizacija.pdf 8. http://www.medical.uns.ac.rs/katedrazaopstumedicinu.php 9. www.medf.ucg.ac.me/ 10. http://www.fakulteti.mk/ 11. www.med.pr.ac.rs/ 12. www.uns.ac.rs 13. http://www.iime.org/database/europe/bulgaria.htm14.,Non-OADS,/arxiv_data1/oa_pdf/9c/62/MSM-26-411.PMC4314160.pdf
"http://www.iime.org/database/europe/romania.htm 15. http://www.lf1.cuni.cz/magisterske-studium-vseobecne-lekarstvi-v-akademickem-roce-20142015 16. http://www.iime.org/database/europe/slovakrep.htm 17. http://www.iime.org/database/europe/hungary.htm 18. http://porodicnamedicina.com/site/index.php/Specijalizacija/Pravilnik.html 19. http://family-medicine.ba/wp-content/uploads/EGPRN-Ljubljana-2012.doc 20. http://www.mf.uni-lj.si/en/ 21. http:/ /hr.wikipedia.org/wiki/Medicinski_fakultet_u_Splitu 22. http://www.mef.unizg.hr/meddb/slike/pisac40/file4959p40.pdf 23. http://www.mef.unizg.hr/meddb/slike/pisac40/file4959p40.pdf 24. http://family-medicine.ba/wp-content/uploads/EGPRN-Ljubljana-2012.doc 25. http://www.unsaporodmed.org/category/generalno/ 26. http://www.unsaporodmed.org/category/generalno/ 27. http://www.mf.unsa.ba/dodiplomski-studij.html 28. http://www.medical.uns.ac.rs/katedrazaopstumedicinu.php 29. http://www.medf.ucg.ac.me//nastava/specijalizacije/ 30. http://www.med.pr.ac.rs/studije/integrisane-akademske.php 31. http://www.umed.edu.al/medicine/fakultetet/fakulteti-i-mjekesise.html# 32. http://translate.googleusercontent.com/translate_c?depth=1&hl=bs&prev=/search%3Fq%3Dmedical%2Bfaculty%2Bof%2Bbulgaria%26biw%3D1366%26bih%3D600&rurl=translate.google.ba&sl=en&u=http://www.medicalstudyguide.com/en/medicine-in-romania.html&usg=ALkJrhhtp60USrnbemdW9iMTZR3iFLkeRw 33. http://www.umft.ro/facultatea-de-medicina-generala_133 34. http://www.lf1.cuni.cz/magisterske-studium-vseobecne-lekarstvi-v-akademickem-roce-20142015 35. file:/ / /C:/Users/eldin.donlagic/Downloads/LFUK_VZ%202013.pdf 36. http:/ /www.lfp.cuni.cz/predmety-nak/1-vseob-lekarstvi/rocnik-5 37. http:/ /www.lfp.cuni.cz/predmety-nak/1-vseob-lekarstvi/rocnik-6 38. http://eng.szu.sk/index.php?id=378 39. http://www.upjs.sk/ 40. http://www.jfmed.uniba.sk/novyweb/novahomepage.htm    http://www.fmed.uniba.sk/www/enindex.html 41. http://www.sote.hu/ 42. http://www.dote.hu/ 43. http://www.pote.hu/ 44. http://www.szote.u-szeged.hu/ 45. http://www.mf.uni-lj.si/en/Country: Bosnia &  Herzegovina Croatia Greece Romania Slovenia Tur ke y Bulgaria Serbia Macedonia T otal length of specialist training (years) 3 4 4 3 4 3 3 4 3 GP setting min (years) 1 2 1 0 2 1,5 2 1,5 GP setting max (years) 1,5 0 1 0 2 1,5 1,5 GP setting avg (years) 0 0 1 1,5 2 1,5 1,5 1,5 Hospital setting min (years) 1 2 3 1,2 2 1,5 1,5 1,5 Hospital setting max (years) 1,5 0 3 0 2 1,5 1,5 Is it a compulsory program?",Non-OADS,/arxiv_data1/oa_pdf/9c/62/MSM-26-411.PMC4314160.pdf
2013 05/07/2013 [cited 16/07/2014]; Available from: http://www.nhs.uk/NHSEngland/thenhs/nhshistory/Pages/the-nhs%20history.aspx.,Non-OADS,/arxiv_data1/oa_pdf/59/cf/MSM-26-419.PMC4314161.pdf
"Global Youth Tobacco Survey GYTS 2003- 2008 in the Federation of Bos-nia and Herzegovina, Federal Ministry of Health, Federal Public Health Institute http://www.zzjzfbih.ba.",Non-OADS,/arxiv_data1/oa_pdf/2e/23/MA-68-399.PMC4314162.pdf
http://en.wikipedia.org/wiki/Utilization_man - agement.,Non-OADS,/arxiv_data1/oa_pdf/87/80/MA-68-419.PMC4314170.pdf
http://www.cmsa.org/Individual/NewsEvents/HealthTechnologyArti - cles/tabid/649/Default.aspx.Accessed 12 June 2014 31.,Non-OADS,/arxiv_data1/oa_pdf/87/80/MA-68-419.PMC4314170.pdf
"Geneva, World Health  Organization (WHO), (http://www.who.int/healthinfo/ global_burden_disease/GlobalHealthRisks_report_full.pdf) 3.",Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
(http://www.who.int/cardiovascular_diseases/ resources/atlas/en/ 7.,Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
2008; http://www.medscape.com/viewarticle/571347_3 8.,Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
1995: 155(7): 701-709 (http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
2012. http://www.who.int/nutrition/publications/ guidelines/sodium_intake_printversion.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/4c/3f/MSM-26-385.PMC4314172.pdf
Available at : http://www.lisna.ir/Note/9170- %D8%A2%DB%8C%D8%A7- 21.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/MSM-26-356.PMC4314177.pdf
16. http://ask.rks-gov.net/eng/Kosovo.,Non-OADS,/arxiv_data1/oa_pdf/ff/9b/MA-68-407.PMC4314179.pdf
http://www.thl.fi/pub - lications/monica/manual/index.htm 9.,Non-OADS,/arxiv_data1/oa_pdf/fc/a1/MA-68-394.PMC4314181.pdf
9 The aim of this case-control study was to assess the frequency of sensorineural hearing loss in ET patients without depression and toFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"14However, certain accompanying neurological signs have recently been reported in many ET patients, such asYilmaz NH, Akbostanci MC Sensorineural Hearing Loss and Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Abbreviation: SISI, Short Increment Sensitivity Index.Sensorineural Hearing Loss and Essential Tremor Yilmaz NH, Akbostanci MC Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Table 4.Comparison of the Right and Left Ear OAE Results in Patients and Controls Patients Controls pValue n (%) n (%) Right OAE + 21 (61.3%) 39 (86.7%) 0.022 2 13 (38.7%) 6 (13.3%) Left OAE + 23 (67.7%) 38 (84.4%) 0.136 2 11 (32.3%) 7 (15.6%) Abbreviation: OAE, Otoacoustic Emission.Yilmaz NH, Akbostanci MC Sensorineural Hearing Loss and Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Mov Disord 1998;13:5–10, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Nat Clin Pract Neurol 2006;2:666–677, doi: http://dx.doi.org/10.1038/ ncpneuro0347.Table 5.Comparison of the Audiological Test Results in Patients and Controls Older than 65 Test Patients Controls pValue n510 n 515 PTA Right 31.50 (18–58) 22 (15–42) 0.048 PTA Left 31.50 (20–57) 23 (15–42) 0.014 SRT Right 32.50 (20–58) 25 (15–45) 0.177 SRT Left 30 (20–58) 25 (15–45) 0.062 SISI 500 Right 0.0 (0–0) 0.0 (0–0) 1.000 SISI 500 Left 0.0 (0–0) 0.0 (0–0) 1.000 SISI 1,000 Right 0 (0–20) 0 (0–45) 0.807 SISI 1,000 Left 0 (0–65) 0 (0–65) 0.367 SISI 2,000 Right 12.50 (0–85) 0 (0–80) 0.115 SISI 2,000 Left 22.50 (0–90) 0 (0–80) 0.091 SISI 4,000 Right 82.50 (0–95) 0 (0–90) 0.091 SISI 4,000 Left 67.50 (0–100) 0 (0–95) 0.160 Tone Decay 500 Right 0.0 (0–0) 0.0 (0–0) 1.000 Tone Decay 500 Left 0.0 (0–0) 0.0 (0–0) 1.000 Tone Decay 1,000 Right 0 (0–5) 0.0 (0–0) 0.683 Tone Decay 1,000 Left 0 (0–5) 0 (0–5) 0.605 Tone Decay 2,000 Right 2.50 (0–15) 0 (0–5) 0.103 Tone Decay 2,000 Left 5 (0–15) 0 (0–10) 0.031 Tone Decay 4,000 Right 10 (0–15) 0 (0–10) 0.004 Tone Decay 4,000 Left 10 (0–20) 0 (0–15) 0.023 The scores are expressed as median score (minimum–maximum).",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Abbreviations: PTA, Pure Tone Audiometry; SISI, Short Increment Sensitivity Index; SR T, Speech Recognition Threshold.Sensorineural Hearing Loss and Essential Tremor Yilmaz NH, Akbostanci MC Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Am J Epidemiol 1998;148:879–886, doi: http://dx.doi.org/10.1093/ oxfordjournals.aje.a009713.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Neuroepidemiology 2007; 29:213–217, doi: http://dx.doi.org/10.1159/000112463.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Eur Arch Otorhinolaryngol 2012;269:1577–1581, doi: http://dx.doi.org/10.1007/s00405-011-1801-x.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Ann Intern Med 1990;113:188–194, doi: http://dx.doi.org/10.7326/0003-4819-113-3-188.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"J Neurol Sci 2010;289:144–148, doi: http://dx.doi.org/10.1016/j.jns.2009.08.029.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Eur J Neurol 2012;19:1349–1354, doi: http://dx.doi.org/10.1111/j.1468-1331.2012.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Mov Disord 1997;12:973– 976, doi: http://dx.doi.org/10.1002/mds.870120621.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"J Neurol Neurosurg Psychiatry 1993;56:868–873, doi: http://dx.doi.org/10.1136/jnnp.56.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"J Neurol Neurosurg Psychiatry 1960;23:56–62, doi: http://dx.doi.org/10.1136/jnnp.23.1.56.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Mov Disord 2009;24:2033– 2041, doi: http://dx.doi.org/10.1002/mds.22755.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Eur Neurol 2010;63:302–306, doi: http://dx.doi.org/10.1159/000304194.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Int J Epidemiol 2001;30:1371– 1378, doi: http://dx.doi.org/10.1093/ije/30.6.1371.17.Saunders AZ, Stein AV, Shuster NL.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Part I. Audiology 1982;21:273–293, doi: http://dx.doi.org/10.3109/00206098209072744.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Laryngoscope 1969;79:1879–1890, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"J Acoust Soc Am 2003;114:3283–3294, doi: http://dx.doi.org/10.1121/1.1624063.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Ann Neurol 1993;34:82–90, doi: http://dx.doi.org/10.1002/ana.",OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Arch Neurol 2008;65:101–107, doi:http://dx.doi.org/10.1001/archneurol.2007.8.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology?Eur J Neurol 2002;9:143–151, doi: http://dx.doi.org/10.1046/j.1468-1331.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"N Engl J Med 1998;339: 1545–1547, doi: http://dx.doi.org/10.1056/NEJM199811193392110.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"Neurology 2011;76:461–466, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"J Neurol Sci 2013;32:109–112, doi: http://dx.doi.org/10.1016/j.jns.2012.10.013.Yilmaz NH, Akbostanci MC Sensorineural Hearing Loss and Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/c8/74/tre-05-281-6513-1.PMC4314288.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)CD160FCA assessment of MRD TW Farren et al 7 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/bf/50/bcj201492a.PMC4314455.pdf
"The SWOG 1304 phase 2 study, which compares standard-dose (20/27 mg/m2) with high-dose (20/56 mg/m2) carﬁlzomib, included serial cardiac proﬁling in its study design to better examine any cardiac events (https://clinicaltrials.gov/ ct2/show/NCT01903811); similar end points are included in the ENDEAVOR phase 3 trial that compares carﬁlzomib –dexamethasone with bortezomib –dexamethasone (http://clinicaltrials.gov/show/NCT01568866).",Non-OADS,/arxiv_data1/oa_pdf/8a/a9/bcj201493a.PMC4314456.pdf
Availableat http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/8a/a9/bcj201493a.PMC4314456.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/8a/a9/bcj201493a.PMC4314456.pdf
Computational tools for predicting the functional consequence of sequence changes targeting N244 and G245 suggested that the aforementioned ETNK1 mutations were functionally deleterious ( http://snps.biofold.org/phd-snp/phd-snp.,Non-OADS,/arxiv_data1/oa_pdf/f9/f9/bcj201494a.PMC4314457.pdf
html and http://genetics.bwh.harvard.edu/pph2/index.shtml ).,OADS,/arxiv_data1/oa_pdf/f9/f9/bcj201494a.PMC4314457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)ETNK1 mutations in mastocytosis and chronic myelomonocytic leukemia TL Lasho et al 4 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/f9/f9/bcj201494a.PMC4314457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Autophagy and ubiquitination downregulate leukemic E2A/Pbx1 N Yuan et al 9 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/57/af/bcj201496a.PMC4314458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
"Received September 24, 2014 /C15Revision received October 17, 2014 /C15Accepted October 20, 2014 /C15Available online 24 October 2014 http://dx.doi.org/10.1016/j.molmet.2014.10.002 Original article MOLECULAR METABOLISM 4 (2015) 3 e14/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
"5Takeda press release, December 27, 2013; http://www.takeda.com/news/2013/ 20131227_6117.html .Original article 4MOLECULAR METABOLISM 4 (2015) 3 e14/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
The Novo Nordisk Foundation Center for Basic Metabolic Research ( http://www.metabol.ku.dk ) is supported by an uncondi- tional grant from the Novo Nordisk Foundation to University of Copenhagen.,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9c/main.PMC4314522.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
"Received October 2, 2014 /C15Revision received October 18, 2014 /C15Accepted October 23, 2014 /C15Available online 1 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.10.004 Brief communication 64MOLECULAR METABOLISM 4 (2015) 64 e69/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
Bone 40:1190 e 1195. http://dx.doi.org/10.1016/j.bone.2006.12.062 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1073/ pnas.101545198 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1016/j.cell.2007.05.047 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
Cell 144:796 e 809. http://dx.doi.org/10.1016/j.cell.2011.02.004 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1016/ j.cell.2013.08.042 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1016/ j.cell.2010.06.003 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1146/ annurev-physiol-020911-153233 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
Journal of Clinical Investigation 120:357 e 368. http://dx.doi.org/10.1172/JCI39901 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/ 10.1083/jcb.201002111 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1172/JCI39366 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1242/jcs.134510 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/ 10.1016/S0168-9525(03)00073-8 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
Nature Reviews Genetics 10:32 e42.http://dx.doi.org/10.1038/nrg2485 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1128/MCB.25.8.2873-2884.2005 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1126/science.1063127 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1002/jbmr.417 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1083/jcb.200809113 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1016/j.cell.2004.10.024 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1172/JCI31960 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1016/j.cmet.2010.05.005 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1128/ MCB.24.19.8467-8476.2004 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/10.1210/ en.2008-0673 .,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
http://dx.doi.org/ 10.1016/j.bbrc.2010.06.008 .,OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/main.PMC4314523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
"Received September 19, 2014 /C15Accepted September 30, 2014 /C15Available online 8 October 2014 http://dx.doi.org/10.1016/j.molmet.2014.09.008 Brief communication MOLECULAR METABOLISM 4 (2015) 51 e57/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/7f/main.PMC4314524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
"Abbreviations: 2-[14C]DG, 2-[1-14C]deoxyglucose; GIR, glucose infusion rate; Rd, rate of disappearance; Ra, rate of appearance; EGP, endogenous (hepatic) glucose production; AUC, area under the curve; HF, high-fat diet; LF, low-fat diet; WAT, white adipose tissue; ROS, reactive oxygen species; DAG, diacylglyc erol; TAG, triacylglycerol; WAT, white adipose tissue; NEFA, non-esteri ﬁed fatty acids; ALT, alanine aminotransferase; Basal, 17 h fasting; Rg, glucose metabolic index; PCaa, diacylglycer- ophosphocholine; PCae, glycerophosphocholine; lysoPC, lysophosphatidylcholines; SM, sphingolipid; B, basal; IS, insulin-stimulated Received October 21, 2014 /C15Revision received November 5, 2014 /C15Accepted November 7, 2014 /C15Available online 14 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.11.004 Original article MOLECULAR METABOLISM 4 (2015) 39 e50/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK26871/ .,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/main.PMC4314525.pdf
"”,http://dx.doi.org/10.1016/j.molmet.2014.",OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
Available online 14 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.11.002 Commentary MOLECULAR METABOLISM 4 (2015) 1 e2/C2112014 Published by Elsevier GmbH.,OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
http://dx.doi.org/10.1016/ j.molmet.2013.12.003 eCollection 2014 Jun.,OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
Mediators of In ﬂammation 2013:509502. http://dx.doi.org/10.1155/2013/ 509502 .,Non-OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/ef/main.PMC4314528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
"Abbreviations: CNS, central nervous system; GFAP, glial- ﬁbrillary acidic protein; HFD, high-fat diet; MBH, medial basal hypothalamus; NF kB, nuclear factor kappa B Received September 29, 2014 /C15Revision received October 9, 2014 /C15Accepted October 10, 2014 /C15Available online 17 October 2014 http://dx.doi.org/10.1016/j.molmet.2014.10.001 Brief communication 58MOLECULAR METABOLISM 4 (2015) 58 e63/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/57/main.PMC4314532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
"Received September 23, 2014 /C15Revision received October 21, 2014 /C15Accepted October 26, 2014 /C15Available online 1 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.10.005 Brief communication 70MOLECULAR METABOLISM 4 (2015) 70 e76/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/f3/main.PMC4314533.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
"Abbreviations: AgRP, agouti-related peptide; ARH, arcuate nucleus; DMH, dorsomedial nucleus; GOAT, ghrelin O-acyltransferase; GHSR, growth hormone secretagog ue receptor; HFHS, high-fat/high-sucrose diet; LHA, lateral hypothalamic area; MBH, mediobasal hypothalamus; ME, median eminence; NL, normal litte rs; NPY, neuropeptide Y; P, postnatal day; POMC, pro-opiomelanocortin; PVH, paraventricular nucleus; SL, small litter Received October 4, 2014 /C15Revision received October 18, 2014 /C15Accepted October 20, 2014 /C15Available online 24 October 2014 http://dx.doi.org/10.1016/j.molmet.2014.10.003 Original article MOLECULAR METABOLISM 4 (2015) 15 e24/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/11/main.PMC4314535.pdf
Available online 13 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.004 Commentary MOLECULAR METABOLISM 4 (2015) 81 e82/C2112014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1056/NEJMoa1008862 .,OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1038/nrendo.2013.47 .,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.2337/db11-1-378 .,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.2337/db11-1-378 .,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1007/s12325- 013-0039-y .,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1111/j.1476- 5381.2011.01714.x .,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1016/j.molmet.2013.12.001 .,OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
http://dx.doi.org/10.1007/s10741-010-9208-0 .Commentary 82MOLECULAR METABOLISM 4 (2015) 81 e82/C2112014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/75/main.PMC4314537.pdf
"”,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC4314538.pdf
Available online 13 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.002 Commentary MOLECULAR METABOLISM 4 (2015) 77 e78/C2112014 Published by Elsevier GmbH.,Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC4314538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC4314538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC4314538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
"Received December 5, 2014 /C15Revision received December 17, 2014 /C15Accepted December 18, 2014 /C15Available online 26 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.009 Original article 106MOLECULAR METABOLISM 4 (2015) 106 e117/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/c1/main.PMC4314540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
"Received December 3, 2014 /C15Revision received December 11, 2014 /C15Accepted December 13, 2014 /C15Available online 19 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.008 Original article 118MOLECULAR METABOLISM 4 (2015) 118 e131/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
Animal phenotyping All clinical tests were carried out according to standard operational procedures (SOPs) established and validated within the Eumorphia program ( http://empress.har.mrc.ac.uk/ )[6].,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
Complete details on the method for this analysis are available on the http://www.broad.mit.edu/gsea website.,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
http://www.nature.com/ncomms/journal/v1/n1/full/ ncomms1001.html .,OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/d9/main.PMC4314542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
"Received November 17, 2014 /C15Revision received November 23, 2014 /C15Accepted November 24, 2014 /C15Available online 29 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.11.005 Original article 132MOLECULAR METABOLISM 4 (2015) 132 e143/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/main.PMC4314543.pdf
"Received December 2, 2014 /C15Accepted December 2, 2014 /C15Available online 13 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.003 Commentary MOLECULAR METABOLISM 4 (2015) 79 e80/C2112014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/98/61/main.PMC4314544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/61/main.PMC4314544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/61/main.PMC4314544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
"Abbreviations: sR3, soluble-VEGFR-3; HFD, high-fat diet; SWAT, subcutaneous white adipose tissue; EWAT, epididymal white adipose tissue; CM, conditioned medium Received November 10, 2014 /C15Revision received November 24, 2014 /C15Accepted November 27, 2014 /C15Available online 4 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.11.006 Original article MOLECULAR METABOLISM 4 (2015) 93 e105/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
Adipocyte size was measured using the Cell- Proﬁler software ( http://www.cellpro ﬁler.org ).,OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/6e/main.PMC4314545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
"Abbreviations: AgRP, agouti-related protein; Angptl4, angiopoietin-like 4; ARC, arcuate nucleus; CART, cocaine-and-amphetamine-regulated transcript; CNS, c entral nervous system; FFA, free fatty acid; LPL, lipoprotein lipase; NPY, neuropeptide-Y; POMC, pro-opiomelanocortin; STZ, streptozotocin; TG, triglyceride Received September 9, 2014 /C15Revision received November 3, 2014 /C15Accepted November 5, 2014 /C15Available online 13 November 2014 http://dx.doi.org/10.1016/j.molmet.2014.11.003 Brief communication 144MOLECULAR METABOLISM 4 (2015) 144 e150/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
SUPPLEMENTARY MATERIAL Supplementary material related to this article can be found online at http://dx.doi.org/ 10.1016/j.molmet.2014.11.003 .,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/66/main.PMC4314546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
"Abbreviations: ACTH, adrenocorticotropic hormone; AgRP, agouti-related peptide; ARH, arcuate nucleus of the hypothalamus; AVP, arginine vasopressin; CORT, cor tico- sterone; CRH, corticotropin-releasing hormone; FST, forced swim test; Gr, Glucocorticoid receptor; HPA axis, Hypothalamus ePituitary eAdrenal axis; InsR, insulin receptor; IRAgrpKO, knockout of InsR using Agrp-Cre ;I RNkx2.1KO, knockout of InsR using Nkx2.1-Cre ;I RSim1KO, knockout of InsR using Sim1-Cre ; MB, marble burying test; MBH, mediobasal hypothalamus; ME, median eminence; NPY, neuropeptide Y; NSF, novelty suppressed feeding test; OF, open ﬁeld test; POMC, pro-opiomelanocortin; SIH, stress- induced hyperthermia test Received November 18, 2014 /C15Revision received November 26, 2014 /C15Accepted December 1, 2014 /C15Available online 10 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.001 Original article MOLECULAR METABOLISM 4 (2015) 83 e92/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/3b/main.PMC4314547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Vitamin D supplementation and obesity PD Chandler et al 7 Nutrition & Diabetes (2015) 1 –7",Non-OADS,/arxiv_data1/oa_pdf/2c/37/nutd201444a.PMC4314577.pdf
"The LONI (Laboratory of Neuroimaging) pipeline (http://pipeline.loni.usc.edu/), a graphical work ﬂow environment, was used to obtain total brain volumes for all subjects.",OADS,/arxiv_data1/oa_pdf/ef/d9/nutd201445a.PMC4314578.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Altered brain connectivity in obese women K Coveleskie et al 7 Nutrition & Diabetes (2015) 1 –7",Non-OADS,/arxiv_data1/oa_pdf/ef/d9/nutd201445a.PMC4314578.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/EBV as a therapeutic target in EBV+ lymphomas E Tse and Y-L Kwong 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/73/82/emm2014102a.PMC4314579.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/EBV-associated T/NK-cell lymphoproliferative disorders QC a i et al 14 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/ef/37/emm2014105a.PMC4314580.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Editorial 3 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/32/7e/emm2014109a.PMC4314581.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/EBV pathogenesis in humanized mice S Fujiwara et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/8a/27/emm201488a.PMC4314584.pdf
"BMP2 protein expression was measured by western blot ( a), and relative expression was quanti ﬁed using ImageJ software (http://rsb.info.nih.gov/ij/index.html) ( b).",OADS,/arxiv_data1/oa_pdf/11/0b/emm201495a.PMC4314586.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Fucoidan promotes osteoblast differentiation BS Kim et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/11/0b/emm201495a.PMC4314586.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/BAFF modulates systemic in ﬂammation in obesity D-H Kim and M-S Do 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/be/dd/emm201498a.PMC4314587.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/KRAS promotes mesenchymal features R-K Kim et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/46/3c/emm201499a.PMC4314588.pdf
http://www.nada  kth se/utbildning/grukth/exjobb/ rapportlistor/2011/rapporter11/ ringman_olsson_mikael_11072 pdf  2014.,Non-OADS,/arxiv_data1/oa_pdf/95/c6/JBS-32-1127282.PMC4314604.pdf
Available from: http://sportsci.org/ resource/stats [Accessed 2014 July 4].,Non-OADS,/arxiv_data1/oa_pdf/ff/a2/JBS-32-1127284.PMC4314606.pdf
"The concept ofneurovascular units has been proposed to explain the vascular contributions to neurodegeneration; blood–brain barrier breakdown,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
Vascular Risk Factors in Spinocerebellar Ataxias Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
Vascular Risk Factors in Spinocerebellar Ataxias Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Handb Clin Neurol 2012;103:389–398, doi: http://dx.doi.org/10.1016/B978-0-444-51892- 7.00024-3.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Neurology 2011;77:1035– 1041, doi: http://dx.doi.org/10.1212/WNL.0b013e31822e7ca0.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Orphanet J Rare Dis 2013;8:177, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Brain 2006;129:1357–1370, doi: http://dx.doi.org/10.1093/ brain/awl081.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Nat Genet 1993;4: 221–226, doi: http://dx.doi.org/10.1038/ng0793-221.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Ann Neurol 1997;42:924–932, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Eur J Hum Genet 2000;8:4–18, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Cerebellum 2014; 13:17–28, doi: http://dx.doi.org/10.1007/s12311-013-0510-y.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"J Neurol Sci 2012;322:141–147, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Neurology 2007;69: 1688–1695, doi: http://dx.doi.org/10.1212/01.wnl.0000271883.45010.8a.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Arch Neurol 2012;69:380–384, doi: http://dx.doi.org/10.1001/archneurol.2011.1060.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Neurology 2013;81: 410–416, doi: http://dx.doi.org/10.1212/WNL.0b013e31829d873c.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Parkinsonism Relat Disord 2013;19:680–683, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Exp Neurol 2013;250:20–30, doi: http://dx.doi.org/10.1016/j.expneurol.2013.08.019.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Handb Clin Neurol 2012;103:111–125, doi: http://dx.doi.org/10.1016/B978-0-444-51892- 7.00005-X.",OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
Tremor Other Hyperkinet Mov (NY) 2012; http://tremorjournal.org/ article/view/28.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Neurology 2006;66:1717–1720, doi: http://dx.doi.org/10.1212/01.wnl.0000219042.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Neurology 2013;80:1009–1017, doi: http://dx.doi.org/10.1212/WNL.0b013e318287281b.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"Pharmacotherapy 2012;32:285–296, doi: http://dx.doi.org/10.1002/j.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/95/9e/tre-05-287-6461-1.PMC4314609.pdf
"2Poor understanding of underlying pathophysiology, inadequate animal models and absence of biomarkers have limitedFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"39–41Non-human primates treated with intracartoid MPTP (1-methyl-4-phenyl-1,2 3, 6-tetrahydropyridine) dev elop transient dystonia.Karimi M, Perlmutter JS Dopamine in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Figure 1.Binding Sites of Relevant Radiotracers at a Dopaminergic Synapse.Dopamine in Dystonia Karimi M, Perlmutter JS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Nonetheless, the patient population,number of participants, strength of the magnetic field, data acquisitionand the processing method have been highly variable among theseKarimi M, Perlmutter JS Dopamine in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Reanalysis with focus on BG: correlation between BG and mean of the RSNQFC from right mid-dorsal putamen/ right GPe to leftFPN; Zhou et al.91Blepharospasm9SPM2/ALFF 1.5 mm threshold of frame exclusionUncorrected p-value qALFF in putamen, GP, insula, medial PFC,QALFF in SSR, thalami, CC, cerebellum, Mohammadi et al.88Writer’scramp16IC 3.09 (FSL)/ICA: individual level: dual regressionapproach, non-linear image registrationMotion correction FEW threshold-free clusterenhancement25 networks as a result of ICAQFC in DMN and in SMA Castrop et al., 89Writer’scramp12SPM5/activation study, block design: imagination of hand movementSmall volume correctionprimary motor, PM, SMA, and SM1, the thalamus, BGQActivation in SM1, PM, SMA, putamen, and thalamus Delnooz et al.94Writer’scramp16FSL 1.1/Seed based 36 correction parameters EMG, sex, and ageFWE From prior activation studies: dorsal PFC, BG examined against PMD and PCC as controlQFC of superior parietal cortex to PM Q, Decreased; q, Increased; ALFF, Amplitude of Low Frequency Fluctuations; BG, Basal Ganglia; CC, Cingulate Cortex; CONN, A Functional Connectivity Toolbox; CSF, Cerebrospinal Fluid; DMN, Default Mode Network (basal ganglia and cerebellum included); ECN, Executive Control Network; EMG, Electromyography; FC, Functional Connectivit y; FEAT, A Software Package in FSL; FNIRT, An FSL Software that Provides Non-linear Image Coregistration; FPN, Frontoparietal Network; FWE, Family-wise Error; FSL, A Comprehensive Library of Ana lysis Tools for Functional and Anatomical MRI Analysis; GP(e), Globus Pallidus (external); ICA, Independent Component Analysis; ICoh, Imaginary Coherence; PCC, Posterior Cingulate Cortex; PFC, Prefro ntal Cortex; PM, Premotor Cortex; PMD: Dorsal premotor; PVN, Primary Visual Network; ROI, Region of Interest; RSN, Resting State Networks; SMA, Supplementary Motor Area; SM1, Sensory Motor Cort ex; SMN, Sensory Motor Network; SPM, Statistical Parametric Mapping, a Software Package for Image Analysis; SSR, Somatosensory Region.Dopamine in Dystonia Karimi M, Perlmutter JS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2013;28:863–873, doi: http://dx.doi.org/10.1002/mds.25475.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Curr Neurol Neurosci Rep 2014;14:462, doi: http://dx.doi.org/10.1007/ s11910-014-0462-8.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2008;23: 558–565, doi: http://dx.doi.org/10.1002/mds.21870.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 1993;43:2252–2257, doi: http://dx.doi.org/10.1212/ WNL.43.11.2252.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"6.Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T. Changes in the balance between motor cortical excitation and inhibition in focal, taskKarimi M, Perlmutter JS Dopamine in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2002;17:1017–1025, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neurol Neurosurg Psychiatry 2008;79:985–990, doi: http://dx.doi.org/10.1136/ jnnp.2007.121632.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"9.Odergren T, Stone-Elander S, Ingvar M. Cerebral and cerebellar activation in correlation to the action-induced dystonia in writer’s cramp.Mov Disord 1998;13:497–508, doi: http://dx.doi.org/10.1002/mds.870130321.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 1998;13:125–134, doi: http://dx.doi.org/10.1002/mds.870130124.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2003;61:1228–1231, doi: http://dx.doi.org/10.1212/01.WNL.0000094240.93745.83.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2007;68:2157–2158, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2007;22:1117–1123, doi: http://dx.doi.org/10.1002/mds.21495.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neuroreport 2004;15:1887–1890, doi: http://dx.doi.org/10.1097/00001756-200408260-00010.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neurol 2003;250:42–50, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 2008; 131:2499–2509, doi: http://dx.doi.org/10.1093/brain/awn168.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neurosci 2009;29:9740–9747, doi: http://dx.doi.org/10.1523/JNEUROSCI.2300-09.2009.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Front Neuroanat 2011;5:48, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Trends Neurosci 2013;36:717–725, doi: http://dx.doi.org/10.1016/j.tins.2013.09.003.21.Charlesworth G, Plagnol V, Holmstrom KM, et al.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Am J Hum Genet 2012;91:1041–1050, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Annu Rev Neurosci 1986;9:357–381, doi: http://dx.doi.org/10.1146/annurev.ne.09.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Trends Neurosci 1990;13:266– 271, doi: http://dx.doi.org/10.1016/0166-2236(90)90107-L. 24.Gerfen CR.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Trends Neurosci 1992;15:133–139, doi: http://dx.doi.org/10.1016/ 0166-2236(92)90355-C. 25.Mink JW.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Arch Neurol 2003;60:1365–1368, doi: http://dx.doi.org/10.1001/archneur.60.10.1365.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain Res 1984;302:267–275, doi: http://dx.doi.org/10.1016/0006-8993(84)90239-7.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Int Rev Neurobiol 1993;35:391–415, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurosci Biobehav Rev 2000;24:125–132, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Pharmacol Sci 2010;114:6–16, doi: http://dx.doi.org/10.1254/ jphs.10R01FM.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Nat Rev Neurosci 2001;2:861–870, doi: http://dx.doi.org/ 10.1038/35104049.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Nat Neurosci 2006;9:157–158, doi: http://dx.doi.org/10.1038/nn0206- 157.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"PLoS ONE 2012;7:e49483, doi: http://dx.doi.org/10.1371/journal.pone.0049483.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Nat Neurosci 2000;3:226–230, doi: http://dx.doi.org/10.1038/72929.Dopamine in Dystonia Karimi M, Perlmutter JS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Annu Rev Neurosci 2000;23:185–215, doi: http://dx.doi.org/10.1146/annurev.neuro.23.1.185.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Curr Opin Pharmacol 2010; 10:87–92, doi: http://dx.doi.org/10.1016/j.coph.2009.09.008.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Psychopharmacology (Berl) 1986;88:403–419, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"MPTP induces dystonia and parkinsonism: Clues to the pathophysiology of dystonia.Neurology 1997;49:1432–1438, doi: http://dx.doi.org/10.1212/WNL.49.5.1432.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Parkinsonism Relat Disord 2007;13:170–173, doi: http://dx.doi.org/10.1016/j.parkreldis.2006.09.003.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neurol Neurosurg Psychiatry 1997;62: 672–673, doi: http://dx.doi.org/10.1136/jnnp.62.6.672-a.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2005;64:347–349, doi: http://dx.doi.org/10.1212/01.WNL.0000149764.34953.BF.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.Neurology 2009;72:2097–2103, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Eur J Nucl Med Mol Imaging 2009;36:269–274, doi: http://dx.doi.org/10.1007/s00259- 008-0924-9.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Synapse 2010;64:449–459, doi: http://dx.doi.org/10.1002/syn.20748.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Synapse 1989;3:96–97, doi: http://dx.doi.org/10.1002/syn.890030113.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2011;26:100–106, doi: http://dx.doi.org/10.1002/mds.23401.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"CNS Neurol Disord Drug Targets 2006;5:25–43, doi: http://dx.doi.org/10.2174/ 187152706784111551.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"55.Heidbreder C. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: A review of preclinical evidence.CNS Neurol Disord Drug Targets 2008;7:410–421, doi: http://dx.doi.org/10.2174/ 187152708786927822.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Biol Chem 2007;282:35842–35854, doi: http://dx.doi.org/10.1074/jbc.M611758200.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2000; 54:1193–1195, doi: http://dx.doi.org/10.1212/WNL.54.5.1193.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neurosci 2013;33:14705–14714, doi: http://dx.doi.org/10.1523/ JNEUROSCI.0407-13.2013.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 2013;136:3645–3658, doi: http://dx.doi.org/10.1093/brain/awt282.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"PLoS ONE 2014;9:e88121, doi: http://dx.doi.org/10.1371/journal.pone.0088121.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 1995;118:1473–1484, doi: http://dx.doi.org/ 10.1093/brain/118.6.1473.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neural Transm 2004;111:59–67, doi: http://dx.doi.org/10.1007/ s00702-003-0053-3.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2013;28:2002–2006, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"25720.Karimi M, Perlmutter JS Dopamine in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Ann Neurol 2013;73:390–396, doi: http://dx.doi.org/10.1002/ana.23798.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET.Synapse 2003;49:20–28, doi: http://dx.doi.org/10.1002/syn.10199.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Nature 2001; 412:150–157, doi: http://dx.doi.org/10.1038/35084005.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Clin Neurophysiol 2012;123:755– 763, doi: http://dx.doi.org/10.1016/j.clinph.2011.08.002.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 1999;53: 96–105, doi: http://dx.doi.org/10.1212/WNL.53.1.96.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neuroimage 2000;12:257–267, doi: http://dx.doi.org/10.1006/nimg.2000.0615.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Cereb Cortex 2010;20:2749–2759, doi: http://dx.doi.org/10.1093/cercor/bhq023.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 1999;52:291–297, doi: http://dx.doi.org/10.1212/WNL.52.2.291.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Acta Neurol Scand 1996; 94:172–176, doi: http://dx.doi.org/10.1111/j.1600-0404.1996.tb07049.x.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 1992;42:1540–1544, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 1995;118(Pt 6):1473–1484, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Ann Neurol 1998;44:303–312, doi: http://dx.doi.org/10.1002/ ana.410440304.81.Hutchinson M, Nakamura T, Moeller JR, et al.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2000;55:673–677, doi: http://dx.doi.org/10.1212/ WNL.55.5.673.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Ann Neurol 2002;52:853–856, doi: http://dx.doi.org/10.1002/ana.10418.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 2004;62:1384–1390, doi: http://dx.doi.org/10.1212/01.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Front Neurol 2013;4:149, doi: http://dx.doi.org/10.3389/fneur.2013.00149.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"PLoS ONE 2013;8:e62877, doi: http://dx.doi.org/10.1371/journal.pone.0062877.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Hum Brain Map 2012;33:840–848, doi: http://dx.doi.org/10.1002/hbm.21250.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"89.Castrop F, Dresel C, Hennenlotter A, Zimmer C, Haslinger B. Basal ganglia-premotor dysfunction during movement imagination in writer’s cramp.Mov Disord 2012;27:1432–1439, doi: http://dx.doi.org/10.1002/mds.24944.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Neuroophthalmol 2013;33:235–240, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neuroimage 2012;59:2142–2154, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 2012; 135:3699–3711, doi: http://dx.doi.org/10.1093/brain/aws281.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2012;27:1425–1431, doi: http://dx.doi.org/10.1002/mds.25029.Dopamine in Dystonia Karimi M, Perlmutter JS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"95.Grimes JD, Hassan MN, Quarrington AM, D 9Alton J. Delayed-onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology.Neurology 1982;32:1033–1035, doi: http://dx.doi.org/10.1212/WNL.32.9.1033.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Ital J Neurol Sci 1983;4:335–337, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurology 1984;34:962–965, doi: http://dx.doi.org/10.1212/WNL.34.7.962.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain 1985;108:463–483, doi: http://dx.doi.org/ 10.1093/brain/108.2.463.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neuroimage 2001;14:723–735, doi: http://dx.doi.org/10.1006/nimg.2001.0861.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Neurotherapeutics 2007;4:316–329, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Eur Radiol 2006;16:1651–1658, doi: http://dx.doi.org/10.1007/s00330-006-0175-8.105.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Brain Connect 2013;3:72–86, doi: http://dx.doi.org/10.1089/brain.2012.0114.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Magn Reson Med 2012;68:882–889, doi: http://dx.doi.org/10.1002/mrm.23308.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Ann Neurol 2004;56:283–286, doi: http://dx.doi.org/10.1002/ana.20177.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Mov Disord 2008;23:234–239, doi: http://dx.doi.org/10.1002/mds.21806.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Curr Neurol Neurosci Rep 2013;13:401, doi: http://dx.doi.org/10.1007/s11910-013-0401-0.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Proc Natl Acad Sci USA 2010;107:8452–8456, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Pharmacol Exp Ther 2009;328:785–795, doi: http://dx.doi.org/10.1124/jpet.108.146332.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"J Nucl Med 2014;55:1297–1304, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
"Philos Trans R Soc Lond B Biol Sci 2005;360:1001–1013, doi: 10.1098/rstb.2005.1634.Karimi M, Perlmutter JS Dopamine in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/d6/de/tre-05-280-6447-2.PMC4314610.pdf
Search keywords were deepFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Huntington’s disease HD is a neurodegenerative disease primarily characterized by chorea, cognitive decline, and psychiatric features, but also involvingSmith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"cIn 17 reports.Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Table 2.Cases in the Literature of GPi Deep Brain Stimulation for Huntington’s Disease N Age Disease Duration(years)Follow-up (months)Stimulation Parameters % Change UHDRSTotal (6–12months post-operatively)% Change UHDRS ChoreaSubscore (6–12months post-operatively)Reference Contact ConfigurationAmplitude/Pulse Width/Frequency 1 43 8 8 R: C+2 2 3.5 V/120 ms/40 Hz 31.4 44.0 Moro et al.28 L: C+2 2 5 V/90 ms/40 Hz 1 41 13 12 Bilateral: R: C+022.8 V/120 ms/180 Hz 37.5a50aHebb et al.29 1 60 10 48 Bilateral: 1 22+ 1.9 V/450 ms/130 Hz 5.4b21.4bBiolsi et al.30 1 72 17 12 Bilateral: C+1 2 2.0 V/90 ms/40 Hz nr 82.4 Fasano et al.31 25 7 1 0 2 4 R : 0 21+ 3.6 V/180 ms/160 Hz 45.3 62.5 Kang et al.32 L: 0+12 3.6 V/180 ms/130 Hz 50 5 24 R: 1 20+ 3.6 V/210 ms/130 Hz 11.1 50 Kang et al.32 L: 1+22 3.6 V/210 ms/130 Hz 1 30 9 24 Bilateral: C+02122.0 V/60 ms/130 Hz 15.2 75 Spielberger et al.33 1 30 10 12 Bilateral C+0 2 3.6 V/60/130 30.2 nr Garcia-Ruiz et al.34 1 40 3 12 Bilateral: C+02121.5 V/90 ms/130 Hz 24 nr Huys et al.35 1.5 V/90 ms/130 Hz 1 31 15 48 nr 2.0 V/210 ms/80 hz 17.8 100 Cislaghi et al.36 2 34 7 12 Bilateral: C+1 2 2.0–3.2 V/150 ms/60– 80 hz11.8 73.7 Velez-Lago et al.37 25 6 12 Many tried Many tried 9.8 n/acVelez-Lago et al.37 1 41 9 48 GPi R:C+2 2 0.5 V/160 Hz 38.2 50 Gruber et al.38,d L:C+22 1.0 V/160 Hz STN R: 3 22+ 5.0 V/40 Hz L: 322+ 5.0 V/40 Hz 7 Mean 49.714.86 (¡2.27)36 Monopolar or bipolar1.4–3.6 V/90–450 ms/ 130 HzMean 10.91% (p50.090)Mean 58.34% (p50.018)Gonzalez et al.39Smith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"dBilateral GPi and STN leads implanted.Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"53Smith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"77 Globus pallidus interna Am or Pvl GPi 5 CS 3–24 37.8 (21–60) 29 (10.8–62.8) 26 Martinez-Fernandez R et al.79 Pvl GPi 4 CS 5–48 33.8 (25–44) 40.75 ( 26–88)anr Dehning et al.,80Dehning et al.81 6 CR 6–51 27.8 (16–44) 48.8 (20–84) 43 (17–69) Motlagh et al.,56Ackermans et al.,71Diederich et al.,82 Gallagher et al.,83Shahed et al.84, Dueck et al.89Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"fSingle case of simultaneous CM-Pf/Vo and ALIC/NA outcome not included in analysis.Smith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"fReported in only three studies.Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"In both of theseSmith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"136In both this case and a prior report,137GPi DBS improved self-injurious behavior.Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2001;16:769–771, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol 2001;248:695–700, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2010;25:1733–1743, doi: http://dx.doi.org/10.1002/mds.23312.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2010;112:1267–1270, doi: http://dx.doi.org/10.3171/2009.10.JNS091062.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2013;28:282–287, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Front Neurol 2012; 3:22, doi: http://dx.doi.org/10.3389/fneur.2012.00022.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2004;19:724–727, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Arch Neurol 2011; 68:1087–8; author reply 1088–1089, doi: http://dx.doi.org/10.1001/archneurol.2011.180.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2007;22:369–376, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"doi.org/10.1002/mds.22551.Smith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Clin Neurol Neurosurg 2009;111:303–306, doi: http://dx.doi.org/10.1016/j.clineuro.2008.10.015.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Clin Neurol Neurosurg 2010;112:149–152, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol Neurosurg Psychiatry 2005;76:989–991, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2002;17:346–353, doi: http://dx.doi.org/10.1002/mds.10038.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2014;29:E3, doi: http://dx.doi.org/10.1002/mds.23783.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2006;105:21–25, doi: http://dx.doi.org/10.3171/jns.2006.105.1.21.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2003;18: 436–442, doi: http://dx.doi.org/10.1002/mds.10380.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Child Neurol 2013;28:1418–1422, doi: http://dx.doi.org/ 10.1177/0883073813488677.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Parkinsonism Relat Disord 2014;20:915–918, doi: http://dx.doi.org/10.1016/j.parkreldis.2014.04.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2011;76:1270–1272, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Stereotact Funct Neurosurg 2010;88:259–263, doi: http://dx.doi.org/10.1159/ 000315464.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2005;102:1137–1141, doi: http://dx.doi.org/ 10.3171/jns.2005.102.6.1137.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2009;24:1697–1698, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2011;115:966–970, doi: http://dx.doi.org/ 10.3171/2011.6.JNS101388.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Ann Neurol 2004;56:290–294, doi: http://dx.doi.org/10.1002/ana.20183.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurosurgery 2006;58:E383; discussion E383, doi: http://dx.doi.org/10.1227/01.NEU.0000195068.19801.18.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2008;109:130–132, doi: http://dx.doi.org/10.3171/ JNS/2008/109/7/0130.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2008;23:1289–1292, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol Neurosurg Psychiatry 2011;82:272–277, doi: http://dx.doi.org/10.1136/jnnp.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"2012;27:806– 7; author reply 807–808, doi: http://dx.doi.org/10.1002/mds.24959.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Deep brain stimulation in disabling involuntary vocalization associated with Huntington’s disease.Parkinsonism Relat Disord 2012;18:803–804, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Fortschr Neurol Psychiatr 2013;81:202–205, doi: http://dx.doi.org/10.1055/s-0033-1335097.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2014;121: 114–122, doi: http://dx.doi.org/10.3171/2014.2.JNS131722.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Cereb Blood Flow Metab 2011;31:41–46, doi: http://dx.doi.org/10.1038/jcbfm.2010.186.Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services13",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2002;59:1982–1984, doi: http://dx.doi.org/10.1212/01.WNL.0000038389.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"PLoS One 2013;8:e79241, doi: http://dx.doi.org/10.1371/journal.pone.0079241.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2007;68:160–161, doi: http://dx.doi.org/10.1212/01.wnl.0000250536.81426.1a.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurol Sci 2012; 33:269–274, doi: http://dx.doi.org/10.1007/s10072-011-0741-y.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2009;24:1546–1547, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"47.Xie T, Awad I, Kang UJ, Warnke P. DBS reduced hemichorea associated with a developmental venous anomaly and microbleeding in STN.Neurology 2014;82:636–637, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2000;92:718–721, doi: http://dx.doi.org/10.3171/jns.2000.92.4.0718.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2003;98: 785–792, doi: http://dx.doi.org/10.3171/jns.2003.98.4.0785.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Dev Med Child Neurol 2001;43:350–353, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Brain Dev 2009;31:452–455, doi: http://dx.doi.org/10.1016/j.braindev.2008.08.003.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2004;19:597–602, doi: http://dx.doi.org/10.1002/mds.10716.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Lancet 1999;353:724, doi: http://dx.doi.org/10.1016/ S0140-6736(98)05964-9.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurosurg Clin N Am 2014;25:117–135, doi: http://dx.doi.org/10.1016/j.nec.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2006;21:1831–1838, doi: http://dx.doi.org/10.1002/mds.21039.56.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2014;29:452–453, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"2007;107:1004–1014, doi: http://dx.doi.org/ 10.3171/JNS-07/11/1004.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Brain 2011; 134:832–844, doi: http://dx.doi.org/10.1093/brain/awq380.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neuromodulation 2010;13:187–194, doi: http://dx.doi.org/10.1111/j.1525-1403.2009.00253.x.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Acta Neurochir (Wien) 2012;154:2029–2041, doi: http://dx.doi.org/10.1007/s00701-012- 1497-8.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2010;25:300–308, doi: http://dx.doi.org/10.1002/mds.22982.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"PLoS One 2012;7:e44215, doi: http://dx.doi.org/10.1371/journal.pone.0044215.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2003;99:1094–1100, doi: http://dx.doi.org/ 10.3171/jns.2003.99.6.1094.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol Neurosurg Psychiatry 2010;81:1068–1072, doi: http://dx.doi.org/10.1136/jnnp.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Eur Child Adolesc Psychiatry 2012;21:529–531, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Deep brain stimulation in Tourette syndrome: A description of 3 patients with excellentSmith KM, Spindler MA Uncommon Applications of DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services14",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mayo Clin Proc 2012;87:59–62, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2007;22:1346–1350, doi: http://dx.doi.org/ 10.1002/mds.21398.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neuromodulation 2011;14:123–8; discussion 129, doi: http://dx.doi.org/ 10.1111/j.1525-1403.2010.00324.x.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Clin Neurosci 2010;17:1343–1344, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Biol Psychiatry 2009;66:e15–7, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol 2013;260:2417–2419, doi: http://dx.doi.org/10.1007/ s00415-013-7049-1.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2011;26:1922–1930, doi: http://dx.doi.org/10.1002/mds.23734.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"2008;23:1300–1302, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2011;26:2440–2441, doi: http://dx.doi.org/10.1002/mds.23892.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"82.Diederich NJ, Kalteis K, Stamenkovic M, Pieri V, Alesch F. Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: A case report.Mov Disord 2005;20:1496–1499, doi: http://dx.doi.org/10.1002/mds.20551.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2006;66:E12, doi: http://dx.doi.org/10.1212/01.wnl.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"0000190258.92496.a4.84.Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities.Neurology 2007;68:159–160, doi: http://dx.doi.org/10.1212/01.wnl.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Am J Psychiatry 2012;169:860–866, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"PLoS One 2014;9: e104926, doi: http://dx.doi.org/10.1371/journal.pone.0104926.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Int Med Res 2012;40:2021–2028, doi: http://dx.doi.org/10.1177/ 030006051204000545.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"World J Biol Psychiatry 2014;15:66–75, doi: http://dx.doi.org/10.3109/15622975.2013.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"2009;40:239–242, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Parkinsonism Relat Disord 2014;20:1022–1023, doi: http://dx.doi.org/10.1016/j.parkreldis.2014.05.009.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"BMC Psychiatry 2014;14:214, doi: http://dx.doi.org/10.1186/s12888-014-0214-y.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol 2007;254:963–965, doi: http://dx.doi.org/10.1007/s00415- 006-0404-8.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Biol Psychiatry 2010;68:e19–20, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Lack of benefit of accumbens/ capsular deep brain stimulation in a patient with both tics and obsessive-Uncommon Applications of DBS Smith KM, Spindler MA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services15",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurocase 2010;16:321–330, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol 2009;256:1533–1539, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Stereotact Funct Neurosurg 2008;86:87–91, doi: http://dx.doi.org/10.1159/000112429.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neuromodulation 2013;16:55–58; discussion 58, doi: http://dx.doi.org/10.1111/j.1525-1403.2012.00526.x.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2009; 72: 1787–1789, doi: http://dx.doi.org/10.1212/WNL.0b013e3181a60a0c.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Arch Neurol 2008;65:952–957, doi: http://dx.doi.org/10.1001/archneur.65.7.952.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neuromodulation 2008;11: 128–131, doi: http://dx.doi.org/10.1111/j.1525-1403.2008.00154.x.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"JAMA Neurol 2013;70:85–94, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurol Neurosurg Psychiatry 2001;70:557–559, doi: http://dx.doi.org/10.1136/ jnnp.70.4.557.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2004;19:969–972, doi: http://dx.doi.org/ 10.1002/mds.20092.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Mov Disord 2004;19:583–585, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurosurgery 2004;55:1361–1368; discussion 1368–1370, doi: http://dx.doi.org/10.1227/01.NEU.0000143331.86101.5E.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2005;102:721–725, doi: http://dx.doi.org/10.3171/jns.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neurology 2005;64:344– 346, doi: http://dx.doi.org/10.1212/01.WNL.0000149762.80932.55.",Non-OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"J Neurosurg 2006;104:488–501, doi: http://dx.doi.org/10.3171/jns.2006.104.4.488.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Parkinsonism Relat Disord 2007;13:541–544, doi: http://dx.doi.org/10.1016/j.parkreldis.2006.11.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
"Neuroscience 2008;152:558–571, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/85/8e/tre-05-278-6406-1.PMC4314611.pdf
